id	sid	tid	token	lemma	pos
ajlm-2846	1	1	abstract	abstract	ADJ
ajlm-2846	1	2	introduction	introduction	NOUN
ajlm-2846	1	3	methods	method	NOUN
ajlm-2846	1	4	results	result	VERB
ajlm-2846	1	5	discussion	discussion	NOUN
ajlm-2846	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2846	1	7	references	reference	NOUN
ajlm-2846	1	8	about	about	ADP
ajlm-2846	1	9	the	the	DET
ajlm-2846	1	10	author(s	author(s	NOUN
ajlm-2846	1	11	)	)	PUNCT
ajlm-2846	1	12	amah	amah	PROPN
ajlm-2846	2	1	p.v	p.v	PROPN
ajlm-2846	2	2	.	.	PROPN
ajlm-2846	2	3	goran	goran	PROPN
ajlm-2846	2	4	-	-	PUNCT
ajlm-2846	2	5	kouacou	kouacou	PROPN
ajlm-2846	2	6	laboratory	laboratory	NOUN
ajlm-2846	2	7	of	of	ADP
ajlm-2846	2	8	immunology	immunology	NOUN
ajlm-2846	2	9	and	and	CCONJ
ajlm-2846	2	10	hematology	hematology	NOUN
ajlm-2846	2	11	,	,	PUNCT
ajlm-2846	2	12	university	university	NOUN
ajlm-2846	2	13	hospital	hospital	NOUN
ajlm-2846	2	14	of	of	ADP
ajlm-2846	2	15	cocody	cocody	PROPN
ajlm-2846	2	16	,	,	PUNCT
ajlm-2846	2	17	abidjan	abidjan	PROPN
ajlm-2846	2	18	,	,	PUNCT
ajlm-2846	2	19	côte	côte	NOUN
ajlm-2846	2	20	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	21	faculty	faculty	NOUN
ajlm-2846	2	22	of	of	ADP
ajlm-2846	2	23	medicine	medicine	NOUN
ajlm-2846	2	24	,	,	PUNCT
ajlm-2846	2	25	félix	félix	ADJ
ajlm-2846	2	26	houphouët	houphouët	PROPN
ajlm-2846	2	27	-	-	PUNCT
ajlm-2846	2	28	boigny	boigny	PROPN
ajlm-2846	2	29	university	university	PROPN
ajlm-2846	2	30	,	,	PUNCT
ajlm-2846	2	31	abidjan	abidjan	PROPN
ajlm-2846	2	32	,	,	PUNCT
ajlm-2846	2	33	côte	côte	PROPN
ajlm-2846	2	34	d’ivoire	d’ivoire	VERB
ajlm-2846	2	35	oppong	oppong	PROPN
ajlm-2846	2	36	r.	r.	PROPN
ajlm-2846	2	37	yéboah	yéboah	PROPN
ajlm-2846	2	38	laboratory	laboratory	PROPN
ajlm-2846	2	39	of	of	ADP
ajlm-2846	2	40	immunology	immunology	NOUN
ajlm-2846	2	41	and	and	CCONJ
ajlm-2846	2	42	hematology	hematology	NOUN
ajlm-2846	2	43	,	,	PUNCT
ajlm-2846	2	44	university	university	NOUN
ajlm-2846	2	45	hospital	hospital	NOUN
ajlm-2846	2	46	of	of	ADP
ajlm-2846	2	47	cocody	cocody	PROPN
ajlm-2846	2	48	,	,	PUNCT
ajlm-2846	2	49	abidjan	abidjan	PROPN
ajlm-2846	2	50	,	,	PUNCT
ajlm-2846	2	51	côte	côte	NOUN
ajlm-2846	2	52	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	53	faculty	faculty	NOUN
ajlm-2846	2	54	of	of	ADP
ajlm-2846	2	55	medicine	medicine	NOUN
ajlm-2846	2	56	,	,	PUNCT
ajlm-2846	2	57	félix	félix	ADJ
ajlm-2846	2	58	houphouët	houphouët	PROPN
ajlm-2846	2	59	-	-	PUNCT
ajlm-2846	2	60	boigny	boigny	PROPN
ajlm-2846	2	61	university	university	PROPN
ajlm-2846	2	62	,	,	PUNCT
ajlm-2846	2	63	abidjan	abidjan	PROPN
ajlm-2846	2	64	,	,	PUNCT
ajlm-2846	2	65	côte	côte	PROPN
ajlm-2846	2	66	d’ivoire	d’ivoire	PROPN
ajlm-2846	2	67	aya	aya	PROPN
ajlm-2846	2	68	u.a	u.a	PROPN
ajlm-2846	2	69	.	.	PROPN
ajlm-2846	2	70	assi	assi	PROPN
ajlm-2846	2	71	laboratory	laboratory	NOUN
ajlm-2846	2	72	of	of	ADP
ajlm-2846	2	73	immunology	immunology	NOUN
ajlm-2846	2	74	and	and	CCONJ
ajlm-2846	2	75	hematology	hematology	NOUN
ajlm-2846	2	76	,	,	PUNCT
ajlm-2846	2	77	university	university	NOUN
ajlm-2846	2	78	hospital	hospital	NOUN
ajlm-2846	2	79	of	of	ADP
ajlm-2846	2	80	cocody	cocody	PROPN
ajlm-2846	2	81	,	,	PUNCT
ajlm-2846	2	82	abidjan	abidjan	PROPN
ajlm-2846	2	83	,	,	PUNCT
ajlm-2846	2	84	côte	côte	NOUN
ajlm-2846	2	85	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	86	faculty	faculty	NOUN
ajlm-2846	2	87	of	of	ADP
ajlm-2846	2	88	medicine	medicine	NOUN
ajlm-2846	2	89	,	,	PUNCT
ajlm-2846	2	90	félix	félix	ADJ
ajlm-2846	2	91	houphouët	houphouët	PROPN
ajlm-2846	2	92	-	-	PUNCT
ajlm-2846	2	93	boigny	boigny	PROPN
ajlm-2846	2	94	university	university	PROPN
ajlm-2846	2	95	,	,	PUNCT
ajlm-2846	2	96	abidjan	abidjan	PROPN
ajlm-2846	2	97	,	,	PUNCT
ajlm-2846	2	98	côte	côte	PROPN
ajlm-2846	2	99	d’ivoire	d’ivoire	PROPN
ajlm-2846	2	100	yida	yida	PROPN
ajlm-2846	2	101	j.	j.	PROPN
ajlm-2846	2	102	séri	séri	PROPN
ajlm-2846	2	103	laboratory	laboratory	PROPN
ajlm-2846	2	104	of	of	ADP
ajlm-2846	2	105	immunology	immunology	NOUN
ajlm-2846	2	106	and	and	CCONJ
ajlm-2846	2	107	hematology	hematology	NOUN
ajlm-2846	2	108	,	,	PUNCT
ajlm-2846	2	109	university	university	NOUN
ajlm-2846	2	110	hospital	hospital	NOUN
ajlm-2846	2	111	of	of	ADP
ajlm-2846	2	112	cocody	cocody	PROPN
ajlm-2846	2	113	,	,	PUNCT
ajlm-2846	2	114	abidjan	abidjan	PROPN
ajlm-2846	2	115	,	,	PUNCT
ajlm-2846	2	116	côte	côte	NOUN
ajlm-2846	2	117	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	118	faculty	faculty	NOUN
ajlm-2846	2	119	of	of	ADP
ajlm-2846	2	120	medicine	medicine	NOUN
ajlm-2846	2	121	,	,	PUNCT
ajlm-2846	2	122	félix	félix	ADJ
ajlm-2846	2	123	houphouët	houphouët	PROPN
ajlm-2846	2	124	-	-	PUNCT
ajlm-2846	2	125	boigny	boigny	PROPN
ajlm-2846	2	126	university	university	PROPN
ajlm-2846	2	127	,	,	PUNCT
ajlm-2846	2	128	abidjan	abidjan	PROPN
ajlm-2846	2	129	,	,	PUNCT
ajlm-2846	2	130	côte	côte	PROPN
ajlm-2846	2	131	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	132	séry	séry	NOUN
ajlm-2846	2	133	r.	r.	PROPN
ajlm-2846	2	134	dassé	dassé	PROPN
ajlm-2846	2	135	laboratory	laboratory	NOUN
ajlm-2846	2	136	of	of	ADP
ajlm-2846	2	137	immunology	immunology	NOUN
ajlm-2846	2	138	and	and	CCONJ
ajlm-2846	2	139	hematology	hematology	NOUN
ajlm-2846	2	140	,	,	PUNCT
ajlm-2846	2	141	university	university	NOUN
ajlm-2846	2	142	hospital	hospital	NOUN
ajlm-2846	2	143	of	of	ADP
ajlm-2846	2	144	cocody	cocody	PROPN
ajlm-2846	2	145	,	,	PUNCT
ajlm-2846	2	146	abidjan	abidjan	PROPN
ajlm-2846	2	147	,	,	PUNCT
ajlm-2846	2	148	côte	côte	NOUN
ajlm-2846	2	149	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	150	faculty	faculty	NOUN
ajlm-2846	2	151	of	of	ADP
ajlm-2846	2	152	medicine	medicine	NOUN
ajlm-2846	2	153	,	,	PUNCT
ajlm-2846	2	154	félix	félix	ADJ
ajlm-2846	2	155	houphouët	houphouët	PROPN
ajlm-2846	2	156	-	-	PUNCT
ajlm-2846	2	157	boigny	boigny	PROPN
ajlm-2846	2	158	university	university	PROPN
ajlm-2846	2	159	,	,	PUNCT
ajlm-2846	2	160	abidjan	abidjan	PROPN
ajlm-2846	2	161	,	,	PUNCT
ajlm-2846	2	162	côte	côte	PROPN
ajlm-2846	2	163	d’ivoire	d’ivoire	NOUN
ajlm-2846	2	164	citation	citation	NOUN
ajlm-2846	2	165	goran	goran	NOUN
ajlm-2846	2	166	-	-	PUNCT
ajlm-2846	2	167	kouacou	kouacou	PROPN
ajlm-2846	2	168	apv	apv	PROPN
ajlm-2846	2	169	,	,	PUNCT
ajlm-2846	2	170	yéboah	yéboah	NOUN
ajlm-2846	2	171	or	or	CCONJ
ajlm-2846	2	172	,	,	PUNCT
ajlm-2846	2	173	assi	assi	PROPN
ajlm-2846	2	174	aua	aua	PROPN
ajlm-2846	2	175	,	,	PUNCT
ajlm-2846	2	176	séri	séri	PROPN
ajlm-2846	2	177	yj	yj	PROPN
ajlm-2846	2	178	,	,	PUNCT
ajlm-2846	2	179	dassé	dassé	PROPN
ajlm-2846	2	180	sr	sr	PROPN
ajlm-2846	2	181	.	.	PUNCT
ajlm-2846	3	1	antenatal	antenatal	ADJ
ajlm-2846	3	2	toxoplasma	toxoplasma	PROPN
ajlm-2846	3	3	gondii	gondii	VERB
ajlm-2846	3	4	igg	igg	PROPN
ajlm-2846	3	5	/	/	SYM
ajlm-2846	3	6	igm	igm	PROPN
ajlm-2846	3	7	seroprevalence	seroprevalence	NOUN
ajlm-2846	3	8	at	at	ADP
ajlm-2846	3	9	the	the	DET
ajlm-2846	3	10	university	university	NOUN
ajlm-2846	3	11	hospital	hospital	NOUN
ajlm-2846	3	12	of	of	ADP
ajlm-2846	3	13	cocody	cocody	NOUN
ajlm-2846	3	14	.	.	PUNCT
ajlm-2846	4	1	afr	afr	PROPN
ajlm-2846	4	2	j	j	PROPN
ajlm-2846	4	3	lab	lab	PROPN
ajlm-2846	4	4	med	med	PROPN
ajlm-2846	4	5	.	.	PUNCT
ajlm-2846	5	1	2025;14(1	2025;14(1	NUM
ajlm-2846	5	2	)	)	PUNCT
ajlm-2846	5	3	,	,	PUNCT
ajlm-2846	5	4	a2846	a2846	PROPN
ajlm-2846	5	5	.	.	PROPN
ajlm-2846	5	6	https://doi.org/10.4102/ajlm.v14i1.2846	https://doi.org/10.4102/ajlm.v14i1.2846	PROPN
ajlm-2846	5	7	original	original	ADJ
ajlm-2846	5	8	research	research	NOUN
ajlm-2846	5	9	antenatal	antenatal	NOUN
ajlm-2846	5	10	toxoplasma	toxoplasma	NOUN
ajlm-2846	5	11	gondii	gondii	VERB
ajlm-2846	5	12	igg	igg	PROPN
ajlm-2846	5	13	/	/	SYM
ajlm-2846	5	14	igm	igm	PROPN
ajlm-2846	5	15	seroprevalence	seroprevalence	NOUN
ajlm-2846	5	16	at	at	ADP
ajlm-2846	5	17	the	the	DET
ajlm-2846	5	18	university	university	NOUN
ajlm-2846	5	19	hospital	hospital	NOUN
ajlm-2846	5	20	of	of	ADP
ajlm-2846	5	21	cocody	cocody	PROPN
ajlm-2846	5	22	amah	amah	PROPN
ajlm-2846	5	23	p.v	p.v	PROPN
ajlm-2846	5	24	.	.	PROPN
ajlm-2846	5	25	goran	goran	PROPN
ajlm-2846	5	26	-	-	PUNCT
ajlm-2846	5	27	kouacou	kouacou	PROPN
ajlm-2846	5	28	,	,	PUNCT
ajlm-2846	5	29	oppong	oppong	PROPN
ajlm-2846	5	30	r.	r.	PROPN
ajlm-2846	5	31	yéboah	yéboah	PROPN
ajlm-2846	5	32	,	,	PUNCT
ajlm-2846	5	33	aya	aya	PROPN
ajlm-2846	5	34	u.a	u.a	PROPN
ajlm-2846	5	35	.	.	PROPN
ajlm-2846	5	36	assi	assi	PROPN
ajlm-2846	5	37	,	,	PUNCT
ajlm-2846	5	38	yida	yida	PROPN
ajlm-2846	5	39	j.	j.	PROPN
ajlm-2846	5	40	séri	séri	PROPN
ajlm-2846	5	41	,	,	PUNCT
ajlm-2846	6	1	séry	séry	PROPN
ajlm-2846	6	2	r.	r.	PROPN
ajlm-2846	6	3	dassé	dassé	PROPN
ajlm-2846	6	4	received	receive	VERB
ajlm-2846	6	5	:	:	PUNCT
ajlm-2846	6	6	25	25	NUM
ajlm-2846	6	7	apr	apr	NOUN
ajlm-2846	6	8	.	.	PUNCT
ajlm-2846	6	9	2025	2025	NUM
ajlm-2846	6	10	;	;	PUNCT
ajlm-2846	6	11	accepted	accept	VERB
ajlm-2846	6	12	:	:	PUNCT
ajlm-2846	6	13	25	25	NUM
ajlm-2846	6	14	aug	aug	PROPN
ajlm-2846	6	15	.	.	PROPN
ajlm-2846	6	16	2025	2025	NUM
ajlm-2846	6	17	;	;	PUNCT
ajlm-2846	6	18	published	publish	VERB
ajlm-2846	6	19	:	:	PUNCT
ajlm-2846	6	20	16	16	NUM
ajlm-2846	6	21	dec	dec	PROPN
ajlm-2846	6	22	.	.	PROPN
ajlm-2846	7	1	2025	2025	NUM
ajlm-2846	7	2	copyright	copyright	NOUN
ajlm-2846	7	3	:	:	PUNCT
ajlm-2846	7	4	©	©	PROPN
ajlm-2846	7	5	2025	2025	NUM
ajlm-2846	7	6	.	.	PUNCT
ajlm-2846	8	1	the	the	DET
ajlm-2846	8	2	author(s	author(s	PROPN
ajlm-2846	8	3	)	)	PUNCT
ajlm-2846	8	4	.	.	PUNCT
ajlm-2846	9	1	licensee	licensee	NOUN
ajlm-2846	9	2	:	:	PUNCT
ajlm-2846	9	3	aosis	aosis	NOUN
ajlm-2846	9	4	.	.	PUNCT
ajlm-2846	10	1	this	this	DET
ajlm-2846	10	2	work	work	NOUN
ajlm-2846	10	3	is	be	AUX
ajlm-2846	10	4	licensed	license	VERB
ajlm-2846	10	5	under	under	ADP
ajlm-2846	10	6	the	the	DET
ajlm-2846	10	7	creative	creative	ADJ
ajlm-2846	10	8	commons	common	NOUN
ajlm-2846	10	9	attribution	attribution	NOUN
ajlm-2846	10	10	4.0	4.0	NUM
ajlm-2846	10	11	international	international	NOUN
ajlm-2846	10	12	(	(	PUNCT
ajlm-2846	10	13	cc	cc	NOUN
ajlm-2846	10	14	by	by	ADP
ajlm-2846	10	15	4.0	4.0	NUM
ajlm-2846	10	16	)	)	PUNCT
ajlm-2846	10	17	license	license	NOUN
ajlm-2846	10	18	(	(	PUNCT
ajlm-2846	10	19	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ajlm-2846	10	20	)	)	PUNCT
ajlm-2846	10	21	.	.	PUNCT
ajlm-2846	11	1	abstract	abstract	ADJ
ajlm-2846	11	2	background	background	NOUN
ajlm-2846	11	3	:	:	PUNCT
ajlm-2846	11	4	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	11	5	is	be	AUX
ajlm-2846	11	6	a	a	DET
ajlm-2846	11	7	parasitic	parasitic	ADJ
ajlm-2846	11	8	zoonosis	zoonosis	NOUN
ajlm-2846	11	9	of	of	ADP
ajlm-2846	11	10	major	major	ADJ
ajlm-2846	11	11	importance	importance	NOUN
ajlm-2846	11	12	,	,	PUNCT
ajlm-2846	11	13	particularly	particularly	ADV
ajlm-2846	11	14	during	during	ADP
ajlm-2846	11	15	pregnancy	pregnancy	NOUN
ajlm-2846	11	16	because	because	SCONJ
ajlm-2846	11	17	of	of	ADP
ajlm-2846	11	18	the	the	DET
ajlm-2846	11	19	risk	risk	NOUN
ajlm-2846	11	20	of	of	ADP
ajlm-2846	11	21	maternal	maternal	ADJ
ajlm-2846	11	22	–	–	PUNCT
ajlm-2846	11	23	foetal	foetal	ADJ
ajlm-2846	11	24	transmission	transmission	NOUN
ajlm-2846	11	25	.	.	PUNCT
ajlm-2846	12	1	objective	objective	NOUN
ajlm-2846	12	2	:	:	PUNCT
ajlm-2846	12	3	the	the	DET
ajlm-2846	12	4	aim	aim	NOUN
ajlm-2846	12	5	of	of	ADP
ajlm-2846	12	6	the	the	DET
ajlm-2846	12	7	study	study	NOUN
ajlm-2846	12	8	was	be	AUX
ajlm-2846	12	9	to	to	PART
ajlm-2846	12	10	estimate	estimate	VERB
ajlm-2846	12	11	the	the	DET
ajlm-2846	12	12	seroprevalence	seroprevalence	NOUN
ajlm-2846	12	13	of	of	ADP
ajlm-2846	12	14	toxoplasma	toxoplasma	NOUN
ajlm-2846	12	15	gondii	gondii	NOUN
ajlm-2846	12	16	in	in	ADP
ajlm-2846	12	17	pregnant	pregnant	ADJ
ajlm-2846	12	18	women	woman	NOUN
ajlm-2846	12	19	at	at	ADP
ajlm-2846	12	20	the	the	DET
ajlm-2846	12	21	university	university	NOUN
ajlm-2846	12	22	hospital	hospital	NOUN
ajlm-2846	12	23	of	of	ADP
ajlm-2846	12	24	cocody	cocody	NOUN
ajlm-2846	12	25	and	and	CCONJ
ajlm-2846	12	26	to	to	PART
ajlm-2846	12	27	describe	describe	VERB
ajlm-2846	12	28	igg	igg	PROPN
ajlm-2846	12	29	/	/	SYM
ajlm-2846	12	30	igm	igm	PROPN
ajlm-2846	12	31	serological	serological	ADJ
ajlm-2846	12	32	profiles	profile	NOUN
ajlm-2846	12	33	.	.	PUNCT
ajlm-2846	13	1	methods	method	NOUN
ajlm-2846	13	2	:	:	PUNCT
ajlm-2846	13	3	we	we	PRON
ajlm-2846	13	4	conducted	conduct	VERB
ajlm-2846	13	5	a	a	DET
ajlm-2846	13	6	retrospective	retrospective	ADJ
ajlm-2846	13	7	cross	cross	ADJ
ajlm-2846	13	8	-	-	ADJ
ajlm-2846	13	9	sectional	sectional	ADJ
ajlm-2846	13	10	study	study	NOUN
ajlm-2846	13	11	from	from	ADP
ajlm-2846	13	12	april	april	PROPN
ajlm-2846	13	13	2022	2022	NUM
ajlm-2846	13	14	to	to	ADP
ajlm-2846	13	15	march	march	PROPN
ajlm-2846	13	16	2023	2023	NUM
ajlm-2846	13	17	at	at	ADP
ajlm-2846	13	18	the	the	DET
ajlm-2846	13	19	immunology	immunology	NOUN
ajlm-2846	13	20	laboratory	laboratory	NOUN
ajlm-2846	13	21	of	of	ADP
ajlm-2846	13	22	the	the	DET
ajlm-2846	13	23	university	university	NOUN
ajlm-2846	13	24	hospital	hospital	NOUN
ajlm-2846	13	25	of	of	ADP
ajlm-2846	13	26	cocody	cocody	NOUN
ajlm-2846	13	27	.	.	PUNCT
ajlm-2846	14	1	toxoplasma	toxoplasma	NOUN
ajlm-2846	14	2	gondii	gondii	NOUN
ajlm-2846	14	3	-	-	PUNCT
ajlm-2846	14	4	specific	specific	ADJ
ajlm-2846	14	5	igg	igg	NOUN
ajlm-2846	14	6	and	and	CCONJ
ajlm-2846	14	7	igm	igm	PROPN
ajlm-2846	14	8	antibodies	antibody	NOUN
ajlm-2846	14	9	were	be	AUX
ajlm-2846	14	10	measured	measure	VERB
ajlm-2846	14	11	by	by	ADP
ajlm-2846	14	12	electrochemiluminescence	electrochemiluminescence	NOUN
ajlm-2846	14	13	immunoassay	immunoassay	PROPN
ajlm-2846	14	14	and	and	CCONJ
ajlm-2846	14	15	then	then	ADV
ajlm-2846	14	16	interpreted	interpret	VERB
ajlm-2846	14	17	according	accord	VERB
ajlm-2846	14	18	to	to	ADP
ajlm-2846	14	19	serological	serological	ADJ
ajlm-2846	14	20	profiles	profile	NOUN
ajlm-2846	14	21	.	.	PUNCT
ajlm-2846	15	1	chi	chi	ADJ
ajlm-2846	15	2	-	-	PUNCT
ajlm-2846	15	3	square	square	PROPN
ajlm-2846	15	4	test	test	NOUN
ajlm-2846	15	5	was	be	AUX
ajlm-2846	15	6	used	use	VERB
ajlm-2846	15	7	to	to	PART
ajlm-2846	15	8	assess	assess	VERB
ajlm-2846	15	9	the	the	DET
ajlm-2846	15	10	association	association	NOUN
ajlm-2846	15	11	between	between	ADP
ajlm-2846	15	12	igm	igm	PROPN
ajlm-2846	15	13	positivity	positivity	NOUN
ajlm-2846	15	14	and	and	CCONJ
ajlm-2846	15	15	pregnancy	pregnancy	NOUN
ajlm-2846	15	16	trimester	trimester	NOUN
ajlm-2846	15	17	.	.	PUNCT
ajlm-2846	16	1	results	result	NOUN
ajlm-2846	16	2	:	:	PUNCT
ajlm-2846	16	3	out	out	ADP
ajlm-2846	16	4	of	of	ADP
ajlm-2846	16	5	200	200	NUM
ajlm-2846	16	6	pregnant	pregnant	ADJ
ajlm-2846	16	7	women	woman	NOUN
ajlm-2846	16	8	,	,	PUNCT
ajlm-2846	16	9	previous	previous	ADJ
ajlm-2846	16	10	infection	infection	NOUN
ajlm-2846	16	11	was	be	AUX
ajlm-2846	16	12	observed	observe	VERB
ajlm-2846	16	13	in	in	ADP
ajlm-2846	16	14	45.0	45.0	NUM
ajlm-2846	16	15	%	%	NOUN
ajlm-2846	16	16	(	(	PUNCT
ajlm-2846	16	17	igg+/igm−	igg+/igm−	PROPN
ajlm-2846	16	18	)	)	PUNCT
ajlm-2846	16	19	,	,	PUNCT
ajlm-2846	16	20	current	current	ADJ
ajlm-2846	16	21	infection	infection	NOUN
ajlm-2846	16	22	in	in	ADP
ajlm-2846	16	23	4.0	4.0	NUM
ajlm-2846	16	24	%	%	NOUN
ajlm-2846	16	25	(	(	PUNCT
ajlm-2846	16	26	igg+/igm+	igg+/igm+	PROPN
ajlm-2846	16	27	)	)	PUNCT
ajlm-2846	16	28	,	,	PUNCT
ajlm-2846	16	29	recent	recent	ADJ
ajlm-2846	16	30	infection	infection	NOUN
ajlm-2846	16	31	in	in	ADP
ajlm-2846	16	32	5.5	5.5	NUM
ajlm-2846	16	33	%	%	NOUN
ajlm-2846	16	34	(	(	PUNCT
ajlm-2846	16	35	igg−/igm+	igg−/igm+	PROPN
ajlm-2846	16	36	)	)	PUNCT
ajlm-2846	16	37	,	,	PUNCT
ajlm-2846	16	38	and	and	CCONJ
ajlm-2846	16	39	no	no	DET
ajlm-2846	16	40	infection	infection	NOUN
ajlm-2846	16	41	in	in	ADP
ajlm-2846	16	42	45.5	45.5	NUM
ajlm-2846	16	43	%	%	NOUN
ajlm-2846	16	44	(	(	PUNCT
ajlm-2846	16	45	igg−/igm−	igg−/igm−	PROPN
ajlm-2846	16	46	)	)	PUNCT
ajlm-2846	16	47	.	.	PUNCT
ajlm-2846	17	1	of	of	ADP
ajlm-2846	17	2	the	the	DET
ajlm-2846	17	3	women	woman	NOUN
ajlm-2846	17	4	,	,	PUNCT
ajlm-2846	17	5	83	83	NUM
ajlm-2846	17	6	%	%	NOUN
ajlm-2846	17	7	were	be	AUX
ajlm-2846	17	8	tested	test	VERB
ajlm-2846	17	9	after	after	ADP
ajlm-2846	17	10	the	the	DET
ajlm-2846	17	11	first	first	ADJ
ajlm-2846	17	12	trimester	trimester	NOUN
ajlm-2846	17	13	.	.	PUNCT
ajlm-2846	18	1	the	the	DET
ajlm-2846	18	2	proportion	proportion	NOUN
ajlm-2846	18	3	of	of	ADP
ajlm-2846	18	4	recent	recent	ADJ
ajlm-2846	18	5	infections	infection	NOUN
ajlm-2846	18	6	(	(	PUNCT
ajlm-2846	18	7	igm+	igm+	PROPN
ajlm-2846	18	8	)	)	PUNCT
ajlm-2846	18	9	was	be	AUX
ajlm-2846	18	10	higher	high	ADJ
ajlm-2846	18	11	in	in	ADP
ajlm-2846	18	12	the	the	DET
ajlm-2846	18	13	first	first	ADJ
ajlm-2846	18	14	trimester	trimester	NOUN
ajlm-2846	18	15	(	(	PUNCT
ajlm-2846	18	16	17.6	17.6	NUM
ajlm-2846	18	17	%	%	NOUN
ajlm-2846	18	18	)	)	PUNCT
ajlm-2846	18	19	than	than	ADP
ajlm-2846	18	20	in	in	ADP
ajlm-2846	18	21	the	the	DET
ajlm-2846	18	22	second	second	ADJ
ajlm-2846	18	23	(	(	PUNCT
ajlm-2846	18	24	8.2	8.2	NUM
ajlm-2846	18	25	%	%	NOUN
ajlm-2846	18	26	)	)	PUNCT
ajlm-2846	18	27	and	and	CCONJ
ajlm-2846	18	28	third	third	ADV
ajlm-2846	18	29	(	(	PUNCT
ajlm-2846	18	30	7.4	7.4	NUM
ajlm-2846	18	31	%	%	NOUN
ajlm-2846	18	32	)	)	PUNCT
ajlm-2846	18	33	trimesters	trimester	NOUN
ajlm-2846	18	34	,	,	PUNCT
ajlm-2846	18	35	with	with	ADP
ajlm-2846	18	36	no	no	DET
ajlm-2846	18	37	statistically	statistically	ADV
ajlm-2846	18	38	significant	significant	ADJ
ajlm-2846	18	39	difference	difference	NOUN
ajlm-2846	18	40	(	(	PUNCT
ajlm-2846	18	41	p	p	NOUN
ajlm-2846	18	42	=	=	NOUN
ajlm-2846	18	43	0.22	0.22	NUM
ajlm-2846	18	44	)	)	PUNCT
ajlm-2846	18	45	.	.	PUNCT
ajlm-2846	19	1	conclusion	conclusion	NOUN
ajlm-2846	19	2	:	:	PUNCT
ajlm-2846	19	3	the	the	DET
ajlm-2846	19	4	seroprevalence	seroprevalence	NOUN
ajlm-2846	19	5	of	of	ADP
ajlm-2846	19	6	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	19	7	remains	remain	VERB
ajlm-2846	19	8	high	high	ADJ
ajlm-2846	19	9	,	,	PUNCT
ajlm-2846	19	10	with	with	ADP
ajlm-2846	19	11	a	a	DET
ajlm-2846	19	12	non	non	ADJ
ajlm-2846	19	13	-	-	ADJ
ajlm-2846	19	14	negligible	negligible	ADJ
ajlm-2846	19	15	proportion	proportion	NOUN
ajlm-2846	19	16	of	of	ADP
ajlm-2846	19	17	women	woman	NOUN
ajlm-2846	19	18	presenting	present	VERB
ajlm-2846	19	19	recent	recent	ADJ
ajlm-2846	19	20	or	or	CCONJ
ajlm-2846	19	21	current	current	ADJ
ajlm-2846	19	22	infection	infection	NOUN
ajlm-2846	19	23	.	.	PUNCT
ajlm-2846	20	1	late	late	ADJ
ajlm-2846	20	2	initiation	initiation	NOUN
ajlm-2846	20	3	of	of	ADP
ajlm-2846	20	4	screening	screen	VERB
ajlm-2846	20	5	highlights	highlight	NOUN
ajlm-2846	20	6	the	the	DET
ajlm-2846	20	7	need	need	NOUN
ajlm-2846	20	8	for	for	ADP
ajlm-2846	20	9	strengthened	strengthen	VERB
ajlm-2846	20	10	strategies	strategy	NOUN
ajlm-2846	20	11	,	,	PUNCT
ajlm-2846	20	12	including	include	VERB
ajlm-2846	20	13	early	early	ADJ
ajlm-2846	20	14	screening	screening	NOUN
ajlm-2846	20	15	,	,	PUNCT
ajlm-2846	20	16	targeted	target	VERB
ajlm-2846	20	17	antenatal	antenatal	ADJ
ajlm-2846	20	18	education	education	NOUN
ajlm-2846	20	19	and	and	CCONJ
ajlm-2846	20	20	better	well	ADJ
ajlm-2846	20	21	access	access	NOUN
ajlm-2846	20	22	to	to	ADP
ajlm-2846	20	23	diagnostic	diagnostic	ADJ
ajlm-2846	20	24	tools	tool	NOUN
ajlm-2846	20	25	to	to	PART
ajlm-2846	20	26	reduce	reduce	VERB
ajlm-2846	20	27	the	the	DET
ajlm-2846	20	28	risk	risk	NOUN
ajlm-2846	20	29	of	of	ADP
ajlm-2846	20	30	transmission	transmission	NOUN
ajlm-2846	20	31	.	.	PUNCT
ajlm-2846	21	1	what	what	PRON
ajlm-2846	21	2	this	this	DET
ajlm-2846	21	3	study	study	NOUN
ajlm-2846	21	4	adds	add	VERB
ajlm-2846	21	5	:	:	PUNCT
ajlm-2846	21	6	this	this	DET
ajlm-2846	21	7	study	study	NOUN
ajlm-2846	21	8	provides	provide	VERB
ajlm-2846	21	9	updated	update	VERB
ajlm-2846	21	10	data	datum	NOUN
ajlm-2846	21	11	on	on	ADP
ajlm-2846	21	12	the	the	DET
ajlm-2846	21	13	seroprevalence	seroprevalence	NOUN
ajlm-2846	21	14	of	of	ADP
ajlm-2846	21	15	gestational	gestational	ADJ
ajlm-2846	21	16	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	21	17	in	in	ADP
ajlm-2846	21	18	côte	côte	PROPN
ajlm-2846	21	19	d’ivoire	d’ivoire	PROPN
ajlm-2846	21	20	.	.	PUNCT
ajlm-2846	22	1	thus	thus	ADV
ajlm-2846	22	2	,	,	PUNCT
ajlm-2846	22	3	it	it	PRON
ajlm-2846	22	4	reinforces	reinforce	VERB
ajlm-2846	22	5	the	the	DET
ajlm-2846	22	6	need	need	NOUN
ajlm-2846	22	7	for	for	ADP
ajlm-2846	22	8	early	early	ADJ
ajlm-2846	22	9	screening	screening	NOUN
ajlm-2846	22	10	and	and	CCONJ
ajlm-2846	22	11	targeted	target	VERB
ajlm-2846	22	12	health	health	NOUN
ajlm-2846	22	13	awareness	awareness	NOUN
ajlm-2846	22	14	campaigns	campaign	NOUN
ajlm-2846	22	15	.	.	PUNCT
ajlm-2846	23	1	keywords	keyword	NOUN
ajlm-2846	23	2	:	:	PUNCT
ajlm-2846	23	3	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	23	4	;	;	PUNCT
ajlm-2846	23	5	pregnancy	pregnancy	NOUN
ajlm-2846	23	6	;	;	PUNCT
ajlm-2846	23	7	seroprevalence	seroprevalence	NOUN
ajlm-2846	23	8	;	;	PUNCT
ajlm-2846	23	9	antenatal	antenatal	ADJ
ajlm-2846	23	10	screening	screening	NOUN
ajlm-2846	23	11	;	;	PUNCT
ajlm-2846	23	12	immunodiagnosis	immunodiagnosis	NOUN
ajlm-2846	23	13	;	;	PUNCT
ajlm-2846	23	14	maternal	maternal	ADJ
ajlm-2846	23	15	–	–	PUNCT
ajlm-2846	23	16	foetal	foetal	ADJ
ajlm-2846	23	17	transmission	transmission	NOUN
ajlm-2846	23	18	;	;	PUNCT
ajlm-2846	23	19	côte	côte	PROPN
ajlm-2846	23	20	d’ivoire	d’ivoire	PROPN
ajlm-2846	23	21	.	.	PUNCT
ajlm-2846	24	1	introduction	introduction	NOUN
ajlm-2846	24	2	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	24	3	is	be	AUX
ajlm-2846	24	4	a	a	DET
ajlm-2846	24	5	common	common	ADJ
ajlm-2846	24	6	zoonotic	zoonotic	ADJ
ajlm-2846	24	7	infection	infection	NOUN
ajlm-2846	24	8	caused	cause	VERB
ajlm-2846	24	9	by	by	ADP
ajlm-2846	24	10	the	the	DET
ajlm-2846	24	11	protozoan	protozoan	NOUN
ajlm-2846	24	12	toxoplasma	toxoplasma	NOUN
ajlm-2846	24	13	gondii	gondii	NOUN
ajlm-2846	24	14	.	.	PUNCT
ajlm-2846	25	1	humans	human	NOUN
ajlm-2846	25	2	are	be	AUX
ajlm-2846	25	3	typically	typically	ADV
ajlm-2846	25	4	infected	infect	VERB
ajlm-2846	25	5	by	by	ADP
ajlm-2846	25	6	ingesting	ingest	VERB
ajlm-2846	25	7	oocysts	oocyst	NOUN
ajlm-2846	25	8	that	that	PRON
ajlm-2846	25	9	contaminate	contaminate	VERB
ajlm-2846	25	10	water	water	NOUN
ajlm-2846	25	11	or	or	CCONJ
ajlm-2846	25	12	food	food	NOUN
ajlm-2846	25	13	,	,	PUNCT
ajlm-2846	25	14	or	or	CCONJ
ajlm-2846	25	15	by	by	ADP
ajlm-2846	25	16	eating	eat	VERB
ajlm-2846	25	17	undercooked	undercooked	ADJ
ajlm-2846	25	18	meat	meat	NOUN
ajlm-2846	25	19	that	that	PRON
ajlm-2846	25	20	contains	contain	VERB
ajlm-2846	25	21	tissue	tissue	NOUN
ajlm-2846	25	22	cysts.1,2	cysts.1,2	NOUN
ajlm-2846	25	23	in	in	ADP
ajlm-2846	25	24	immunocompetent	immunocompetent	ADJ
ajlm-2846	25	25	individuals	individual	NOUN
ajlm-2846	25	26	,	,	PUNCT
ajlm-2846	25	27	the	the	DET
ajlm-2846	25	28	infection	infection	NOUN
ajlm-2846	25	29	is	be	AUX
ajlm-2846	25	30	often	often	ADV
ajlm-2846	25	31	asymptomatic	asymptomatic	ADJ
ajlm-2846	25	32	,	,	PUNCT
ajlm-2846	25	33	but	but	CCONJ
ajlm-2846	25	34	it	it	PRON
ajlm-2846	25	35	can	can	AUX
ajlm-2846	25	36	cause	cause	VERB
ajlm-2846	25	37	serious	serious	ADJ
ajlm-2846	25	38	disease	disease	NOUN
ajlm-2846	25	39	in	in	ADP
ajlm-2846	25	40	immunocompromised	immunocompromise	VERB
ajlm-2846	25	41	people	people	NOUN
ajlm-2846	25	42	and	and	CCONJ
ajlm-2846	25	43	during	during	ADP
ajlm-2846	25	44	pregnancy.3,4	pregnancy.3,4	ADJ
ajlm-2846	25	45	primary	primary	ADJ
ajlm-2846	25	46	maternal	maternal	ADJ
ajlm-2846	25	47	infection	infection	NOUN
ajlm-2846	25	48	exposes	expose	VERB
ajlm-2846	25	49	the	the	DET
ajlm-2846	25	50	foetus	foetus	NOUN
ajlm-2846	25	51	to	to	ADP
ajlm-2846	25	52	vertical	vertical	VERB
ajlm-2846	25	53	(	(	PUNCT
ajlm-2846	25	54	maternal	maternal	ADJ
ajlm-2846	25	55	–	–	PUNCT
ajlm-2846	25	56	foetal	foetal	ADJ
ajlm-2846	25	57	)	)	PUNCT
ajlm-2846	25	58	transmission	transmission	NOUN
ajlm-2846	25	59	,	,	PUNCT
ajlm-2846	25	60	and	and	CCONJ
ajlm-2846	25	61	may	may	AUX
ajlm-2846	25	62	lead	lead	VERB
ajlm-2846	25	63	to	to	ADP
ajlm-2846	25	64	severe	severe	ADJ
ajlm-2846	25	65	complications	complication	NOUN
ajlm-2846	25	66	,	,	PUNCT
ajlm-2846	25	67	including	include	VERB
ajlm-2846	25	68	neurological	neurological	ADJ
ajlm-2846	25	69	and	and	CCONJ
ajlm-2846	25	70	ocular	ocular	ADJ
ajlm-2846	25	71	damage	damage	NOUN
ajlm-2846	25	72	,	,	PUNCT
ajlm-2846	25	73	and	and	CCONJ
ajlm-2846	25	74	even	even	ADV
ajlm-2846	25	75	death	death	NOUN
ajlm-2846	25	76	in	in	ADP
ajlm-2846	25	77	utero	utero	ADJ
ajlm-2846	25	78	,	,	PUNCT
ajlm-2846	25	79	especially	especially	ADV
ajlm-2846	25	80	in	in	ADP
ajlm-2846	25	81	early	early	ADJ
ajlm-2846	25	82	infection.5,6	infection.5,6	NOUN
ajlm-2846	25	83	diagnosis	diagnosis	NOUN
ajlm-2846	25	84	relies	rely	VERB
ajlm-2846	25	85	mainly	mainly	ADV
ajlm-2846	25	86	on	on	ADP
ajlm-2846	25	87	serological	serological	ADJ
ajlm-2846	25	88	measurement	measurement	NOUN
ajlm-2846	25	89	of	of	ADP
ajlm-2846	25	90	t.	t.	PROPN
ajlm-2846	25	91	gondii	gondii	NOUN
ajlm-2846	25	92	-	-	PUNCT
ajlm-2846	25	93	specific	specific	ADJ
ajlm-2846	25	94	igg	igg	PROPN
ajlm-2846	25	95	and	and	CCONJ
ajlm-2846	25	96	igm	igm	PROPN
ajlm-2846	25	97	;	;	PUNCT
ajlm-2846	25	98	igg	igg	PROPN
ajlm-2846	25	99	-	-	PUNCT
ajlm-2846	25	100	avidity	avidity	NOUN
ajlm-2846	25	101	testing	testing	NOUN
ajlm-2846	25	102	and	and	CCONJ
ajlm-2846	25	103	,	,	PUNCT
ajlm-2846	25	104	where	where	SCONJ
ajlm-2846	25	105	indicated	indicate	VERB
ajlm-2846	25	106	,	,	PUNCT
ajlm-2846	25	107	amniotic	amniotic	ADJ
ajlm-2846	25	108	-	-	PUNCT
ajlm-2846	25	109	fluid	fluid	NOUN
ajlm-2846	25	110	polymerase	polymerase	NOUN
ajlm-2846	25	111	chain	chain	NOUN
ajlm-2846	25	112	reaction	reaction	NOUN
ajlm-2846	25	113	(	(	PUNCT
ajlm-2846	25	114	pcr	pcr	NOUN
ajlm-2846	25	115	)	)	PUNCT
ajlm-2846	25	116	help	help	NOUN
ajlm-2846	25	117	to	to	PART
ajlm-2846	25	118	refine	refine	VERB
ajlm-2846	25	119	the	the	DET
ajlm-2846	25	120	timing	timing	NOUN
ajlm-2846	25	121	of	of	ADP
ajlm-2846	25	122	infection.7,8,9,10,11	infection.7,8,9,10,11	NOUN
ajlm-2846	25	123	in	in	ADP
ajlm-2846	25	124	the	the	DET
ajlm-2846	25	125	absence	absence	NOUN
ajlm-2846	25	126	of	of	ADP
ajlm-2846	25	127	pre	pre	ADJ
ajlm-2846	25	128	-	-	ADJ
ajlm-2846	25	129	existing	existing	ADJ
ajlm-2846	25	130	igg	igg	NOUN
ajlm-2846	25	131	,	,	PUNCT
ajlm-2846	25	132	pregnant	pregnant	ADJ
ajlm-2846	25	133	women	woman	NOUN
ajlm-2846	25	134	remain	remain	VERB
ajlm-2846	25	135	susceptible	susceptible	ADJ
ajlm-2846	25	136	throughout	throughout	ADP
ajlm-2846	25	137	pregnancy	pregnancy	NOUN
ajlm-2846	25	138	.	.	PUNCT
ajlm-2846	26	1	although	although	SCONJ
ajlm-2846	26	2	serological	serological	ADJ
ajlm-2846	26	3	screening	screening	NOUN
ajlm-2846	26	4	is	be	AUX
ajlm-2846	26	5	recommended	recommend	VERB
ajlm-2846	26	6	as	as	ADP
ajlm-2846	26	7	part	part	NOUN
ajlm-2846	26	8	of	of	ADP
ajlm-2846	26	9	antenatal	antenatal	NOUN
ajlm-2846	26	10	care	care	NOUN
ajlm-2846	26	11	in	in	ADP
ajlm-2846	26	12	several	several	ADJ
ajlm-2846	26	13	countries	country	NOUN
ajlm-2846	26	14	,	,	PUNCT
ajlm-2846	26	15	including	include	VERB
ajlm-2846	26	16	côte	côte	PROPN
ajlm-2846	26	17	d’ivoire	d’ivoire	PROPN
ajlm-2846	26	18	,	,	PUNCT
ajlm-2846	26	19	its	its	PRON
ajlm-2846	26	20	implementation	implementation	NOUN
ajlm-2846	26	21	remains	remain	VERB
ajlm-2846	26	22	uneven	uneven	ADJ
ajlm-2846	26	23	,	,	PUNCT
ajlm-2846	26	24	depending	depend	VERB
ajlm-2846	26	25	on	on	ADP
ajlm-2846	26	26	the	the	DET
ajlm-2846	26	27	context	context	NOUN
ajlm-2846	26	28	and	and	CCONJ
ajlm-2846	26	29	the	the	DET
ajlm-2846	26	30	resources	resource	NOUN
ajlm-2846	26	31	available.12,13	available.12,13	PROPN
ajlm-2846	26	32	in	in	ADP
ajlm-2846	26	33	africa	africa	PROPN
ajlm-2846	26	34	,	,	PUNCT
ajlm-2846	26	35	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	26	36	seroprevalence	seroprevalence	NOUN
ajlm-2846	26	37	,	,	PUNCT
ajlm-2846	26	38	typically	typically	ADV
ajlm-2846	26	39	measured	measure	VERB
ajlm-2846	26	40	by	by	ADP
ajlm-2846	26	41	anti	anti	ADJ
ajlm-2846	26	42	-	-	ADJ
ajlm-2846	26	43	toxoplasma	toxoplasma	ADJ
ajlm-2846	26	44	igg	igg	PROPN
ajlm-2846	26	45	seropositivity	seropositivity	PROPN
ajlm-2846	26	46	,	,	PUNCT
ajlm-2846	26	47	varies	vary	VERB
ajlm-2846	26	48	widely	widely	ADV
ajlm-2846	26	49	among	among	ADP
ajlm-2846	26	50	pregnant	pregnant	ADJ
ajlm-2846	26	51	women	woman	NOUN
ajlm-2846	26	52	,	,	PUNCT
ajlm-2846	26	53	with	with	ADP
ajlm-2846	26	54	rates	rate	NOUN
ajlm-2846	26	55	of	of	ADP
ajlm-2846	26	56	44.4	44.4	NUM
ajlm-2846	26	57	%	%	NOUN
ajlm-2846	26	58	in	in	ADP
ajlm-2846	26	59	cotonou,14	cotonou,14	ADV
ajlm-2846	26	60	36.1	36.1	NUM
ajlm-2846	26	61	%	%	NOUN
ajlm-2846	26	62	in	in	ADP
ajlm-2846	26	63	rural	rural	ADJ
ajlm-2846	26	64	benin,13	benin,13	NOUN
ajlm-2846	26	65	and	and	CCONJ
ajlm-2846	26	66	51	51	NUM
ajlm-2846	26	67	%	%	NOUN
ajlm-2846	26	68	in	in	ADP
ajlm-2846	26	69	morocco.15	morocco.15	NOUN
ajlm-2846	26	70	in	in	ADP
ajlm-2846	26	71	côte	côte	PROPN
ajlm-2846	26	72	d’ivoire	d’ivoire	PROPN
ajlm-2846	26	73	,	,	PUNCT
ajlm-2846	26	74	data	datum	NOUN
ajlm-2846	26	75	are	be	AUX
ajlm-2846	26	76	scarce	scarce	ADJ
ajlm-2846	26	77	,	,	PUNCT
ajlm-2846	26	78	with	with	ADP
ajlm-2846	26	79	the	the	DET
ajlm-2846	26	80	most	most	ADV
ajlm-2846	26	81	recent	recent	ADJ
ajlm-2846	26	82	study	study	NOUN
ajlm-2846	26	83	in	in	ADP
ajlm-2846	26	84	abidjan	abidjan	PROPN
ajlm-2846	26	85	reporting	report	VERB
ajlm-2846	26	86	a	a	DET
ajlm-2846	26	87	seroprevalence	seroprevalence	NOUN
ajlm-2846	26	88	rate	rate	NOUN
ajlm-2846	26	89	of	of	ADP
ajlm-2846	26	90	48%,16	48%,16	NUM
ajlm-2846	26	91	underlining	underline	VERB
ajlm-2846	26	92	the	the	DET
ajlm-2846	26	93	high	high	ADJ
ajlm-2846	26	94	level	level	NOUN
ajlm-2846	26	95	of	of	ADP
ajlm-2846	26	96	endemicity	endemicity	NOUN
ajlm-2846	26	97	.	.	PUNCT
ajlm-2846	27	1	however	however	ADV
ajlm-2846	27	2	,	,	PUNCT
ajlm-2846	27	3	these	these	DET
ajlm-2846	27	4	data	datum	NOUN
ajlm-2846	27	5	appear	appear	VERB
ajlm-2846	27	6	outdated	outdated	ADJ
ajlm-2846	27	7	and	and	CCONJ
ajlm-2846	27	8	require	require	VERB
ajlm-2846	27	9	re	re	NOUN
ajlm-2846	27	10	-	-	NOUN
ajlm-2846	27	11	evaluation	evaluation	NOUN
ajlm-2846	27	12	,	,	PUNCT
ajlm-2846	27	13	particularly	particularly	ADV
ajlm-2846	27	14	owing	owe	VERB
ajlm-2846	27	15	to	to	ADP
ajlm-2846	27	16	the	the	DET
ajlm-2846	27	17	continued	continue	VERB
ajlm-2846	27	18	presence	presence	NOUN
ajlm-2846	27	19	of	of	ADP
ajlm-2846	27	20	environmental	environmental	ADJ
ajlm-2846	27	21	and	and	CCONJ
ajlm-2846	27	22	dietary	dietary	ADJ
ajlm-2846	27	23	risk	risk	NOUN
ajlm-2846	27	24	factors	factor	NOUN
ajlm-2846	27	25	.	.	PUNCT
ajlm-2846	28	1	this	this	DET
ajlm-2846	28	2	study	study	NOUN
ajlm-2846	28	3	was	be	AUX
ajlm-2846	28	4	therefore	therefore	ADV
ajlm-2846	28	5	designed	design	VERB
ajlm-2846	28	6	to	to	PART
ajlm-2846	28	7	estimate	estimate	VERB
ajlm-2846	28	8	the	the	DET
ajlm-2846	28	9	seroprevalence	seroprevalence	NOUN
ajlm-2846	28	10	of	of	ADP
ajlm-2846	28	11	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	28	12	and	and	CCONJ
ajlm-2846	28	13	to	to	PART
ajlm-2846	28	14	describe	describe	VERB
ajlm-2846	28	15	igg	igg	PROPN
ajlm-2846	28	16	/	/	SYM
ajlm-2846	28	17	igm	igm	NOUN
ajlm-2846	28	18	serological	serological	ADJ
ajlm-2846	28	19	profiles	profile	NOUN
ajlm-2846	28	20	in	in	ADP
ajlm-2846	28	21	pregnant	pregnant	ADJ
ajlm-2846	28	22	women	woman	NOUN
ajlm-2846	28	23	attending	attend	VERB
ajlm-2846	28	24	the	the	DET
ajlm-2846	28	25	university	university	NOUN
ajlm-2846	28	26	hospital	hospital	NOUN
ajlm-2846	28	27	of	of	ADP
ajlm-2846	28	28	cocody	cocody	NOUN
ajlm-2846	28	29	.	.	PUNCT
ajlm-2846	29	1	methods	method	NOUN
ajlm-2846	29	2	ethical	ethical	ADJ
ajlm-2846	29	3	considerations	consideration	NOUN
ajlm-2846	29	4	the	the	DET
ajlm-2846	29	5	study	study	NOUN
ajlm-2846	29	6	was	be	AUX
ajlm-2846	29	7	carried	carry	VERB
ajlm-2846	29	8	out	out	ADP
ajlm-2846	29	9	with	with	ADP
ajlm-2846	29	10	respect	respect	NOUN
ajlm-2846	29	11	for	for	ADP
ajlm-2846	29	12	the	the	DET
ajlm-2846	29	13	confidentiality	confidentiality	NOUN
ajlm-2846	29	14	of	of	ADP
ajlm-2846	29	15	the	the	DET
ajlm-2846	29	16	data	datum	NOUN
ajlm-2846	29	17	.	.	PUNCT
ajlm-2846	30	1	the	the	DET
ajlm-2846	30	2	information	information	NOUN
ajlm-2846	30	3	used	use	VERB
ajlm-2846	30	4	came	come	VERB
ajlm-2846	30	5	exclusively	exclusively	ADV
ajlm-2846	30	6	from	from	ADP
ajlm-2846	30	7	the	the	DET
ajlm-2846	30	8	laboratory	laboratory	NOUN
ajlm-2846	30	9	registers	register	NOUN
ajlm-2846	30	10	and	and	CCONJ
ajlm-2846	30	11	did	do	AUX
ajlm-2846	30	12	not	not	PART
ajlm-2846	30	13	include	include	VERB
ajlm-2846	30	14	any	any	DET
ajlm-2846	30	15	nominative	nominative	ADJ
ajlm-2846	30	16	elements	element	NOUN
ajlm-2846	30	17	.	.	PUNCT
ajlm-2846	31	1	the	the	DET
ajlm-2846	31	2	study	study	NOUN
ajlm-2846	31	3	was	be	AUX
ajlm-2846	31	4	performed	perform	VERB
ajlm-2846	31	5	in	in	ADP
ajlm-2846	31	6	accordance	accordance	NOUN
ajlm-2846	31	7	with	with	ADP
ajlm-2846	31	8	the	the	DET
ajlm-2846	31	9	ethical	ethical	ADJ
ajlm-2846	31	10	principles	principle	NOUN
ajlm-2846	31	11	of	of	ADP
ajlm-2846	31	12	biomedical	biomedical	ADJ
ajlm-2846	31	13	research	research	NOUN
ajlm-2846	31	14	and	and	CCONJ
ajlm-2846	31	15	received	receive	VERB
ajlm-2846	31	16	the	the	DET
ajlm-2846	31	17	approval	approval	NOUN
ajlm-2846	31	18	of	of	ADP
ajlm-2846	31	19	the	the	DET
ajlm-2846	31	20	institutional	institutional	ADJ
ajlm-2846	31	21	ethics	ethic	NOUN
ajlm-2846	31	22	committee	committee	PROPN
ajlm-2846	31	23	(	(	PUNCT
ajlm-2846	31	24	reference	reference	NOUN
ajlm-2846	31	25	number	number	NOUN
ajlm-2846	31	26	:	:	PUNCT
ajlm-2846	31	27	042	042	NUM
ajlm-2846	31	28	/	/	SYM
ajlm-2846	31	29	mshp	mshp	NOUN
ajlm-2846	31	30	-	-	PUNCT
ajlm-2846	31	31	cmu	cmu	NOUN
ajlm-2846	31	32	/	/	SYM
ajlm-2846	31	33	chu	chu	PROPN
ajlm-2846	31	34	-	-	PUNCT
ajlm-2846	31	35	c	c	NOUN
ajlm-2846	31	36	/	/	SYM
ajlm-2846	31	37	dms	dms	PROPN
ajlm-2846	31	38	/	/	SYM
ajlm-2846	31	39	rk/25	rk/25	NOUN
ajlm-2846	31	40	)	)	PUNCT
ajlm-2846	31	41	of	of	ADP
ajlm-2846	31	42	the	the	DET
ajlm-2846	31	43	university	university	NOUN
ajlm-2846	31	44	hospital	hospital	NOUN
ajlm-2846	31	45	of	of	ADP
ajlm-2846	31	46	cocody	cocody	NOUN
ajlm-2846	31	47	.	.	PUNCT
ajlm-2846	32	1	the	the	DET
ajlm-2846	32	2	anonymity	anonymity	NOUN
ajlm-2846	32	3	and	and	CCONJ
ajlm-2846	32	4	confidentiality	confidentiality	NOUN
ajlm-2846	32	5	of	of	ADP
ajlm-2846	32	6	the	the	DET
ajlm-2846	32	7	data	datum	NOUN
ajlm-2846	32	8	were	be	AUX
ajlm-2846	32	9	guaranteed	guarantee	VERB
ajlm-2846	32	10	.	.	PUNCT
ajlm-2846	33	1	study	study	NOUN
ajlm-2846	33	2	design	design	VERB
ajlm-2846	33	3	a	a	DET
ajlm-2846	33	4	retrospective	retrospective	ADJ
ajlm-2846	33	5	cross	cross	ADJ
ajlm-2846	33	6	-	-	ADJ
ajlm-2846	33	7	sectional	sectional	ADJ
ajlm-2846	33	8	study	study	NOUN
ajlm-2846	33	9	of	of	ADP
ajlm-2846	33	10	serological	serological	ADJ
ajlm-2846	33	11	data	datum	NOUN
ajlm-2846	33	12	from	from	ADP
ajlm-2846	33	13	pregnant	pregnant	ADJ
ajlm-2846	33	14	women	woman	NOUN
ajlm-2846	33	15	was	be	AUX
ajlm-2846	33	16	conducted	conduct	VERB
ajlm-2846	33	17	between	between	ADP
ajlm-2846	33	18	april	april	PROPN
ajlm-2846	33	19	2022	2022	NUM
ajlm-2846	33	20	and	and	CCONJ
ajlm-2846	33	21	march	march	PROPN
ajlm-2846	33	22	2023	2023	NUM
ajlm-2846	33	23	.	.	PUNCT
ajlm-2846	34	1	study	study	NOUN
ajlm-2846	34	2	location	location	NOUN
ajlm-2846	34	3	the	the	DET
ajlm-2846	34	4	study	study	NOUN
ajlm-2846	34	5	took	take	VERB
ajlm-2846	34	6	place	place	NOUN
ajlm-2846	34	7	in	in	ADP
ajlm-2846	34	8	the	the	DET
ajlm-2846	34	9	immunology	immunology	NOUN
ajlm-2846	34	10	laboratory	laboratory	NOUN
ajlm-2846	34	11	at	at	ADP
ajlm-2846	34	12	the	the	DET
ajlm-2846	34	13	university	university	NOUN
ajlm-2846	34	14	hospital	hospital	NOUN
ajlm-2846	34	15	of	of	ADP
ajlm-2846	34	16	cocody	cocody	NOUN
ajlm-2846	34	17	.	.	PUNCT
ajlm-2846	35	1	this	this	DET
ajlm-2846	35	2	laboratory	laboratory	NOUN
ajlm-2846	35	3	is	be	AUX
ajlm-2846	35	4	a	a	DET
ajlm-2846	35	5	reference	reference	NOUN
ajlm-2846	35	6	centre	centre	NOUN
ajlm-2846	35	7	for	for	ADP
ajlm-2846	35	8	prenatal	prenatal	ADJ
ajlm-2846	35	9	immunological	immunological	ADJ
ajlm-2846	35	10	examinations	examination	NOUN
ajlm-2846	35	11	in	in	ADP
ajlm-2846	35	12	the	the	DET
ajlm-2846	35	13	region	region	NOUN
ajlm-2846	35	14	.	.	PUNCT
ajlm-2846	36	1	study	study	NOUN
ajlm-2846	36	2	population	population	NOUN
ajlm-2846	36	3	and	and	CCONJ
ajlm-2846	36	4	selection	selection	NOUN
ajlm-2846	36	5	criteria	criterion	NOUN
ajlm-2846	36	6	the	the	DET
ajlm-2846	36	7	study	study	NOUN
ajlm-2846	36	8	involved	involve	VERB
ajlm-2846	36	9	pregnant	pregnant	ADJ
ajlm-2846	36	10	women	woman	NOUN
ajlm-2846	36	11	who	who	PRON
ajlm-2846	36	12	had	have	AUX
ajlm-2846	36	13	undergone	undergo	VERB
ajlm-2846	36	14	toxoplasma	toxoplasma	NOUN
ajlm-2846	36	15	serology	serology	NOUN
ajlm-2846	36	16	as	as	ADP
ajlm-2846	36	17	part	part	NOUN
ajlm-2846	36	18	of	of	ADP
ajlm-2846	36	19	their	their	PRON
ajlm-2846	36	20	antenatal	antenatal	ADJ
ajlm-2846	36	21	check	check	NOUN
ajlm-2846	36	22	-	-	PUNCT
ajlm-2846	36	23	up	up	NOUN
ajlm-2846	36	24	or	or	CCONJ
ajlm-2846	36	25	as	as	ADP
ajlm-2846	36	26	a	a	DET
ajlm-2846	36	27	follow	follow	NOUN
ajlm-2846	36	28	-	-	PUNCT
ajlm-2846	36	29	up	up	NOUN
ajlm-2846	36	30	to	to	ADP
ajlm-2846	36	31	a	a	DET
ajlm-2846	36	32	previous	previous	ADJ
ajlm-2846	36	33	serology	serology	NOUN
ajlm-2846	36	34	.	.	PUNCT
ajlm-2846	37	1	patients	patient	NOUN
ajlm-2846	37	2	for	for	ADP
ajlm-2846	37	3	whom	whom	PRON
ajlm-2846	37	4	the	the	DET
ajlm-2846	37	5	following	following	ADJ
ajlm-2846	37	6	data	datum	NOUN
ajlm-2846	37	7	were	be	AUX
ajlm-2846	37	8	available	available	ADJ
ajlm-2846	37	9	were	be	AUX
ajlm-2846	37	10	included	include	VERB
ajlm-2846	37	11	:	:	PUNCT
ajlm-2846	37	12	serological	serological	ADJ
ajlm-2846	37	13	results	result	NOUN
ajlm-2846	37	14	(	(	PUNCT
ajlm-2846	37	15	igg	igg	NOUN
ajlm-2846	37	16	and	and	CCONJ
ajlm-2846	37	17	igm	igm	PROPN
ajlm-2846	37	18	)	)	PUNCT
ajlm-2846	37	19	,	,	PUNCT
ajlm-2846	37	20	maternal	maternal	ADJ
ajlm-2846	37	21	age	age	NOUN
ajlm-2846	37	22	and	and	CCONJ
ajlm-2846	37	23	gestational	gestational	ADJ
ajlm-2846	37	24	age	age	NOUN
ajlm-2846	37	25	.	.	PUNCT
ajlm-2846	38	1	files	file	NOUN
ajlm-2846	38	2	with	with	ADP
ajlm-2846	38	3	missing	miss	VERB
ajlm-2846	38	4	data	datum	NOUN
ajlm-2846	38	5	were	be	AUX
ajlm-2846	38	6	excluded	exclude	VERB
ajlm-2846	38	7	.	.	PUNCT
ajlm-2846	39	1	data	datum	NOUN
ajlm-2846	39	2	collection	collection	NOUN
ajlm-2846	39	3	data	datum	NOUN
ajlm-2846	39	4	were	be	AUX
ajlm-2846	39	5	collected	collect	VERB
ajlm-2846	39	6	from	from	ADP
ajlm-2846	39	7	laboratory	laboratory	NOUN
ajlm-2846	39	8	records	record	NOUN
ajlm-2846	39	9	using	use	VERB
ajlm-2846	39	10	a	a	DET
ajlm-2846	39	11	standardised	standardised	ADJ
ajlm-2846	39	12	form	form	NOUN
ajlm-2846	39	13	.	.	PUNCT
ajlm-2846	40	1	the	the	DET
ajlm-2846	40	2	variables	variable	NOUN
ajlm-2846	40	3	collected	collect	VERB
ajlm-2846	40	4	included	include	VERB
ajlm-2846	40	5	the	the	DET
ajlm-2846	40	6	patients	patient	NOUN
ajlm-2846	40	7	’	’	PART
ajlm-2846	40	8	age	age	NOUN
ajlm-2846	40	9	in	in	ADP
ajlm-2846	40	10	years	year	NOUN
ajlm-2846	40	11	,	,	PUNCT
ajlm-2846	40	12	gestational	gestational	ADJ
ajlm-2846	40	13	age	age	NOUN
ajlm-2846	40	14	in	in	ADP
ajlm-2846	40	15	weeks	week	NOUN
ajlm-2846	40	16	of	of	ADP
ajlm-2846	40	17	gestation	gestation	NOUN
ajlm-2846	40	18	,	,	PUNCT
ajlm-2846	40	19	the	the	DET
ajlm-2846	40	20	reason	reason	NOUN
ajlm-2846	40	21	for	for	ADP
ajlm-2846	40	22	the	the	DET
ajlm-2846	40	23	request	request	NOUN
ajlm-2846	40	24	(	(	PUNCT
ajlm-2846	40	25	routine	routine	ADJ
ajlm-2846	40	26	screening	screening	NOUN
ajlm-2846	40	27	or	or	CCONJ
ajlm-2846	40	28	follow	follow	VERB
ajlm-2846	40	29	-	-	PUNCT
ajlm-2846	40	30	up	up	NOUN
ajlm-2846	40	31	)	)	PUNCT
ajlm-2846	40	32	,	,	PUNCT
ajlm-2846	40	33	and	and	CCONJ
ajlm-2846	40	34	the	the	DET
ajlm-2846	40	35	results	result	NOUN
ajlm-2846	40	36	of	of	ADP
ajlm-2846	40	37	specific	specific	ADJ
ajlm-2846	40	38	igg	igg	NOUN
ajlm-2846	40	39	and	and	CCONJ
ajlm-2846	40	40	igm	igm	NOUN
ajlm-2846	40	41	assays	assay	NOUN
ajlm-2846	40	42	for	for	ADP
ajlm-2846	40	43	t.	t.	NOUN
ajlm-2846	40	44	gondii	gondii	NOUN
ajlm-2846	40	45	.	.	PUNCT
ajlm-2846	41	1	in	in	ADP
ajlm-2846	41	2	accordance	accordance	NOUN
ajlm-2846	41	3	with	with	ADP
ajlm-2846	41	4	obstetric	obstetric	ADJ
ajlm-2846	41	5	recommendations	recommendation	NOUN
ajlm-2846	41	6	,	,	PUNCT
ajlm-2846	41	7	the	the	DET
ajlm-2846	41	8	trimesters	trimester	NOUN
ajlm-2846	41	9	were	be	AUX
ajlm-2846	41	10	divided	divide	VERB
ajlm-2846	41	11	as	as	SCONJ
ajlm-2846	41	12	follows	follow	VERB
ajlm-2846	41	13	:	:	PUNCT
ajlm-2846	41	14	first	first	ADJ
ajlm-2846	41	15	trimester	trimester	NOUN
ajlm-2846	41	16	(	(	PUNCT
ajlm-2846	41	17	≤	≤	ADV
ajlm-2846	41	18	14	14	NUM
ajlm-2846	41	19	weeks	week	NOUN
ajlm-2846	41	20	of	of	ADP
ajlm-2846	41	21	gestation	gestation	NOUN
ajlm-2846	41	22	)	)	PUNCT
ajlm-2846	41	23	,	,	PUNCT
ajlm-2846	41	24	second	second	ADJ
ajlm-2846	41	25	trimester	trimester	NOUN
ajlm-2846	41	26	(	(	PUNCT
ajlm-2846	41	27	15–27	15–27	NUM
ajlm-2846	41	28	weeks	week	NOUN
ajlm-2846	41	29	of	of	ADP
ajlm-2846	41	30	gestation	gestation	NOUN
ajlm-2846	41	31	)	)	PUNCT
ajlm-2846	41	32	and	and	CCONJ
ajlm-2846	41	33	third	third	ADJ
ajlm-2846	41	34	trimester	trimester	NOUN
ajlm-2846	41	35	(	(	PUNCT
ajlm-2846	41	36	≥	≥	NOUN
ajlm-2846	41	37	28	28	NUM
ajlm-2846	41	38	weeks	week	NOUN
ajlm-2846	41	39	of	of	ADP
ajlm-2846	41	40	gestation	gestation	NOUN
ajlm-2846	41	41	)	)	PUNCT
ajlm-2846	41	42	.	.	PUNCT
ajlm-2846	42	1	data	datum	NOUN
ajlm-2846	42	2	regarding	regard	VERB
ajlm-2846	42	3	any	any	DET
ajlm-2846	42	4	treatment	treatment	NOUN
ajlm-2846	42	5	and	and	CCONJ
ajlm-2846	42	6	obstetric	obstetric	ADJ
ajlm-2846	42	7	or	or	CCONJ
ajlm-2846	42	8	neonatal	neonatal	ADJ
ajlm-2846	42	9	outcomes	outcome	NOUN
ajlm-2846	42	10	are	be	AUX
ajlm-2846	42	11	not	not	PART
ajlm-2846	42	12	recorded	record	VERB
ajlm-2846	42	13	in	in	ADP
ajlm-2846	42	14	laboratory	laboratory	NOUN
ajlm-2846	42	15	registers	register	NOUN
ajlm-2846	42	16	and	and	CCONJ
ajlm-2846	42	17	were	be	AUX
ajlm-2846	42	18	therefore	therefore	ADV
ajlm-2846	42	19	unavailable	unavailable	ADJ
ajlm-2846	42	20	for	for	ADP
ajlm-2846	42	21	analysis	analysis	NOUN
ajlm-2846	42	22	.	.	PUNCT
ajlm-2846	43	1	laboratory	laboratory	NOUN
ajlm-2846	43	2	tests	test	VERB
ajlm-2846	43	3	igg	igg	PROPN
ajlm-2846	43	4	and	and	CCONJ
ajlm-2846	43	5	igm	igm	PROPN
ajlm-2846	43	6	serologies	serology	NOUN
ajlm-2846	43	7	were	be	AUX
ajlm-2846	43	8	analysed	analyse	VERB
ajlm-2846	43	9	by	by	ADP
ajlm-2846	43	10	sandwich	sandwich	NOUN
ajlm-2846	43	11	electrochemiluminescence	electrochemiluminescence	PROPN
ajlm-2846	43	12	immunoassay	immunoassay	PROPN
ajlm-2846	43	13	on	on	ADP
ajlm-2846	43	14	a	a	DET
ajlm-2846	43	15	cobas	cobas	ADJ
ajlm-2846	43	16	6000	6000	NUM
ajlm-2846	43	17	e601	e601	PROPN
ajlm-2846	43	18	(	(	PUNCT
ajlm-2846	43	19	roche	roche	PROPN
ajlm-2846	43	20	diagnostics	diagnostic	NOUN
ajlm-2846	43	21	gmbh	gmbh	PROPN
ajlm-2846	43	22	,	,	PUNCT
ajlm-2846	43	23	mannheim	mannheim	PROPN
ajlm-2846	43	24	,	,	PUNCT
ajlm-2846	43	25	germany	germany	PROPN
ajlm-2846	43	26	)	)	PUNCT
ajlm-2846	43	27	,	,	PUNCT
ajlm-2846	43	28	using	use	VERB
ajlm-2846	43	29	elecsys	elecsys	PROPN
ajlm-2846	43	30	®	®	NOUN
ajlm-2846	43	31	toxo	toxo	NOUN
ajlm-2846	43	32	igg	igg	PROPN
ajlm-2846	43	33	and	and	CCONJ
ajlm-2846	43	34	igm	igm	NOUN
ajlm-2846	43	35	reagents	reagent	NOUN
ajlm-2846	43	36	.	.	PUNCT
ajlm-2846	44	1	the	the	DET
ajlm-2846	44	2	interpretation	interpretation	NOUN
ajlm-2846	44	3	thresholds	threshold	VERB
ajlm-2846	44	4	,	,	PUNCT
ajlm-2846	44	5	according	accord	VERB
ajlm-2846	44	6	to	to	ADP
ajlm-2846	44	7	the	the	DET
ajlm-2846	44	8	manufacturer	manufacturer	NOUN
ajlm-2846	44	9	’s	’s	PART
ajlm-2846	44	10	recommendations	recommendation	NOUN
ajlm-2846	44	11	,	,	PUNCT
ajlm-2846	44	12	were	be	AUX
ajlm-2846	44	13	as	as	SCONJ
ajlm-2846	44	14	follows	follow	VERB
ajlm-2846	44	15	:	:	PUNCT
ajlm-2846	44	16	specific	specific	ADJ
ajlm-2846	44	17	igg	igg	PROPN
ajlm-2846	44	18	was	be	AUX
ajlm-2846	44	19	considered	consider	VERB
ajlm-2846	44	20	negative	negative	ADJ
ajlm-2846	44	21	(	(	PUNCT
ajlm-2846	44	22	<	<	X
ajlm-2846	44	23	1	1	NUM
ajlm-2846	44	24	iu	iu	NOUN
ajlm-2846	44	25	/	/	SYM
ajlm-2846	44	26	ml	ml	NOUN
ajlm-2846	44	27	)	)	PUNCT
ajlm-2846	44	28	,	,	PUNCT
ajlm-2846	44	29	equivocal	equivocal	ADJ
ajlm-2846	44	30	(	(	PUNCT
ajlm-2846	44	31	1	1	NUM
ajlm-2846	44	32	iu	iu	ADV
ajlm-2846	44	33	/	/	SYM
ajlm-2846	44	34	ml	ml	PROPN
ajlm-2846	44	35	–	–	PUNCT
ajlm-2846	44	36	<	<	X
ajlm-2846	44	37	3	3	NUM
ajlm-2846	44	38	iu	iu	NOUN
ajlm-2846	44	39	/	/	SYM
ajlm-2846	44	40	ml	ml	NOUN
ajlm-2846	44	41	)	)	PUNCT
ajlm-2846	44	42	,	,	PUNCT
ajlm-2846	44	43	or	or	CCONJ
ajlm-2846	44	44	positive	positive	ADJ
ajlm-2846	44	45	(	(	PUNCT
ajlm-2846	44	46	≥	≥	NOUN
ajlm-2846	44	47	3	3	NUM
ajlm-2846	44	48	iu	iu	NOUN
ajlm-2846	44	49	/	/	SYM
ajlm-2846	44	50	ml	ml	NOUN
ajlm-2846	44	51	)	)	PUNCT
ajlm-2846	44	52	;	;	PUNCT
ajlm-2846	44	53	specific	specific	ADJ
ajlm-2846	44	54	igm	igm	NOUN
ajlm-2846	44	55	was	be	AUX
ajlm-2846	44	56	considered	consider	VERB
ajlm-2846	44	57	negative	negative	ADJ
ajlm-2846	44	58	(	(	PUNCT
ajlm-2846	44	59	cut	cut	VERB
ajlm-2846	44	60	-	-	PUNCT
ajlm-2846	44	61	off	off	ADP
ajlm-2846	44	62	index	index	NOUN
ajlm-2846	44	63	:	:	PUNCT
ajlm-2846	44	64	<	<	X
ajlm-2846	44	65	0.8	0.8	NUM
ajlm-2846	44	66	)	)	PUNCT
ajlm-2846	44	67	,	,	PUNCT
ajlm-2846	44	68	equivocal	equivocal	ADJ
ajlm-2846	44	69	(	(	PUNCT
ajlm-2846	44	70	cutt	cutt	VERB
ajlm-2846	44	71	-	-	PUNCT
ajlm-2846	44	72	off	off	ADP
ajlm-2846	44	73	index	index	NOUN
ajlm-2846	44	74	:	:	PUNCT
ajlm-2846	44	75	0.8	0.8	NUM
ajlm-2846	44	76	–	–	PUNCT
ajlm-2846	44	77	<	<	X
ajlm-2846	44	78	1.0	1.0	NUM
ajlm-2846	44	79	)	)	PUNCT
ajlm-2846	44	80	,	,	PUNCT
ajlm-2846	44	81	or	or	CCONJ
ajlm-2846	44	82	positive	positive	ADJ
ajlm-2846	44	83	(	(	PUNCT
ajlm-2846	44	84	cut	cut	VERB
ajlm-2846	44	85	-	-	PUNCT
ajlm-2846	44	86	off	off	ADP
ajlm-2846	44	87	index	index	NOUN
ajlm-2846	44	88	:	:	PUNCT
ajlm-2846	44	89	≥	≥	NOUN
ajlm-2846	44	90	1.0	1.0	NUM
ajlm-2846	44	91	)	)	PUNCT
ajlm-2846	44	92	.	.	PUNCT
ajlm-2846	45	1	serological	serological	ADJ
ajlm-2846	45	2	interpretation	interpretation	NOUN
ajlm-2846	45	3	based	base	VERB
ajlm-2846	45	4	on	on	ADP
ajlm-2846	45	5	igg	igg	PROPN
ajlm-2846	45	6	and	and	CCONJ
ajlm-2846	45	7	igm	igm	PROPN
ajlm-2846	45	8	status	status	PROPN
ajlm-2846	45	9	,	,	PUNCT
ajlm-2846	45	10	four	four	NUM
ajlm-2846	45	11	serological	serological	ADJ
ajlm-2846	45	12	profiles	profile	NOUN
ajlm-2846	45	13	were	be	AUX
ajlm-2846	45	14	defined	define	VERB
ajlm-2846	45	15	:	:	PUNCT
ajlm-2846	45	16	previous	previous	ADJ
ajlm-2846	45	17	infection	infection	NOUN
ajlm-2846	45	18	(	(	PUNCT
ajlm-2846	45	19	igg+/igm	igg+/igm	NOUN
ajlm-2846	45	20	–	–	PUNCT
ajlm-2846	45	21	)	)	PUNCT
ajlm-2846	45	22	,	,	PUNCT
ajlm-2846	45	23	current	current	ADJ
ajlm-2846	45	24	infection	infection	NOUN
ajlm-2846	45	25	(	(	PUNCT
ajlm-2846	45	26	igg+/igm+	igg+/igm+	PROPN
ajlm-2846	45	27	)	)	PUNCT
ajlm-2846	45	28	,	,	PUNCT
ajlm-2846	45	29	recent	recent	ADJ
ajlm-2846	45	30	infection	infection	NOUN
ajlm-2846	45	31	(	(	PUNCT
ajlm-2846	45	32	igg–/igm+	igg–/igm+	NOUN
ajlm-2846	45	33	)	)	PUNCT
ajlm-2846	45	34	,	,	PUNCT
ajlm-2846	45	35	and	and	CCONJ
ajlm-2846	45	36	no	no	DET
ajlm-2846	45	37	infection	infection	NOUN
ajlm-2846	45	38	(	(	PUNCT
ajlm-2846	45	39	igg–/igm–).17	igg–/igm–).17	PROPN
ajlm-2846	45	40	equivocal	equivocal	ADJ
ajlm-2846	45	41	results	result	NOUN
ajlm-2846	45	42	were	be	AUX
ajlm-2846	45	43	interpreted	interpret	VERB
ajlm-2846	45	44	according	accord	VERB
ajlm-2846	45	45	to	to	ADP
ajlm-2846	45	46	the	the	DET
ajlm-2846	45	47	manufacturer	manufacturer	NOUN
ajlm-2846	45	48	’s	’s	PART
ajlm-2846	45	49	instructions	instruction	NOUN
ajlm-2846	45	50	and	and	CCONJ
ajlm-2846	45	51	were	be	AUX
ajlm-2846	45	52	not	not	PART
ajlm-2846	45	53	used	use	VERB
ajlm-2846	45	54	for	for	ADP
ajlm-2846	45	55	prevalence	prevalence	NOUN
ajlm-2846	45	56	calculations	calculation	NOUN
ajlm-2846	45	57	.	.	PUNCT
ajlm-2846	46	1	data	datum	NOUN
ajlm-2846	46	2	analysis	analysis	NOUN
ajlm-2846	46	3	data	datum	NOUN
ajlm-2846	46	4	were	be	AUX
ajlm-2846	46	5	entered	enter	VERB
ajlm-2846	46	6	and	and	CCONJ
ajlm-2846	46	7	processed	process	VERB
ajlm-2846	46	8	using	use	VERB
ajlm-2846	46	9	microsoft	microsoft	PROPN
ajlm-2846	46	10	excel	excel	VERB
ajlm-2846	46	11	2016	2016	NUM
ajlm-2846	46	12	.	.	PUNCT
ajlm-2846	47	1	statistical	statistical	ADJ
ajlm-2846	47	2	analyses	analysis	NOUN
ajlm-2846	47	3	were	be	AUX
ajlm-2846	47	4	performed	perform	VERB
ajlm-2846	47	5	using	use	VERB
ajlm-2846	47	6	spss	spss	PROPN
ajlm-2846	47	7	version	version	PROPN
ajlm-2846	47	8	26.0	26.0	NUM
ajlm-2846	47	9	.	.	PUNCT
ajlm-2846	48	1	descriptive	descriptive	ADJ
ajlm-2846	48	2	analysis	analysis	NOUN
ajlm-2846	48	3	summarised	summarise	VERB
ajlm-2846	48	4	the	the	DET
ajlm-2846	48	5	sociodemographic	sociodemographic	ADJ
ajlm-2846	48	6	,	,	PUNCT
ajlm-2846	48	7	obstetric	obstetric	ADJ
ajlm-2846	48	8	and	and	CCONJ
ajlm-2846	48	9	serological	serological	ADJ
ajlm-2846	48	10	characteristics	characteristic	NOUN
ajlm-2846	48	11	of	of	ADP
ajlm-2846	48	12	the	the	DET
ajlm-2846	48	13	patients	patient	NOUN
ajlm-2846	48	14	,	,	PUNCT
ajlm-2846	48	15	with	with	ADP
ajlm-2846	48	16	results	result	NOUN
ajlm-2846	48	17	presented	present	VERB
ajlm-2846	48	18	in	in	ADP
ajlm-2846	48	19	absolute	absolute	ADJ
ajlm-2846	48	20	numbers	number	NOUN
ajlm-2846	48	21	and	and	CCONJ
ajlm-2846	48	22	percentages	percentage	NOUN
ajlm-2846	48	23	.	.	PUNCT
ajlm-2846	49	1	comparative	comparative	ADJ
ajlm-2846	49	2	analysis	analysis	NOUN
ajlm-2846	49	3	was	be	AUX
ajlm-2846	49	4	used	use	VERB
ajlm-2846	49	5	to	to	PART
ajlm-2846	49	6	explore	explore	VERB
ajlm-2846	49	7	the	the	DET
ajlm-2846	49	8	association	association	NOUN
ajlm-2846	49	9	between	between	ADP
ajlm-2846	49	10	igm	igm	PROPN
ajlm-2846	49	11	positivity	positivity	NOUN
ajlm-2846	49	12	and	and	CCONJ
ajlm-2846	49	13	the	the	DET
ajlm-2846	49	14	trimester	trimester	NOUN
ajlm-2846	49	15	of	of	ADP
ajlm-2846	49	16	pregnancy	pregnancy	NOUN
ajlm-2846	49	17	,	,	PUNCT
ajlm-2846	49	18	using	use	VERB
ajlm-2846	49	19	pearson	pearson	PROPN
ajlm-2846	49	20	’s	’s	PART
ajlm-2846	49	21	chi	chi	NOUN
ajlm-2846	49	22	-	-	PUNCT
ajlm-2846	49	23	squared	square	VERB
ajlm-2846	49	24	(	(	PUNCT
ajlm-2846	49	25	χ2	χ2	PROPN
ajlm-2846	49	26	)	)	PUNCT
ajlm-2846	49	27	test	test	NOUN
ajlm-2846	49	28	;	;	PUNCT
ajlm-2846	49	29	p	p	X
ajlm-2846	49	30	<	<	X
ajlm-2846	49	31	0.05	0.05	NUM
ajlm-2846	49	32	was	be	AUX
ajlm-2846	49	33	considered	consider	VERB
ajlm-2846	49	34	statistically	statistically	ADV
ajlm-2846	49	35	significant	significant	ADJ
ajlm-2846	49	36	.	.	PUNCT
ajlm-2846	50	1	results	result	VERB
ajlm-2846	50	2	general	general	ADJ
ajlm-2846	50	3	characteristics	characteristic	NOUN
ajlm-2846	50	4	of	of	ADP
ajlm-2846	50	5	the	the	DET
ajlm-2846	50	6	population	population	NOUN
ajlm-2846	50	7	data	datum	NOUN
ajlm-2846	50	8	were	be	AUX
ajlm-2846	50	9	analysed	analyse	VERB
ajlm-2846	50	10	from	from	ADP
ajlm-2846	50	11	200	200	NUM
ajlm-2846	50	12	pregnant	pregnant	ADJ
ajlm-2846	50	13	women	woman	NOUN
ajlm-2846	50	14	aged	age	VERB
ajlm-2846	50	15	18–44	18–44	NUM
ajlm-2846	50	16	years	year	NOUN
ajlm-2846	50	17	,	,	PUNCT
ajlm-2846	50	18	with	with	ADP
ajlm-2846	50	19	a	a	DET
ajlm-2846	50	20	predominance	predominance	NOUN
ajlm-2846	50	21	in	in	ADP
ajlm-2846	50	22	the	the	DET
ajlm-2846	50	23	25–34	25–34	NUM
ajlm-2846	50	24	age	age	NOUN
ajlm-2846	50	25	group	group	NOUN
ajlm-2846	50	26	(	(	PUNCT
ajlm-2846	50	27	44.0	44.0	NUM
ajlm-2846	50	28	%	%	NOUN
ajlm-2846	50	29	)	)	PUNCT
ajlm-2846	50	30	,	,	PUNCT
ajlm-2846	50	31	followed	follow	VERB
ajlm-2846	50	32	by	by	ADP
ajlm-2846	50	33	those	those	DET
ajlm-2846	50	34	younger	young	ADJ
ajlm-2846	50	35	than	than	ADP
ajlm-2846	50	36	25	25	NUM
ajlm-2846	50	37	years	year	NOUN
ajlm-2846	50	38	(	(	PUNCT
ajlm-2846	50	39	31.5	31.5	NUM
ajlm-2846	50	40	%	%	NOUN
ajlm-2846	50	41	)	)	PUNCT
ajlm-2846	50	42	(	(	PUNCT
ajlm-2846	50	43	table	table	NOUN
ajlm-2846	50	44	1	1	NUM
ajlm-2846	50	45	)	)	PUNCT
ajlm-2846	50	46	.	.	PUNCT
ajlm-2846	51	1	the	the	DET
ajlm-2846	51	2	majority	majority	NOUN
ajlm-2846	51	3	were	be	AUX
ajlm-2846	51	4	in	in	ADP
ajlm-2846	51	5	the	the	DET
ajlm-2846	51	6	second	second	ADJ
ajlm-2846	51	7	trimester	trimester	NOUN
ajlm-2846	51	8	(	(	PUNCT
ajlm-2846	51	9	42.5	42.5	NUM
ajlm-2846	51	10	%	%	NOUN
ajlm-2846	51	11	)	)	PUNCT
ajlm-2846	51	12	,	,	PUNCT
ajlm-2846	51	13	compared	compare	VERB
ajlm-2846	51	14	with	with	ADP
ajlm-2846	51	15	40.5	40.5	NUM
ajlm-2846	51	16	%	%	NOUN
ajlm-2846	51	17	in	in	ADP
ajlm-2846	51	18	the	the	DET
ajlm-2846	51	19	third	third	ADJ
ajlm-2846	51	20	and	and	CCONJ
ajlm-2846	51	21	17.0	17.0	NUM
ajlm-2846	51	22	%	%	NOUN
ajlm-2846	51	23	in	in	ADP
ajlm-2846	51	24	the	the	DET
ajlm-2846	51	25	first	first	ADJ
ajlm-2846	51	26	(	(	PUNCT
ajlm-2846	51	27	table	table	NOUN
ajlm-2846	51	28	1	1	NUM
ajlm-2846	51	29	)	)	PUNCT
ajlm-2846	51	30	.	.	PUNCT
ajlm-2846	52	1	table	table	NOUN
ajlm-2846	52	2	1	1	NUM
ajlm-2846	52	3	:	:	PUNCT
ajlm-2846	52	4	 	 	SPACE
ajlm-2846	52	5	distribution	distribution	NOUN
ajlm-2846	52	6	of	of	ADP
ajlm-2846	52	7	pregnant	pregnant	ADJ
ajlm-2846	52	8	women	woman	NOUN
ajlm-2846	52	9	according	accord	VERB
ajlm-2846	52	10	to	to	ADP
ajlm-2846	52	11	demographic	demographic	ADJ
ajlm-2846	52	12	,	,	PUNCT
ajlm-2846	52	13	clinical	clinical	ADJ
ajlm-2846	52	14	and	and	CCONJ
ajlm-2846	52	15	serological	serological	ADJ
ajlm-2846	52	16	data	datum	NOUN
ajlm-2846	52	17	,	,	PUNCT
ajlm-2846	52	18	immunology	immunology	NOUN
ajlm-2846	52	19	laboratory	laboratory	NOUN
ajlm-2846	52	20	,	,	PUNCT
ajlm-2846	52	21	university	university	NOUN
ajlm-2846	52	22	hospital	hospital	NOUN
ajlm-2846	52	23	of	of	ADP
ajlm-2846	52	24	cocody	cocody	PROPN
ajlm-2846	52	25	,	,	PUNCT
ajlm-2846	52	26	abidjan	abidjan	PROPN
ajlm-2846	52	27	,	,	PUNCT
ajlm-2846	52	28	côte	côte	PROPN
ajlm-2846	52	29	d’ivoire	d’ivoire	PROPN
ajlm-2846	52	30	,	,	PUNCT
ajlm-2846	52	31	april	april	PROPN
ajlm-2846	52	32	2022	2022	NUM
ajlm-2846	52	33	–	–	PUNCT
ajlm-2846	52	34	march	march	PROPN
ajlm-2846	52	35	2023	2023	NUM
ajlm-2846	52	36	.	.	PUNCT
ajlm-2846	53	1	serological	serological	ADJ
ajlm-2846	53	2	distribution	distribution	NOUN
ajlm-2846	53	3	based	base	VERB
ajlm-2846	53	4	on	on	ADP
ajlm-2846	53	5	t.	t.	PROPN
ajlm-2846	53	6	gondii	gondii	PROPN
ajlm-2846	53	7	igg	igg	PROPN
ajlm-2846	53	8	/	/	SYM
ajlm-2846	53	9	igm	igm	PROPN
ajlm-2846	53	10	results	result	NOUN
ajlm-2846	53	11	,	,	PUNCT
ajlm-2846	53	12	four	four	NUM
ajlm-2846	53	13	serological	serological	ADJ
ajlm-2846	53	14	profiles	profile	NOUN
ajlm-2846	53	15	were	be	AUX
ajlm-2846	53	16	identified	identify	VERB
ajlm-2846	53	17	(	(	PUNCT
ajlm-2846	53	18	table	table	NOUN
ajlm-2846	53	19	2	2	NUM
ajlm-2846	53	20	:	:	PUNCT
ajlm-2846	53	21	previous	previous	ADJ
ajlm-2846	53	22	infection	infection	NOUN
ajlm-2846	53	23	,	,	PUNCT
ajlm-2846	53	24	current	current	ADJ
ajlm-2846	53	25	infection	infection	NOUN
ajlm-2846	53	26	,	,	PUNCT
ajlm-2846	53	27	recent	recent	ADJ
ajlm-2846	53	28	infection	infection	NOUN
ajlm-2846	53	29	,	,	PUNCT
ajlm-2846	53	30	and	and	CCONJ
ajlm-2846	53	31	no	no	DET
ajlm-2846	53	32	infection	infection	NOUN
ajlm-2846	53	33	)	)	PUNCT
ajlm-2846	53	34	.	.	PUNCT
ajlm-2846	54	1	overall	overall	ADJ
ajlm-2846	54	2	igg	igg	PROPN
ajlm-2846	54	3	seroprevalence	seroprevalence	NOUN
ajlm-2846	54	4	was	be	AUX
ajlm-2846	54	5	49.0	49.0	NUM
ajlm-2846	54	6	%	%	NOUN
ajlm-2846	54	7	(	(	PUNCT
ajlm-2846	54	8	45.0	45.0	NUM
ajlm-2846	54	9	%	%	NOUN
ajlm-2846	54	10	igg+/igm−	igg+/igm−	X
ajlm-2846	54	11	;	;	PUNCT
ajlm-2846	54	12	4.0	4.0	NUM
ajlm-2846	54	13	%	%	NOUN
ajlm-2846	54	14	igg+/igm+	igg+/igm+	PROPN
ajlm-2846	54	15	)	)	PUNCT
ajlm-2846	54	16	.	.	PUNCT
ajlm-2846	55	1	nineteen	nineteen	NUM
ajlm-2846	55	2	women	woman	NOUN
ajlm-2846	55	3	(	(	PUNCT
ajlm-2846	55	4	9.5	9.5	NUM
ajlm-2846	55	5	%	%	NOUN
ajlm-2846	55	6	)	)	PUNCT
ajlm-2846	55	7	had	have	VERB
ajlm-2846	55	8	igm	igm	ADJ
ajlm-2846	55	9	-	-	PUNCT
ajlm-2846	55	10	positive	positive	ADJ
ajlm-2846	55	11	profiles	profile	NOUN
ajlm-2846	55	12	,	,	PUNCT
ajlm-2846	55	13	indicating	indicate	VERB
ajlm-2846	55	14	recent	recent	ADJ
ajlm-2846	55	15	or	or	CCONJ
ajlm-2846	55	16	current	current	ADJ
ajlm-2846	55	17	infection	infection	NOUN
ajlm-2846	55	18	.	.	PUNCT
ajlm-2846	56	1	igm	igm	PROPN
ajlm-2846	56	2	positivity	positivity	NOUN
ajlm-2846	56	3	was	be	AUX
ajlm-2846	56	4	most	most	ADV
ajlm-2846	56	5	frequent	frequent	ADJ
ajlm-2846	56	6	in	in	ADP
ajlm-2846	56	7	the	the	DET
ajlm-2846	56	8	first	first	ADJ
ajlm-2846	56	9	trimester	trimester	NOUN
ajlm-2846	56	10	(	(	PUNCT
ajlm-2846	56	11	17.6	17.6	NUM
ajlm-2846	56	12	%	%	NOUN
ajlm-2846	56	13	)	)	PUNCT
ajlm-2846	56	14	,	,	PUNCT
ajlm-2846	56	15	followed	follow	VERB
ajlm-2846	56	16	by	by	ADP
ajlm-2846	56	17	the	the	DET
ajlm-2846	56	18	second	second	ADJ
ajlm-2846	56	19	(	(	PUNCT
ajlm-2846	56	20	8.2	8.2	NUM
ajlm-2846	56	21	%	%	NOUN
ajlm-2846	56	22	)	)	PUNCT
ajlm-2846	56	23	and	and	CCONJ
ajlm-2846	56	24	third	third	ADJ
ajlm-2846	56	25	trimesters	trimester	NOUN
ajlm-2846	56	26	(	(	PUNCT
ajlm-2846	56	27	7.4	7.4	NUM
ajlm-2846	56	28	%	%	NOUN
ajlm-2846	56	29	)	)	PUNCT
ajlm-2846	56	30	(	(	PUNCT
ajlm-2846	56	31	table	table	NOUN
ajlm-2846	56	32	3	3	NUM
ajlm-2846	56	33	)	)	PUNCT
ajlm-2846	56	34	,	,	PUNCT
ajlm-2846	56	35	with	with	ADP
ajlm-2846	56	36	no	no	DET
ajlm-2846	56	37	statistically	statistically	ADV
ajlm-2846	56	38	significant	significant	ADJ
ajlm-2846	56	39	difference	difference	NOUN
ajlm-2846	56	40	(	(	PUNCT
ajlm-2846	56	41	χ2	χ2	NOUN
ajlm-2846	56	42	=	=	SYM
ajlm-2846	56	43	2.99	2.99	NUM
ajlm-2846	56	44	;	;	PUNCT
ajlm-2846	56	45	df	df	PROPN
ajlm-2846	56	46	=	=	SYM
ajlm-2846	56	47	2	2	NUM
ajlm-2846	56	48	;	;	PUNCT
ajlm-2846	56	49	p	p	NOUN
ajlm-2846	56	50	=	=	NOUN
ajlm-2846	56	51	0.22	0.22	NUM
ajlm-2846	56	52	)	)	PUNCT
ajlm-2846	56	53	.	.	PUNCT
ajlm-2846	57	1	table	table	NOUN
ajlm-2846	57	2	2	2	NUM
ajlm-2846	57	3	:	:	PUNCT
ajlm-2846	57	4	 	 	SPACE
ajlm-2846	57	5	distribution	distribution	NOUN
ajlm-2846	57	6	of	of	ADP
ajlm-2846	57	7	immunological	immunological	ADJ
ajlm-2846	57	8	profiles	profile	NOUN
ajlm-2846	57	9	based	base	VERB
ajlm-2846	57	10	on	on	ADP
ajlm-2846	57	11	igg	igg	PROPN
ajlm-2846	57	12	and	and	CCONJ
ajlm-2846	57	13	igm	igm	PROPN
ajlm-2846	57	14	results	result	NOUN
ajlm-2846	57	15	for	for	ADP
ajlm-2846	57	16	toxoplasma	toxoplasma	NOUN
ajlm-2846	57	17	gondii	gondii	NOUN
ajlm-2846	57	18	,	,	PUNCT
ajlm-2846	57	19	immunology	immunology	NOUN
ajlm-2846	57	20	laboratory	laboratory	NOUN
ajlm-2846	57	21	,	,	PUNCT
ajlm-2846	57	22	university	university	NOUN
ajlm-2846	57	23	hospital	hospital	NOUN
ajlm-2846	57	24	of	of	ADP
ajlm-2846	57	25	cocody	cocody	PROPN
ajlm-2846	57	26	,	,	PUNCT
ajlm-2846	57	27	abidjan	abidjan	PROPN
ajlm-2846	57	28	,	,	PUNCT
ajlm-2846	57	29	côte	côte	PROPN
ajlm-2846	57	30	d’ivoire	d’ivoire	PROPN
ajlm-2846	57	31	,	,	PUNCT
ajlm-2846	57	32	april	april	PROPN
ajlm-2846	57	33	2022	2022	NUM
ajlm-2846	57	34	–	–	PUNCT
ajlm-2846	57	35	march	march	PROPN
ajlm-2846	57	36	2023	2023	NUM
ajlm-2846	57	37	.	.	PUNCT
ajlm-2846	58	1	table	table	NOUN
ajlm-2846	58	2	3	3	NUM
ajlm-2846	58	3	:	:	PUNCT
ajlm-2846	58	4	 	 	SPACE
ajlm-2846	58	5	distribution	distribution	NOUN
ajlm-2846	58	6	of	of	ADP
ajlm-2846	58	7	igm	igm	ADJ
ajlm-2846	58	8	-	-	PUNCT
ajlm-2846	58	9	positive	positive	ADJ
ajlm-2846	58	10	profiles	profile	NOUN
ajlm-2846	58	11	according	accord	VERB
ajlm-2846	58	12	to	to	ADP
ajlm-2846	58	13	the	the	DET
ajlm-2846	58	14	age	age	NOUN
ajlm-2846	58	15	of	of	ADP
ajlm-2846	58	16	pregnancy	pregnancy	NOUN
ajlm-2846	58	17	,	,	PUNCT
ajlm-2846	58	18	immunology	immunology	NOUN
ajlm-2846	58	19	laboratory	laboratory	NOUN
ajlm-2846	58	20	,	,	PUNCT
ajlm-2846	58	21	university	university	NOUN
ajlm-2846	58	22	hospital	hospital	NOUN
ajlm-2846	58	23	of	of	ADP
ajlm-2846	58	24	cocody	cocody	PROPN
ajlm-2846	58	25	,	,	PUNCT
ajlm-2846	58	26	abidjan	abidjan	PROPN
ajlm-2846	58	27	,	,	PUNCT
ajlm-2846	58	28	côte	côte	PROPN
ajlm-2846	58	29	d’ivoire	d’ivoire	PROPN
ajlm-2846	58	30	,	,	PUNCT
ajlm-2846	58	31	april	april	PROPN
ajlm-2846	58	32	2022	2022	NUM
ajlm-2846	58	33	–	–	PUNCT
ajlm-2846	58	34	march	march	PROPN
ajlm-2846	58	35	2023	2023	NUM
ajlm-2846	58	36	.	.	PUNCT
ajlm-2846	59	1	reason	reason	NOUN
ajlm-2846	59	2	for	for	ADP
ajlm-2846	59	3	requesting	request	VERB
ajlm-2846	59	4	serology	serology	NOUN
ajlm-2846	59	5	toxoplasma	toxoplasma	NOUN
ajlm-2846	59	6	serology	serology	NOUN
ajlm-2846	59	7	was	be	AUX
ajlm-2846	59	8	carried	carry	VERB
ajlm-2846	59	9	out	out	ADP
ajlm-2846	59	10	as	as	ADP
ajlm-2846	59	11	part	part	NOUN
ajlm-2846	59	12	of	of	ADP
ajlm-2846	59	13	routine	routine	ADJ
ajlm-2846	59	14	prenatal	prenatal	ADJ
ajlm-2846	59	15	screening	screening	NOUN
ajlm-2846	59	16	in	in	ADP
ajlm-2846	59	17	169	169	NUM
ajlm-2846	59	18	women	woman	NOUN
ajlm-2846	59	19	(	(	PUNCT
ajlm-2846	59	20	84.5	84.5	NUM
ajlm-2846	59	21	%	%	NOUN
ajlm-2846	59	22	)	)	PUNCT
ajlm-2846	59	23	and	and	CCONJ
ajlm-2846	59	24	as	as	ADP
ajlm-2846	59	25	part	part	NOUN
ajlm-2846	59	26	of	of	ADP
ajlm-2846	59	27	the	the	DET
ajlm-2846	59	28	follow	follow	NOUN
ajlm-2846	59	29	-	-	PUNCT
ajlm-2846	59	30	up	up	NOUN
ajlm-2846	59	31	of	of	ADP
ajlm-2846	59	32	patients	patient	NOUN
ajlm-2846	59	33	at	at	ADP
ajlm-2846	59	34	risk	risk	NOUN
ajlm-2846	59	35	in	in	ADP
ajlm-2846	59	36	31	31	NUM
ajlm-2846	59	37	women	woman	NOUN
ajlm-2846	59	38	(	(	PUNCT
ajlm-2846	59	39	15.5	15.5	NUM
ajlm-2846	59	40	%	%	NOUN
ajlm-2846	59	41	)	)	PUNCT
ajlm-2846	59	42	(	(	PUNCT
ajlm-2846	59	43	table	table	NOUN
ajlm-2846	59	44	1	1	NUM
ajlm-2846	59	45	)	)	PUNCT
ajlm-2846	59	46	.	.	PUNCT
ajlm-2846	60	1	of	of	ADP
ajlm-2846	60	2	the	the	DET
ajlm-2846	60	3	169	169	NUM
ajlm-2846	60	4	screened	screen	VERB
ajlm-2846	60	5	,	,	PUNCT
ajlm-2846	60	6	only	only	ADV
ajlm-2846	60	7	29	29	NUM
ajlm-2846	60	8	(	(	PUNCT
ajlm-2846	60	9	17.2	17.2	NUM
ajlm-2846	60	10	%	%	NOUN
ajlm-2846	60	11	)	)	PUNCT
ajlm-2846	60	12	were	be	AUX
ajlm-2846	60	13	tested	test	VERB
ajlm-2846	60	14	in	in	ADP
ajlm-2846	60	15	the	the	DET
ajlm-2846	60	16	first	first	ADJ
ajlm-2846	60	17	trimester	trimester	NOUN
ajlm-2846	60	18	,	,	PUNCT
ajlm-2846	60	19	compared	compare	VERB
ajlm-2846	60	20	with	with	ADP
ajlm-2846	60	21	74	74	NUM
ajlm-2846	60	22	(	(	PUNCT
ajlm-2846	60	23	43.8	43.8	NUM
ajlm-2846	60	24	%	%	NOUN
ajlm-2846	60	25	)	)	PUNCT
ajlm-2846	60	26	in	in	ADP
ajlm-2846	60	27	the	the	DET
ajlm-2846	60	28	second	second	ADJ
ajlm-2846	60	29	and	and	CCONJ
ajlm-2846	60	30	66	66	NUM
ajlm-2846	60	31	(	(	PUNCT
ajlm-2846	60	32	39.0	39.0	NUM
ajlm-2846	60	33	%	%	NOUN
ajlm-2846	60	34	)	)	PUNCT
ajlm-2846	60	35	in	in	ADP
ajlm-2846	60	36	the	the	DET
ajlm-2846	60	37	third	third	ADJ
ajlm-2846	60	38	(	(	PUNCT
ajlm-2846	60	39	table	table	NOUN
ajlm-2846	60	40	4	4	NUM
ajlm-2846	60	41	)	)	PUNCT
ajlm-2846	60	42	.	.	PUNCT
ajlm-2846	61	1	table	table	NOUN
ajlm-2846	61	2	4	4	NUM
ajlm-2846	61	3	:	:	PUNCT
ajlm-2846	61	4	 	 	SPACE
ajlm-2846	61	5	distribution	distribution	NOUN
ajlm-2846	61	6	of	of	ADP
ajlm-2846	61	7	requests	request	NOUN
ajlm-2846	61	8	for	for	ADP
ajlm-2846	61	9	toxoplasma	toxoplasma	NOUN
ajlm-2846	61	10	serology	serology	NOUN
ajlm-2846	61	11	according	accord	VERB
ajlm-2846	61	12	to	to	ADP
ajlm-2846	61	13	the	the	DET
ajlm-2846	61	14	age	age	NOUN
ajlm-2846	61	15	of	of	ADP
ajlm-2846	61	16	pregnancy	pregnancy	NOUN
ajlm-2846	61	17	and	and	CCONJ
ajlm-2846	61	18	the	the	DET
ajlm-2846	61	19	reason	reason	NOUN
ajlm-2846	61	20	for	for	ADP
ajlm-2846	61	21	carrying	carry	VERB
ajlm-2846	61	22	out	out	ADP
ajlm-2846	61	23	the	the	DET
ajlm-2846	61	24	test	test	NOUN
ajlm-2846	61	25	,	,	PUNCT
ajlm-2846	61	26	immunology	immunology	NOUN
ajlm-2846	61	27	laboratory	laboratory	NOUN
ajlm-2846	61	28	,	,	PUNCT
ajlm-2846	61	29	university	university	NOUN
ajlm-2846	61	30	hospital	hospital	NOUN
ajlm-2846	61	31	of	of	ADP
ajlm-2846	61	32	cocody	cocody	PROPN
ajlm-2846	61	33	,	,	PUNCT
ajlm-2846	61	34	abidjan	abidjan	PROPN
ajlm-2846	61	35	,	,	PUNCT
ajlm-2846	61	36	côte	côte	PROPN
ajlm-2846	61	37	d’ivoire	d’ivoire	PROPN
ajlm-2846	61	38	,	,	PUNCT
ajlm-2846	61	39	april	april	PROPN
ajlm-2846	61	40	2022	2022	NUM
ajlm-2846	61	41	–	–	PUNCT
ajlm-2846	61	42	march	march	PROPN
ajlm-2846	61	43	2023	2023	NUM
ajlm-2846	61	44	.	.	PUNCT
ajlm-2846	62	1	discussion	discussion	NOUN
ajlm-2846	62	2	the	the	DET
ajlm-2846	62	3	results	result	NOUN
ajlm-2846	62	4	of	of	ADP
ajlm-2846	62	5	this	this	DET
ajlm-2846	62	6	study	study	NOUN
ajlm-2846	62	7	show	show	VERB
ajlm-2846	62	8	an	an	DET
ajlm-2846	62	9	overall	overall	ADJ
ajlm-2846	62	10	igg	igg	NOUN
ajlm-2846	62	11	seroprevalence	seroprevalence	NOUN
ajlm-2846	62	12	of	of	ADP
ajlm-2846	62	13	49.0	49.0	NUM
ajlm-2846	62	14	%	%	NOUN
ajlm-2846	62	15	among	among	ADP
ajlm-2846	62	16	pregnant	pregnant	ADJ
ajlm-2846	62	17	women	woman	NOUN
ajlm-2846	62	18	.	.	PUNCT
ajlm-2846	63	1	this	this	DET
ajlm-2846	63	2	rate	rate	NOUN
ajlm-2846	63	3	is	be	AUX
ajlm-2846	63	4	comparable	comparable	ADJ
ajlm-2846	63	5	to	to	ADP
ajlm-2846	63	6	those	those	PRON
ajlm-2846	63	7	reported	report	VERB
ajlm-2846	63	8	in	in	ADP
ajlm-2846	63	9	côte	côte	PROPN
ajlm-2846	63	10	d’ivoire	d’ivoire	NOUN
ajlm-2846	63	11	in	in	ADP
ajlm-2846	63	12	abidjan	abidjan	PROPN
ajlm-2846	63	13	(	(	PUNCT
ajlm-2846	63	14	48%),16	48%),16	NOUN
ajlm-2846	63	15	and	and	CCONJ
ajlm-2846	63	16	in	in	ADP
ajlm-2846	63	17	daloa	daloa	NOUN
ajlm-2846	63	18	(	(	PUNCT
ajlm-2846	63	19	54.16%),18	54.16%),18	NUM
ajlm-2846	63	20	as	as	ADV
ajlm-2846	63	21	well	well	ADV
ajlm-2846	63	22	as	as	ADP
ajlm-2846	63	23	in	in	ADP
ajlm-2846	63	24	benin	benin	PROPN
ajlm-2846	63	25	in	in	ADP
ajlm-2846	63	26	cotonou	cotonou	PROPN
ajlm-2846	63	27	(	(	PUNCT
ajlm-2846	63	28	44.4%),14	44.4%),14	X
ajlm-2846	63	29	and	and	CCONJ
ajlm-2846	63	30	in	in	ADP
ajlm-2846	63	31	rural	rural	ADJ
ajlm-2846	63	32	areas	area	NOUN
ajlm-2846	63	33	(	(	PUNCT
ajlm-2846	63	34	36.1%),13	36.1%),13	PROPN
ajlm-2846	63	35	indicating	indicate	VERB
ajlm-2846	63	36	sustained	sustain	VERB
ajlm-2846	63	37	t.	t.	NOUN
ajlm-2846	63	38	gondii	gondii	NOUN
ajlm-2846	63	39	endemicity	endemicity	NOUN
ajlm-2846	63	40	in	in	ADP
ajlm-2846	63	41	west	west	PROPN
ajlm-2846	63	42	africa	africa	PROPN
ajlm-2846	63	43	.	.	PUNCT
ajlm-2846	64	1	similar	similar	ADJ
ajlm-2846	64	2	rates	rate	NOUN
ajlm-2846	64	3	have	have	AUX
ajlm-2846	64	4	also	also	ADV
ajlm-2846	64	5	been	be	AUX
ajlm-2846	64	6	observed	observe	VERB
ajlm-2846	64	7	in	in	ADP
ajlm-2846	64	8	other	other	ADJ
ajlm-2846	64	9	tropical	tropical	ADJ
ajlm-2846	64	10	contexts	contexts	NOUN
ajlm-2846	64	11	,	,	PUNCT
ajlm-2846	64	12	such	such	ADJ
ajlm-2846	64	13	as	as	ADP
ajlm-2846	64	14	mayotte19	mayotte19	NOUN
ajlm-2846	64	15	and	and	CCONJ
ajlm-2846	64	16	morocco.15	morocco.15	NOUN
ajlm-2846	64	17	at	at	ADP
ajlm-2846	64	18	the	the	DET
ajlm-2846	64	19	individual	individual	ADJ
ajlm-2846	64	20	level	level	NOUN
ajlm-2846	64	21	,	,	PUNCT
ajlm-2846	64	22	previous	previous	ADJ
ajlm-2846	64	23	infection	infection	NOUN
ajlm-2846	64	24	(	(	PUNCT
ajlm-2846	64	25	igg+/igm−	igg+/igm−	PROPN
ajlm-2846	64	26	)	)	PUNCT
ajlm-2846	64	27	is	be	AUX
ajlm-2846	64	28	generally	generally	ADV
ajlm-2846	64	29	considered	consider	VERB
ajlm-2846	64	30	reassuring	reassure	VERB
ajlm-2846	64	31	for	for	ADP
ajlm-2846	64	32	the	the	DET
ajlm-2846	64	33	current	current	ADJ
ajlm-2846	64	34	pregnancy	pregnancy	NOUN
ajlm-2846	64	35	.	.	PUNCT
ajlm-2846	65	1	however	however	ADV
ajlm-2846	65	2	,	,	PUNCT
ajlm-2846	65	3	the	the	DET
ajlm-2846	65	4	significant	significant	ADJ
ajlm-2846	65	5	proportion	proportion	NOUN
ajlm-2846	65	6	of	of	ADP
ajlm-2846	65	7	women	woman	NOUN
ajlm-2846	65	8	with	with	ADP
ajlm-2846	65	9	positive	positive	ADJ
ajlm-2846	65	10	igm	igm	NOUN
ajlm-2846	65	11	(	(	PUNCT
ajlm-2846	65	12	9.5	9.5	NUM
ajlm-2846	65	13	%	%	NOUN
ajlm-2846	65	14	)	)	PUNCT
ajlm-2846	65	15	,	,	PUNCT
ajlm-2846	65	16	including	include	VERB
ajlm-2846	65	17	5.5	5.5	NUM
ajlm-2846	65	18	%	%	NOUN
ajlm-2846	65	19	with	with	ADP
ajlm-2846	65	20	igg−/igm+	igg−/igm+	PROPN
ajlm-2846	65	21	and	and	CCONJ
ajlm-2846	65	22	4.0	4.0	NUM
ajlm-2846	65	23	%	%	NOUN
ajlm-2846	65	24	with	with	ADP
ajlm-2846	65	25	igg+/igm+	igg+/igm+	PROPN
ajlm-2846	65	26	,	,	PUNCT
ajlm-2846	65	27	is	be	AUX
ajlm-2846	65	28	of	of	ADP
ajlm-2846	65	29	concern	concern	NOUN
ajlm-2846	65	30	.	.	PUNCT
ajlm-2846	66	1	these	these	DET
ajlm-2846	66	2	serological	serological	ADJ
ajlm-2846	66	3	profiles	profile	NOUN
ajlm-2846	66	4	reflect	reflect	VERB
ajlm-2846	66	5	recent	recent	ADJ
ajlm-2846	66	6	or	or	CCONJ
ajlm-2846	66	7	current	current	ADJ
ajlm-2846	66	8	infection	infection	NOUN
ajlm-2846	66	9	,	,	PUNCT
ajlm-2846	66	10	with	with	ADP
ajlm-2846	66	11	a	a	DET
ajlm-2846	66	12	risk	risk	NOUN
ajlm-2846	66	13	of	of	ADP
ajlm-2846	66	14	foetal	foetal	ADJ
ajlm-2846	66	15	transmission	transmission	NOUN
ajlm-2846	66	16	,	,	PUNCT
ajlm-2846	66	17	particularly	particularly	ADV
ajlm-2846	66	18	during	during	ADP
ajlm-2846	66	19	the	the	DET
ajlm-2846	66	20	first	first	ADJ
ajlm-2846	66	21	two	two	NUM
ajlm-2846	66	22	trimesters.6,20	trimesters.6,20	NOUN
ajlm-2846	66	23	in	in	ADP
ajlm-2846	66	24	the	the	DET
ajlm-2846	66	25	absence	absence	NOUN
ajlm-2846	66	26	of	of	ADP
ajlm-2846	66	27	an	an	DET
ajlm-2846	66	28	igg	igg	NOUN
ajlm-2846	66	29	-	-	PUNCT
ajlm-2846	66	30	avidity	avidity	NOUN
ajlm-2846	66	31	test	test	NOUN
ajlm-2846	66	32	,	,	PUNCT
ajlm-2846	66	33	it	it	PRON
ajlm-2846	66	34	remains	remain	VERB
ajlm-2846	66	35	difficult	difficult	ADJ
ajlm-2846	66	36	to	to	PART
ajlm-2846	66	37	distinguish	distinguish	VERB
ajlm-2846	66	38	acute	acute	ADJ
ajlm-2846	66	39	infection	infection	NOUN
ajlm-2846	66	40	,	,	PUNCT
ajlm-2846	66	41	reinfection	reinfection	NOUN
ajlm-2846	66	42	or	or	CCONJ
ajlm-2846	66	43	persistence	persistence	NOUN
ajlm-2846	66	44	of	of	ADP
ajlm-2846	66	45	igm.9,10	igm.9,10	NOUN
ajlm-2846	66	46	however	however	ADV
ajlm-2846	66	47	,	,	PUNCT
ajlm-2846	66	48	several	several	ADJ
ajlm-2846	66	49	authors	author	NOUN
ajlm-2846	66	50	recommend	recommend	VERB
ajlm-2846	66	51	that	that	SCONJ
ajlm-2846	66	52	,	,	PUNCT
ajlm-2846	66	53	in	in	ADP
ajlm-2846	66	54	cases	case	NOUN
ajlm-2846	66	55	of	of	ADP
ajlm-2846	66	56	igm	igm	NOUN
ajlm-2846	66	57	positivity	positivity	NOUN
ajlm-2846	66	58	,	,	PUNCT
ajlm-2846	66	59	treatment	treatment	NOUN
ajlm-2846	66	60	with	with	ADP
ajlm-2846	66	61	spiramycin	spiramycin	PROPN
ajlm-2846	66	62	be	be	AUX
ajlm-2846	66	63	initiated	initiate	VERB
ajlm-2846	66	64	early	early	ADV
ajlm-2846	66	65	,	,	PUNCT
ajlm-2846	66	66	accompanied	accompany	VERB
ajlm-2846	66	67	by	by	ADP
ajlm-2846	66	68	close	close	ADJ
ajlm-2846	66	69	ultrasound	ultrasound	ADJ
ajlm-2846	66	70	monitoring	monitoring	NOUN
ajlm-2846	66	71	,	,	PUNCT
ajlm-2846	66	72	even	even	ADV
ajlm-2846	66	73	in	in	ADP
ajlm-2846	66	74	the	the	DET
ajlm-2846	66	75	absence	absence	NOUN
ajlm-2846	66	76	of	of	ADP
ajlm-2846	66	77	confirmation	confirmation	NOUN
ajlm-2846	66	78	by	by	ADP
ajlm-2846	66	79	igg	igg	PROPN
ajlm-2846	66	80	-	-	PUNCT
ajlm-2846	66	81	avidity	avidity	NOUN
ajlm-2846	66	82	testing.12	testing.12	NOUN
ajlm-2846	66	83	furthermore	furthermore	ADV
ajlm-2846	66	84	,	,	PUNCT
ajlm-2846	66	85	a	a	DET
ajlm-2846	66	86	substantial	substantial	ADJ
ajlm-2846	66	87	proportion	proportion	NOUN
ajlm-2846	66	88	of	of	ADP
ajlm-2846	66	89	women	woman	NOUN
ajlm-2846	66	90	with	with	ADP
ajlm-2846	66	91	no	no	DET
ajlm-2846	66	92	infection	infection	NOUN
ajlm-2846	66	93	(	(	PUNCT
ajlm-2846	66	94	igg−/igm−	igg−/igm−	ADJ
ajlm-2846	66	95	;	;	PUNCT
ajlm-2846	66	96	45.5	45.5	NUM
ajlm-2846	66	97	%	%	NOUN
ajlm-2846	66	98	)	)	PUNCT
ajlm-2846	66	99	constitutes	constitute	VERB
ajlm-2846	66	100	a	a	DET
ajlm-2846	66	101	susceptible	susceptible	ADJ
ajlm-2846	66	102	group	group	NOUN
ajlm-2846	66	103	lacking	lack	VERB
ajlm-2846	66	104	protective	protective	ADJ
ajlm-2846	66	105	igg	igg	PROPN
ajlm-2846	66	106	.	.	PUNCT
ajlm-2846	67	1	although	although	SCONJ
ajlm-2846	67	2	exposure	exposure	NOUN
ajlm-2846	67	3	pathways	pathway	NOUN
ajlm-2846	67	4	were	be	AUX
ajlm-2846	67	5	not	not	PART
ajlm-2846	67	6	assessed	assess	VERB
ajlm-2846	67	7	in	in	ADP
ajlm-2846	67	8	this	this	DET
ajlm-2846	67	9	study	study	NOUN
ajlm-2846	67	10	,	,	PUNCT
ajlm-2846	67	11	targeted	target	VERB
ajlm-2846	67	12	antenatal	antenatal	ADJ
ajlm-2846	67	13	counselling	counselling	NOUN
ajlm-2846	67	14	on	on	ADP
ajlm-2846	67	15	food	food	NOUN
ajlm-2846	67	16	and	and	CCONJ
ajlm-2846	67	17	environmental	environmental	ADJ
ajlm-2846	67	18	hygiene	hygiene	NOUN
ajlm-2846	67	19	,	,	PUNCT
ajlm-2846	67	20	including	include	VERB
ajlm-2846	67	21	thorough	thorough	ADJ
ajlm-2846	67	22	cooking	cooking	NOUN
ajlm-2846	67	23	of	of	ADP
ajlm-2846	67	24	meat	meat	NOUN
ajlm-2846	67	25	,	,	PUNCT
ajlm-2846	67	26	remains	remain	VERB
ajlm-2846	67	27	essential	essential	ADJ
ajlm-2846	67	28	to	to	PART
ajlm-2846	67	29	prevent	prevent	VERB
ajlm-2846	67	30	primary	primary	ADJ
ajlm-2846	67	31	infection	infection	NOUN
ajlm-2846	67	32	during	during	ADP
ajlm-2846	67	33	pregnancy	pregnancy	NOUN
ajlm-2846	67	34	.	.	PUNCT
ajlm-2846	68	1	in	in	ADP
ajlm-2846	68	2	a	a	DET
ajlm-2846	68	3	highly	highly	ADV
ajlm-2846	68	4	endemic	endemic	ADJ
ajlm-2846	68	5	context	context	NOUN
ajlm-2846	68	6	such	such	ADJ
ajlm-2846	68	7	as	as	ADP
ajlm-2846	68	8	côte	côte	NOUN
ajlm-2846	68	9	d’ivoire,3,21	d’ivoire,3,21	NOUN
ajlm-2846	68	10	this	this	DET
ajlm-2846	68	11	risk	risk	NOUN
ajlm-2846	68	12	must	must	AUX
ajlm-2846	68	13	be	be	AUX
ajlm-2846	68	14	considered	consider	VERB
ajlm-2846	68	15	actively	actively	ADV
ajlm-2846	68	16	.	.	PUNCT
ajlm-2846	69	1	evidence	evidence	NOUN
ajlm-2846	69	2	indicates	indicate	VERB
ajlm-2846	69	3	that	that	SCONJ
ajlm-2846	69	4	the	the	DET
ajlm-2846	69	5	risk	risk	NOUN
ajlm-2846	69	6	of	of	ADP
ajlm-2846	69	7	vertical	vertical	ADJ
ajlm-2846	69	8	transmission	transmission	NOUN
ajlm-2846	69	9	rises	rise	VERB
ajlm-2846	69	10	with	with	ADP
ajlm-2846	69	11	advancing	advance	VERB
ajlm-2846	69	12	gestation	gestation	NOUN
ajlm-2846	69	13	,	,	PUNCT
ajlm-2846	69	14	from	from	ADP
ajlm-2846	69	15	10	10	NUM
ajlm-2846	69	16	%	%	NOUN
ajlm-2846	69	17	–	–	PUNCT
ajlm-2846	69	18	15	15	NUM
ajlm-2846	69	19	%	%	NOUN
ajlm-2846	69	20	in	in	ADP
ajlm-2846	69	21	the	the	DET
ajlm-2846	69	22	first	first	ADJ
ajlm-2846	69	23	trimester	trimester	NOUN
ajlm-2846	69	24	to	to	ADP
ajlm-2846	69	25	more	more	ADJ
ajlm-2846	69	26	than	than	ADP
ajlm-2846	69	27	60	60	NUM
ajlm-2846	69	28	%	%	NOUN
ajlm-2846	69	29	in	in	ADP
ajlm-2846	69	30	the	the	DET
ajlm-2846	69	31	third	third	NOUN
ajlm-2846	69	32	,	,	PUNCT
ajlm-2846	69	33	although	although	SCONJ
ajlm-2846	69	34	the	the	DET
ajlm-2846	69	35	most	most	ADV
ajlm-2846	69	36	severe	severe	ADJ
ajlm-2846	69	37	clinical	clinical	ADJ
ajlm-2846	69	38	forms	form	NOUN
ajlm-2846	69	39	of	of	ADP
ajlm-2846	69	40	congenital	congenital	ADJ
ajlm-2846	69	41	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	69	42	are	be	AUX
ajlm-2846	69	43	linked	link	VERB
ajlm-2846	69	44	to	to	ADP
ajlm-2846	69	45	early	early	PROPN
ajlm-2846	69	46	infections.22	infections.22	PROPN
ajlm-2846	69	47	cross	cross	NOUN
ajlm-2846	69	48	-	-	NOUN
ajlm-2846	69	49	analysis	analysis	NOUN
ajlm-2846	69	50	between	between	ADP
ajlm-2846	69	51	pregnancy	pregnancy	NOUN
ajlm-2846	69	52	trimesters	trimester	NOUN
ajlm-2846	69	53	and	and	CCONJ
ajlm-2846	69	54	serological	serological	ADJ
ajlm-2846	69	55	profiles	profile	NOUN
ajlm-2846	69	56	showed	show	VERB
ajlm-2846	69	57	that	that	SCONJ
ajlm-2846	69	58	igm	igm	ADJ
ajlm-2846	69	59	-	-	PUNCT
ajlm-2846	69	60	positive	positive	ADJ
ajlm-2846	69	61	cases	case	NOUN
ajlm-2846	69	62	occurred	occur	VERB
ajlm-2846	69	63	in	in	ADP
ajlm-2846	69	64	all	all	DET
ajlm-2846	69	65	trimesters	trimester	NOUN
ajlm-2846	69	66	,	,	PUNCT
ajlm-2846	69	67	with	with	ADP
ajlm-2846	69	68	a	a	DET
ajlm-2846	69	69	higher	high	ADJ
ajlm-2846	69	70	proportion	proportion	NOUN
ajlm-2846	69	71	in	in	ADP
ajlm-2846	69	72	the	the	DET
ajlm-2846	69	73	first	first	ADJ
ajlm-2846	69	74	(	(	PUNCT
ajlm-2846	69	75	17.6	17.6	NUM
ajlm-2846	69	76	%	%	NOUN
ajlm-2846	69	77	)	)	PUNCT
ajlm-2846	69	78	than	than	ADP
ajlm-2846	69	79	in	in	ADP
ajlm-2846	69	80	the	the	DET
ajlm-2846	69	81	second	second	ADJ
ajlm-2846	69	82	(	(	PUNCT
ajlm-2846	69	83	8.2	8.2	NUM
ajlm-2846	69	84	%	%	NOUN
ajlm-2846	69	85	)	)	PUNCT
ajlm-2846	69	86	and	and	CCONJ
ajlm-2846	69	87	third	third	ADV
ajlm-2846	69	88	(	(	PUNCT
ajlm-2846	69	89	7.4	7.4	NUM
ajlm-2846	69	90	%	%	NOUN
ajlm-2846	69	91	)	)	PUNCT
ajlm-2846	69	92	.	.	PUNCT
ajlm-2846	70	1	although	although	SCONJ
ajlm-2846	70	2	this	this	DET
ajlm-2846	70	3	difference	difference	NOUN
ajlm-2846	70	4	did	do	AUX
ajlm-2846	70	5	not	not	PART
ajlm-2846	70	6	reach	reach	VERB
ajlm-2846	70	7	statistical	statistical	ADJ
ajlm-2846	70	8	significance	significance	NOUN
ajlm-2846	70	9	(	(	PUNCT
ajlm-2846	70	10	χ2	χ2	NOUN
ajlm-2846	70	11	=	=	SYM
ajlm-2846	70	12	2.99	2.99	NUM
ajlm-2846	70	13	;	;	PUNCT
ajlm-2846	70	14	df	df	PROPN
ajlm-2846	70	15	=	=	SYM
ajlm-2846	70	16	2	2	NUM
ajlm-2846	70	17	;	;	PUNCT
ajlm-2846	70	18	p	p	NOUN
ajlm-2846	70	19	=	=	NOUN
ajlm-2846	70	20	0.22	0.22	NUM
ajlm-2846	70	21	)	)	PUNCT
ajlm-2846	70	22	,	,	PUNCT
ajlm-2846	70	23	the	the	DET
ajlm-2846	70	24	pattern	pattern	NOUN
ajlm-2846	70	25	is	be	AUX
ajlm-2846	70	26	consistent	consistent	ADJ
ajlm-2846	70	27	with	with	ADP
ajlm-2846	70	28	a	a	DET
ajlm-2846	70	29	higher	high	ADJ
ajlm-2846	70	30	risk	risk	NOUN
ajlm-2846	70	31	of	of	ADP
ajlm-2846	70	32	primary	primary	ADJ
ajlm-2846	70	33	infection	infection	NOUN
ajlm-2846	70	34	in	in	ADP
ajlm-2846	70	35	early	early	ADJ
ajlm-2846	70	36	pregnancy	pregnancy	NOUN
ajlm-2846	70	37	,	,	PUNCT
ajlm-2846	70	38	a	a	DET
ajlm-2846	70	39	critical	critical	ADJ
ajlm-2846	70	40	period	period	NOUN
ajlm-2846	70	41	for	for	ADP
ajlm-2846	70	42	the	the	DET
ajlm-2846	70	43	foetus	foetus	NOUN
ajlm-2846	70	44	.	.	PUNCT
ajlm-2846	71	1	these	these	DET
ajlm-2846	71	2	results	result	NOUN
ajlm-2846	71	3	,	,	PUNCT
ajlm-2846	71	4	although	although	SCONJ
ajlm-2846	71	5	observed	observe	VERB
ajlm-2846	71	6	in	in	ADP
ajlm-2846	71	7	the	the	DET
ajlm-2846	71	8	absence	absence	NOUN
ajlm-2846	71	9	of	of	ADP
ajlm-2846	71	10	ultrasound	ultrasound	NOUN
ajlm-2846	71	11	or	or	CCONJ
ajlm-2846	71	12	neonatal	neonatal	ADJ
ajlm-2846	71	13	confirmation	confirmation	NOUN
ajlm-2846	71	14	,	,	PUNCT
ajlm-2846	71	15	underscore	underscore	VERB
ajlm-2846	71	16	the	the	DET
ajlm-2846	71	17	need	need	NOUN
ajlm-2846	71	18	for	for	ADP
ajlm-2846	71	19	increased	increase	VERB
ajlm-2846	71	20	vigilance	vigilance	NOUN
ajlm-2846	71	21	from	from	ADP
ajlm-2846	71	22	the	the	DET
ajlm-2846	71	23	first	first	ADJ
ajlm-2846	71	24	trimester	trimester	NOUN
ajlm-2846	71	25	,	,	PUNCT
ajlm-2846	71	26	including	include	VERB
ajlm-2846	71	27	,	,	PUNCT
ajlm-2846	71	28	where	where	SCONJ
ajlm-2846	71	29	possible	possible	ADJ
ajlm-2846	71	30	,	,	PUNCT
ajlm-2846	71	31	amniotic	amniotic	ADJ
ajlm-2846	71	32	-	-	PUNCT
ajlm-2846	71	33	fluid	fluid	NOUN
ajlm-2846	71	34	pcr	pcr	NOUN
ajlm-2846	71	35	when	when	SCONJ
ajlm-2846	71	36	a	a	DET
ajlm-2846	71	37	recent	recent	ADJ
ajlm-2846	71	38	infection	infection	NOUN
ajlm-2846	71	39	is	be	AUX
ajlm-2846	71	40	suspected.11,12,23	suspected.11,12,23	NOUN
ajlm-2846	71	41	our	our	PRON
ajlm-2846	71	42	work	work	NOUN
ajlm-2846	71	43	is	be	AUX
ajlm-2846	71	44	a	a	DET
ajlm-2846	71	45	seroprevalence	seroprevalence	NOUN
ajlm-2846	71	46	study	study	NOUN
ajlm-2846	71	47	based	base	VERB
ajlm-2846	71	48	on	on	ADP
ajlm-2846	71	49	laboratory	laboratory	NOUN
ajlm-2846	71	50	data	datum	NOUN
ajlm-2846	71	51	;	;	PUNCT
ajlm-2846	71	52	the	the	DET
ajlm-2846	71	53	assessment	assessment	NOUN
ajlm-2846	71	54	of	of	ADP
ajlm-2846	71	55	clinical	clinical	ADJ
ajlm-2846	71	56	management	management	NOUN
ajlm-2846	71	57	and	and	CCONJ
ajlm-2846	71	58	obstetric	obstetric	ADJ
ajlm-2846	71	59	or	or	CCONJ
ajlm-2846	71	60	neonatal	neonatal	ADJ
ajlm-2846	71	61	outcomes	outcome	NOUN
ajlm-2846	71	62	was	be	AUX
ajlm-2846	71	63	not	not	PART
ajlm-2846	71	64	part	part	NOUN
ajlm-2846	71	65	of	of	ADP
ajlm-2846	71	66	the	the	DET
ajlm-2846	71	67	present	present	ADJ
ajlm-2846	71	68	analysis	analysis	NOUN
ajlm-2846	71	69	.	.	PUNCT
ajlm-2846	72	1	furthermore	furthermore	ADV
ajlm-2846	72	2	,	,	PUNCT
ajlm-2846	72	3	our	our	PRON
ajlm-2846	72	4	study	study	NOUN
ajlm-2846	72	5	revealed	reveal	VERB
ajlm-2846	72	6	late	late	ADJ
ajlm-2846	72	7	initiation	initiation	NOUN
ajlm-2846	72	8	of	of	ADP
ajlm-2846	72	9	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	72	10	screening	screen	VERB
ajlm-2846	72	11	among	among	ADP
ajlm-2846	72	12	pregnant	pregnant	ADJ
ajlm-2846	72	13	women	woman	NOUN
ajlm-2846	72	14	.	.	PUNCT
ajlm-2846	73	1	only	only	ADV
ajlm-2846	73	2	17.2	17.2	NUM
ajlm-2846	73	3	%	%	NOUN
ajlm-2846	73	4	were	be	AUX
ajlm-2846	73	5	screened	screen	VERB
ajlm-2846	73	6	in	in	ADP
ajlm-2846	73	7	the	the	DET
ajlm-2846	73	8	first	first	ADJ
ajlm-2846	73	9	trimester	trimester	NOUN
ajlm-2846	73	10	,	,	PUNCT
ajlm-2846	73	11	compared	compare	VERB
ajlm-2846	73	12	with	with	ADP
ajlm-2846	73	13	43.8	43.8	NUM
ajlm-2846	73	14	%	%	NOUN
ajlm-2846	73	15	and	and	CCONJ
ajlm-2846	73	16	39.0	39.0	NUM
ajlm-2846	73	17	%	%	NOUN
ajlm-2846	73	18	in	in	ADP
ajlm-2846	73	19	the	the	DET
ajlm-2846	73	20	second	second	ADJ
ajlm-2846	73	21	and	and	CCONJ
ajlm-2846	73	22	third	third	ADJ
ajlm-2846	73	23	trimesters	trimester	NOUN
ajlm-2846	73	24	,	,	PUNCT
ajlm-2846	73	25	respectively	respectively	ADV
ajlm-2846	73	26	.	.	PUNCT
ajlm-2846	74	1	this	this	DET
ajlm-2846	74	2	delay	delay	NOUN
ajlm-2846	74	3	limits	limit	VERB
ajlm-2846	74	4	opportunities	opportunity	NOUN
ajlm-2846	74	5	for	for	ADP
ajlm-2846	74	6	early	early	ADJ
ajlm-2846	74	7	diagnosis	diagnosis	NOUN
ajlm-2846	74	8	and	and	CCONJ
ajlm-2846	74	9	,	,	PUNCT
ajlm-2846	74	10	where	where	SCONJ
ajlm-2846	74	11	indicated	indicate	VERB
ajlm-2846	74	12	,	,	PUNCT
ajlm-2846	74	13	timely	timely	ADJ
ajlm-2846	74	14	preventive	preventive	ADJ
ajlm-2846	74	15	measures	measure	NOUN
ajlm-2846	74	16	.	.	PUNCT
ajlm-2846	75	1	in	in	ADP
ajlm-2846	75	2	côte	côte	PROPN
ajlm-2846	75	3	d’ivoire	d’ivoire	PROPN
ajlm-2846	75	4	,	,	PUNCT
ajlm-2846	75	5	first	first	ADJ
ajlm-2846	75	6	trimester	trimester	NOUN
ajlm-2846	75	7	screening	screen	VERB
ajlm-2846	75	8	is	be	AUX
ajlm-2846	75	9	recommended	recommend	VERB
ajlm-2846	75	10	,	,	PUNCT
ajlm-2846	75	11	but	but	CCONJ
ajlm-2846	75	12	uptake	uptake	ADJ
ajlm-2846	75	13	is	be	AUX
ajlm-2846	75	14	constrained	constrain	VERB
ajlm-2846	75	15	by	by	ADP
ajlm-2846	75	16	out	out	ADV
ajlm-2846	75	17	-	-	PUNCT
ajlm-2846	75	18	of	of	ADP
ajlm-2846	75	19	-	-	PUNCT
ajlm-2846	75	20	pocket	pocket	NOUN
ajlm-2846	75	21	payment	payment	NOUN
ajlm-2846	75	22	,	,	PUNCT
ajlm-2846	75	23	as	as	SCONJ
ajlm-2846	75	24	the	the	DET
ajlm-2846	75	25	test	test	NOUN
ajlm-2846	75	26	is	be	AUX
ajlm-2846	75	27	not	not	PART
ajlm-2846	75	28	covered	cover	VERB
ajlm-2846	75	29	routinely	routinely	ADV
ajlm-2846	75	30	.	.	PUNCT
ajlm-2846	76	1	this	this	DET
ajlm-2846	76	2	financial	financial	ADJ
ajlm-2846	76	3	barrier	barrier	NOUN
ajlm-2846	76	4	delays	delay	NOUN
ajlm-2846	76	5	early	early	ADJ
ajlm-2846	76	6	screening	screening	NOUN
ajlm-2846	76	7	and	and	CCONJ
ajlm-2846	76	8	supports	support	VERB
ajlm-2846	76	9	consideration	consideration	NOUN
ajlm-2846	76	10	of	of	ADP
ajlm-2846	76	11	measures	measure	NOUN
ajlm-2846	76	12	to	to	PART
ajlm-2846	76	13	improve	improve	VERB
ajlm-2846	76	14	affordability	affordability	NOUN
ajlm-2846	76	15	,	,	PUNCT
ajlm-2846	76	16	for	for	ADP
ajlm-2846	76	17	example	example	NOUN
ajlm-2846	76	18	,	,	PUNCT
ajlm-2846	76	19	through	through	ADP
ajlm-2846	76	20	targeted	target	VERB
ajlm-2846	76	21	fee	fee	NOUN
ajlm-2846	76	22	exemptions	exemption	NOUN
ajlm-2846	76	23	or	or	CCONJ
ajlm-2846	76	24	inclusion	inclusion	NOUN
ajlm-2846	76	25	of	of	ADP
ajlm-2846	76	26	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	76	27	serology	serology	NOUN
ajlm-2846	76	28	in	in	ADP
ajlm-2846	76	29	the	the	DET
ajlm-2846	76	30	essential	essential	ADJ
ajlm-2846	76	31	antenatal	antenatal	NOUN
ajlm-2846	76	32	-	-	PUNCT
ajlm-2846	76	33	care	care	NOUN
ajlm-2846	76	34	package	package	NOUN
ajlm-2846	76	35	.	.	PUNCT
ajlm-2846	77	1	the	the	DET
ajlm-2846	77	2	main	main	ADJ
ajlm-2846	77	3	limitation	limitation	NOUN
ajlm-2846	77	4	of	of	ADP
ajlm-2846	77	5	this	this	DET
ajlm-2846	77	6	study	study	NOUN
ajlm-2846	77	7	lies	lie	VERB
ajlm-2846	77	8	in	in	ADP
ajlm-2846	77	9	its	its	PRON
ajlm-2846	77	10	retrospective	retrospective	ADJ
ajlm-2846	77	11	design	design	NOUN
ajlm-2846	77	12	without	without	ADP
ajlm-2846	77	13	longitudinal	longitudinal	ADJ
ajlm-2846	77	14	follow	follow	NOUN
ajlm-2846	77	15	-	-	PUNCT
ajlm-2846	77	16	up	up	NOUN
ajlm-2846	77	17	.	.	PUNCT
ajlm-2846	78	1	seroconversions	seroconversion	NOUN
ajlm-2846	78	2	and	and	CCONJ
ajlm-2846	78	3	pregnancy	pregnancy	NOUN
ajlm-2846	78	4	outcomes	outcome	NOUN
ajlm-2846	78	5	(	(	PUNCT
ajlm-2846	78	6	confirmation	confirmation	NOUN
ajlm-2846	78	7	of	of	ADP
ajlm-2846	78	8	foetal	foetal	ADJ
ajlm-2846	78	9	infection	infection	NOUN
ajlm-2846	78	10	or	or	CCONJ
ajlm-2846	78	11	neonatal	neonatal	ADJ
ajlm-2846	78	12	serology	serology	NOUN
ajlm-2846	78	13	)	)	PUNCT
ajlm-2846	78	14	could	could	AUX
ajlm-2846	78	15	not	not	PART
ajlm-2846	78	16	be	be	AUX
ajlm-2846	78	17	documented.24,25	documented.24,25	ADJ
ajlm-2846	78	18	in	in	ADP
ajlm-2846	78	19	addition	addition	NOUN
ajlm-2846	78	20	,	,	PUNCT
ajlm-2846	78	21	clinical	clinical	ADJ
ajlm-2846	78	22	management	management	NOUN
ajlm-2846	78	23	data	datum	NOUN
ajlm-2846	78	24	(	(	PUNCT
ajlm-2846	78	25	e.g.	e.g.	ADV
ajlm-2846	78	26	treatment	treatment	NOUN
ajlm-2846	78	27	initiation	initiation	NOUN
ajlm-2846	78	28	)	)	PUNCT
ajlm-2846	78	29	and	and	CCONJ
ajlm-2846	78	30	obstetric	obstetric	ADJ
ajlm-2846	78	31	or	or	CCONJ
ajlm-2846	78	32	neonatal	neonatal	ADJ
ajlm-2846	78	33	outcomes	outcome	NOUN
ajlm-2846	78	34	were	be	AUX
ajlm-2846	78	35	not	not	PART
ajlm-2846	78	36	recorded	record	VERB
ajlm-2846	78	37	in	in	ADP
ajlm-2846	78	38	the	the	DET
ajlm-2846	78	39	laboratory	laboratory	NOUN
ajlm-2846	78	40	registers	register	NOUN
ajlm-2846	78	41	and	and	CCONJ
ajlm-2846	78	42	were	be	AUX
ajlm-2846	78	43	therefore	therefore	ADV
ajlm-2846	78	44	unavailable	unavailable	ADJ
ajlm-2846	78	45	for	for	ADP
ajlm-2846	78	46	analysis	analysis	NOUN
ajlm-2846	78	47	,	,	PUNCT
ajlm-2846	78	48	which	which	PRON
ajlm-2846	78	49	,	,	PUNCT
ajlm-2846	78	50	together	together	ADV
ajlm-2846	78	51	with	with	ADP
ajlm-2846	78	52	the	the	DET
ajlm-2846	78	53	absence	absence	NOUN
ajlm-2846	78	54	of	of	ADP
ajlm-2846	78	55	igg	igg	PROPN
ajlm-2846	78	56	-	-	PUNCT
ajlm-2846	78	57	avidity	avidity	NOUN
ajlm-2846	78	58	testing	testing	NOUN
ajlm-2846	78	59	and	and	CCONJ
ajlm-2846	78	60	amniotic	amniotic	ADJ
ajlm-2846	78	61	-	-	PUNCT
ajlm-2846	78	62	fluid	fluid	NOUN
ajlm-2846	78	63	pcr	pcr	NOUN
ajlm-2846	78	64	,	,	PUNCT
ajlm-2846	78	65	limits	limit	VERB
ajlm-2846	78	66	precise	precise	ADJ
ajlm-2846	78	67	dating	dating	NOUN
ajlm-2846	78	68	of	of	ADP
ajlm-2846	78	69	infection	infection	NOUN
ajlm-2846	78	70	phases	phase	NOUN
ajlm-2846	78	71	and	and	CCONJ
ajlm-2846	78	72	the	the	DET
ajlm-2846	78	73	clinical	clinical	ADJ
ajlm-2846	78	74	interpretation	interpretation	NOUN
ajlm-2846	78	75	of	of	ADP
ajlm-2846	78	76	the	the	DET
ajlm-2846	78	77	findings.11,12	findings.11,12	NOUN
ajlm-2846	78	78	although	although	SCONJ
ajlm-2846	78	79	igg	igg	PROPN
ajlm-2846	78	80	titres	titre	NOUN
ajlm-2846	78	81	were	be	AUX
ajlm-2846	78	82	recorded	record	VERB
ajlm-2846	78	83	in	in	ADP
ajlm-2846	78	84	the	the	DET
ajlm-2846	78	85	laboratory	laboratory	NOUN
ajlm-2846	78	86	registers	register	NOUN
ajlm-2846	78	87	,	,	PUNCT
ajlm-2846	78	88	they	they	PRON
ajlm-2846	78	89	were	be	AUX
ajlm-2846	78	90	not	not	PART
ajlm-2846	78	91	analysed	analyse	VERB
ajlm-2846	78	92	here	here	ADV
ajlm-2846	78	93	because	because	SCONJ
ajlm-2846	78	94	their	their	PRON
ajlm-2846	78	95	interpretation	interpretation	NOUN
ajlm-2846	78	96	remains	remain	VERB
ajlm-2846	78	97	difficult	difficult	ADJ
ajlm-2846	78	98	without	without	ADP
ajlm-2846	78	99	avidity	avidity	NOUN
ajlm-2846	78	100	testing	testing	NOUN
ajlm-2846	78	101	;	;	PUNCT
ajlm-2846	78	102	however	however	ADV
ajlm-2846	78	103	,	,	PUNCT
ajlm-2846	78	104	prior	prior	ADJ
ajlm-2846	78	105	reports	report	NOUN
ajlm-2846	78	106	suggest	suggest	VERB
ajlm-2846	78	107	that	that	SCONJ
ajlm-2846	78	108	very	very	ADV
ajlm-2846	78	109	high	high	ADJ
ajlm-2846	78	110	igg	igg	PROPN
ajlm-2846	78	111	titres	titre	NOUN
ajlm-2846	78	112	may	may	AUX
ajlm-2846	78	113	indicate	indicate	VERB
ajlm-2846	78	114	long	long	ADV
ajlm-2846	78	115	-	-	PUNCT
ajlm-2846	78	116	standing	stand	VERB
ajlm-2846	78	117	immunity.10,16	immunity.10,16	NOUN
ajlm-2846	78	118	despite	despite	SCONJ
ajlm-2846	78	119	these	these	DET
ajlm-2846	78	120	limitations	limitation	NOUN
ajlm-2846	78	121	,	,	PUNCT
ajlm-2846	78	122	our	our	PRON
ajlm-2846	78	123	results	result	NOUN
ajlm-2846	78	124	support	support	VERB
ajlm-2846	78	125	strengthening	strengthen	VERB
ajlm-2846	78	126	prenatal	prenatal	ADJ
ajlm-2846	78	127	monitoring	monitoring	NOUN
ajlm-2846	78	128	practices	practice	NOUN
ajlm-2846	78	129	:	:	PUNCT
ajlm-2846	78	130	the	the	DET
ajlm-2846	78	131	implementation	implementation	NOUN
ajlm-2846	78	132	of	of	ADP
ajlm-2846	78	133	systematic	systematic	ADJ
ajlm-2846	78	134	screening	screening	NOUN
ajlm-2846	78	135	from	from	ADP
ajlm-2846	78	136	the	the	DET
ajlm-2846	78	137	first	first	ADJ
ajlm-2846	78	138	trimester	trimester	NOUN
ajlm-2846	78	139	,	,	PUNCT
ajlm-2846	78	140	serological	serological	ADJ
ajlm-2846	78	141	testing	testing	NOUN
ajlm-2846	78	142	in	in	ADP
ajlm-2846	78	143	cases	case	NOUN
ajlm-2846	78	144	of	of	ADP
ajlm-2846	78	145	seronegativity	seronegativity	NOUN
ajlm-2846	78	146	or	or	CCONJ
ajlm-2846	78	147	clinical	clinical	ADJ
ajlm-2846	78	148	doubt	doubt	NOUN
ajlm-2846	78	149	,	,	PUNCT
ajlm-2846	78	150	and	and	CCONJ
ajlm-2846	78	151	better	well	ADJ
ajlm-2846	78	152	interpretation	interpretation	NOUN
ajlm-2846	78	153	of	of	ADP
ajlm-2846	78	154	serological	serological	ADJ
ajlm-2846	78	155	profiles	profile	NOUN
ajlm-2846	78	156	.	.	PUNCT
ajlm-2846	79	1	countries	country	NOUN
ajlm-2846	79	2	such	such	ADJ
ajlm-2846	79	3	as	as	ADP
ajlm-2846	79	4	france	france	PROPN
ajlm-2846	79	5	have	have	AUX
ajlm-2846	79	6	demonstrated	demonstrate	VERB
ajlm-2846	79	7	that	that	SCONJ
ajlm-2846	79	8	early	early	ADJ
ajlm-2846	79	9	treatment	treatment	NOUN
ajlm-2846	79	10	with	with	ADP
ajlm-2846	79	11	spiramycin	spiramycin	PROPN
ajlm-2846	79	12	reduces	reduce	VERB
ajlm-2846	79	13	the	the	DET
ajlm-2846	79	14	foetal	foetal	ADJ
ajlm-2846	79	15	transmission	transmission	NOUN
ajlm-2846	79	16	rate	rate	NOUN
ajlm-2846	79	17	significantly	significantly	ADV
ajlm-2846	79	18	from	from	ADP
ajlm-2846	79	19	more	more	ADJ
ajlm-2846	79	20	than	than	ADP
ajlm-2846	79	21	30	30	NUM
ajlm-2846	79	22	%	%	NOUN
ajlm-2846	79	23	to	to	ADP
ajlm-2846	79	24	less	less	ADJ
ajlm-2846	79	25	than	than	ADP
ajlm-2846	79	26	5%.23	5%.23	NUM
ajlm-2846	79	27	in	in	ADP
ajlm-2846	79	28	côte	côte	PROPN
ajlm-2846	79	29	d’ivoire	d’ivoire	NOUN
ajlm-2846	79	30	,	,	PUNCT
ajlm-2846	79	31	although	although	SCONJ
ajlm-2846	79	32	national	national	ADJ
ajlm-2846	79	33	recommendations	recommendation	NOUN
ajlm-2846	79	34	exist	exist	VERB
ajlm-2846	79	35	,	,	PUNCT
ajlm-2846	79	36	their	their	PRON
ajlm-2846	79	37	application	application	NOUN
ajlm-2846	79	38	remains	remain	VERB
ajlm-2846	79	39	inconsistent	inconsistent	ADJ
ajlm-2846	79	40	.	.	PUNCT
ajlm-2846	80	1	it	it	PRON
ajlm-2846	80	2	is	be	AUX
ajlm-2846	80	3	therefore	therefore	ADV
ajlm-2846	80	4	essential	essential	ADJ
ajlm-2846	80	5	to	to	PART
ajlm-2846	80	6	train	train	VERB
ajlm-2846	80	7	medical	medical	ADJ
ajlm-2846	80	8	personnel	personnel	NOUN
ajlm-2846	80	9	in	in	ADP
ajlm-2846	80	10	serological	serological	ADJ
ajlm-2846	80	11	interpretation	interpretation	NOUN
ajlm-2846	80	12	,	,	PUNCT
ajlm-2846	80	13	to	to	PART
ajlm-2846	80	14	make	make	VERB
ajlm-2846	80	15	igg	igg	NOUN
ajlm-2846	80	16	-	-	PUNCT
ajlm-2846	80	17	avidity	avidity	NOUN
ajlm-2846	80	18	and	and	CCONJ
ajlm-2846	80	19	pcr	pcr	NOUN
ajlm-2846	80	20	testing	testing	NOUN
ajlm-2846	80	21	available	available	ADJ
ajlm-2846	80	22	,	,	PUNCT
ajlm-2846	80	23	to	to	PART
ajlm-2846	80	24	raise	raise	VERB
ajlm-2846	80	25	awareness	awareness	NOUN
ajlm-2846	80	26	among	among	ADP
ajlm-2846	80	27	pregnant	pregnant	ADJ
ajlm-2846	80	28	women	woman	NOUN
ajlm-2846	80	29	about	about	ADP
ajlm-2846	80	30	preventive	preventive	ADJ
ajlm-2846	80	31	measures	measure	NOUN
ajlm-2846	80	32	,	,	PUNCT
ajlm-2846	80	33	and	and	CCONJ
ajlm-2846	80	34	to	to	PART
ajlm-2846	80	35	ensure	ensure	VERB
ajlm-2846	80	36	access	access	NOUN
ajlm-2846	80	37	to	to	ADP
ajlm-2846	80	38	specific	specific	ADJ
ajlm-2846	80	39	treatments	treatment	NOUN
ajlm-2846	80	40	.	.	PUNCT
ajlm-2846	81	1	conclusion	conclusion	NOUN
ajlm-2846	81	2	gestational	gestational	ADJ
ajlm-2846	81	3	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	81	4	remains	remain	VERB
ajlm-2846	81	5	a	a	DET
ajlm-2846	81	6	concern	concern	NOUN
ajlm-2846	81	7	in	in	ADP
ajlm-2846	81	8	our	our	PRON
ajlm-2846	81	9	setting	setting	NOUN
ajlm-2846	81	10	.	.	PUNCT
ajlm-2846	82	1	a	a	DET
ajlm-2846	82	2	notable	notable	ADJ
ajlm-2846	82	3	proportion	proportion	NOUN
ajlm-2846	82	4	of	of	ADP
ajlm-2846	82	5	pregnant	pregnant	ADJ
ajlm-2846	82	6	women	woman	NOUN
ajlm-2846	82	7	had	have	VERB
ajlm-2846	82	8	serological	serological	ADJ
ajlm-2846	82	9	evidence	evidence	NOUN
ajlm-2846	82	10	of	of	ADP
ajlm-2846	82	11	recent	recent	ADJ
ajlm-2846	82	12	or	or	CCONJ
ajlm-2846	82	13	current	current	ADJ
ajlm-2846	82	14	infection	infection	NOUN
ajlm-2846	82	15	.	.	PUNCT
ajlm-2846	83	1	screening	screen	VERB
ajlm-2846	83	2	frequently	frequently	ADV
ajlm-2846	83	3	begins	begin	VERB
ajlm-2846	83	4	after	after	ADP
ajlm-2846	83	5	the	the	DET
ajlm-2846	83	6	first	first	ADJ
ajlm-2846	83	7	trimester	trimester	NOUN
ajlm-2846	83	8	,	,	PUNCT
ajlm-2846	83	9	limiting	limit	VERB
ajlm-2846	83	10	opportunities	opportunity	NOUN
ajlm-2846	83	11	for	for	ADP
ajlm-2846	83	12	early	early	ADJ
ajlm-2846	83	13	diagnosis	diagnosis	NOUN
ajlm-2846	83	14	and	and	CCONJ
ajlm-2846	83	15	timely	timely	ADJ
ajlm-2846	83	16	preventive	preventive	ADJ
ajlm-2846	83	17	management	management	NOUN
ajlm-2846	83	18	.	.	PUNCT
ajlm-2846	84	1	these	these	DET
ajlm-2846	84	2	findings	finding	NOUN
ajlm-2846	84	3	support	support	NOUN
ajlm-2846	84	4	initiating	initiate	VERB
ajlm-2846	84	5	screening	screen	VERB
ajlm-2846	84	6	in	in	ADP
ajlm-2846	84	7	early	early	ADJ
ajlm-2846	84	8	pregnancy	pregnancy	NOUN
ajlm-2846	84	9	,	,	PUNCT
ajlm-2846	84	10	strengthening	strengthen	VERB
ajlm-2846	84	11	targeted	target	VERB
ajlm-2846	84	12	antenatal	antenatal	ADJ
ajlm-2846	84	13	counselling	counselling	NOUN
ajlm-2846	84	14	on	on	ADP
ajlm-2846	84	15	food	food	NOUN
ajlm-2846	84	16	and	and	CCONJ
ajlm-2846	84	17	environmental	environmental	ADJ
ajlm-2846	84	18	hygiene	hygiene	NOUN
ajlm-2846	84	19	,	,	PUNCT
ajlm-2846	84	20	and	and	CCONJ
ajlm-2846	84	21	improving	improve	VERB
ajlm-2846	84	22	access	access	NOUN
ajlm-2846	84	23	to	to	ADP
ajlm-2846	84	24	confirmatory	confirmatory	NOUN
ajlm-2846	84	25	diagnostics	diagnostic	NOUN
ajlm-2846	84	26	(	(	PUNCT
ajlm-2846	84	27	e.g.	e.g.	ADV
ajlm-2846	84	28	igg	igg	PROPN
ajlm-2846	84	29	-	-	PUNCT
ajlm-2846	84	30	avidity	avidity	NOUN
ajlm-2846	84	31	testing	testing	NOUN
ajlm-2846	84	32	and	and	CCONJ
ajlm-2846	84	33	,	,	PUNCT
ajlm-2846	84	34	where	where	SCONJ
ajlm-2846	84	35	indicated	indicate	VERB
ajlm-2846	84	36	,	,	PUNCT
ajlm-2846	84	37	amniotic	amniotic	ADJ
ajlm-2846	84	38	-	-	PUNCT
ajlm-2846	84	39	fluid	fluid	NOUN
ajlm-2846	84	40	pcr	pcr	NOUN
ajlm-2846	84	41	)	)	PUNCT
ajlm-2846	84	42	.	.	PUNCT
ajlm-2846	85	1	acknowledgements	acknowledgement	VERB
ajlm-2846	85	2	the	the	DET
ajlm-2846	85	3	authors	author	NOUN
ajlm-2846	85	4	thank	thank	VERB
ajlm-2846	85	5	the	the	DET
ajlm-2846	85	6	entire	entire	ADJ
ajlm-2846	85	7	staff	staff	NOUN
ajlm-2846	85	8	of	of	ADP
ajlm-2846	85	9	the	the	DET
ajlm-2846	85	10	immunology	immunology	NOUN
ajlm-2846	85	11	laboratory	laboratory	NOUN
ajlm-2846	85	12	at	at	ADP
ajlm-2846	85	13	the	the	DET
ajlm-2846	85	14	university	university	NOUN
ajlm-2846	85	15	hospital	hospital	NOUN
ajlm-2846	85	16	of	of	ADP
ajlm-2846	85	17	cocody	cocody	NOUN
ajlm-2846	85	18	for	for	ADP
ajlm-2846	85	19	their	their	PRON
ajlm-2846	85	20	collaboration	collaboration	NOUN
ajlm-2846	85	21	in	in	ADP
ajlm-2846	85	22	data	datum	NOUN
ajlm-2846	85	23	collection	collection	NOUN
ajlm-2846	85	24	.	.	PUNCT
ajlm-2846	86	1	competing	compete	VERB
ajlm-2846	86	2	interests	interest	NOUN
ajlm-2846	86	3	the	the	DET
ajlm-2846	86	4	authors	author	NOUN
ajlm-2846	86	5	declare	declare	VERB
ajlm-2846	86	6	that	that	SCONJ
ajlm-2846	86	7	they	they	PRON
ajlm-2846	86	8	have	have	VERB
ajlm-2846	86	9	no	no	DET
ajlm-2846	86	10	financial	financial	ADJ
ajlm-2846	86	11	or	or	CCONJ
ajlm-2846	86	12	personal	personal	ADJ
ajlm-2846	86	13	conflicts	conflict	NOUN
ajlm-2846	86	14	of	of	ADP
ajlm-2846	86	15	interest	interest	NOUN
ajlm-2846	86	16	related	relate	VERB
ajlm-2846	86	17	to	to	ADP
ajlm-2846	86	18	this	this	DET
ajlm-2846	86	19	article	article	NOUN
ajlm-2846	86	20	.	.	PUNCT
ajlm-2846	87	1	authors	author	NOUN
ajlm-2846	87	2	’	’	PART
ajlm-2846	87	3	contributions	contribution	NOUN
ajlm-2846	87	4	a.p.v.g.-k	a.p.v.g.-k	PROPN
ajlm-2846	87	5	.	.	PUNCT
ajlm-2846	88	1	designed	design	VERB
ajlm-2846	88	2	the	the	DET
ajlm-2846	88	3	study	study	NOUN
ajlm-2846	88	4	,	,	PUNCT
ajlm-2846	88	5	coordinated	coordinated	ADJ
ajlm-2846	88	6	data	datum	NOUN
ajlm-2846	88	7	collection	collection	NOUN
ajlm-2846	88	8	,	,	PUNCT
ajlm-2846	88	9	performed	perform	VERB
ajlm-2846	88	10	the	the	DET
ajlm-2846	88	11	statistical	statistical	ADJ
ajlm-2846	88	12	analysis	analysis	NOUN
ajlm-2846	88	13	,	,	PUNCT
ajlm-2846	88	14	and	and	CCONJ
ajlm-2846	88	15	wrote	write	VERB
ajlm-2846	88	16	the	the	DET
ajlm-2846	88	17	article	article	NOUN
ajlm-2846	88	18	.	.	PUNCT
ajlm-2846	89	1	o.r.y	o.r.y	PROPN
ajlm-2846	89	2	.	.	PUNCT
ajlm-2846	89	3	and	and	CCONJ
ajlm-2846	89	4	a.u.a.a	a.u.a.a	PROPN
ajlm-2846	89	5	.	.	PROPN
ajlm-2846	89	6	supervised	supervise	VERB
ajlm-2846	89	7	the	the	DET
ajlm-2846	89	8	analysis	analysis	NOUN
ajlm-2846	89	9	of	of	ADP
ajlm-2846	89	10	serological	serological	ADJ
ajlm-2846	89	11	results	result	NOUN
ajlm-2846	89	12	,	,	PUNCT
ajlm-2846	89	13	participated	participate	VERB
ajlm-2846	89	14	in	in	ADP
ajlm-2846	89	15	the	the	DET
ajlm-2846	89	16	clinical	clinical	ADJ
ajlm-2846	89	17	interpretation	interpretation	NOUN
ajlm-2846	89	18	,	,	PUNCT
ajlm-2846	89	19	and	and	CCONJ
ajlm-2846	89	20	critically	critically	ADV
ajlm-2846	89	21	reviewed	review	VERB
ajlm-2846	89	22	the	the	DET
ajlm-2846	89	23	article	article	NOUN
ajlm-2846	89	24	.	.	PUNCT
ajlm-2846	90	1	y.j.s	y.j.s	PROPN
ajlm-2846	90	2	.	.	PROPN
ajlm-2846	90	3	contributed	contribute	VERB
ajlm-2846	90	4	to	to	ADP
ajlm-2846	90	5	data	data	NOUN
ajlm-2846	90	6	collection	collection	NOUN
ajlm-2846	90	7	and	and	CCONJ
ajlm-2846	90	8	editing	editing	NOUN
ajlm-2846	90	9	.	.	PUNCT
ajlm-2846	91	1	s.r.d	s.r.d	NOUN
ajlm-2846	91	2	.	.	PUNCT
ajlm-2846	91	3	scientifically	scientifically	ADV
ajlm-2846	91	4	validated	validate	VERB
ajlm-2846	91	5	the	the	DET
ajlm-2846	91	6	protocol	protocol	NOUN
ajlm-2846	91	7	and	and	CCONJ
ajlm-2846	91	8	supervised	supervise	VERB
ajlm-2846	91	9	the	the	DET
ajlm-2846	91	10	work	work	NOUN
ajlm-2846	91	11	.	.	PUNCT
ajlm-2846	92	1	all	all	DET
ajlm-2846	92	2	authors	author	NOUN
ajlm-2846	92	3	,	,	PUNCT
ajlm-2846	92	4	a.p.v.g.-k	a.p.v.g.-k	PROPN
ajlm-2846	92	5	.	.	PUNCT
ajlm-2846	92	6	,	,	PUNCT
ajlm-2846	92	7	o.r.y	o.r.y	PROPN
ajlm-2846	92	8	.	.	PROPN
ajlm-2846	92	9	,	,	PUNCT
ajlm-2846	92	10	a.u.a.a	a.u.a.a	PROPN
ajlm-2846	92	11	.	.	PROPN
ajlm-2846	92	12	,	,	PUNCT
ajlm-2846	92	13	y.j.s	y.j.s	INTJ
ajlm-2846	92	14	.	.	PUNCT
ajlm-2846	92	15	,	,	PUNCT
ajlm-2846	92	16	and	and	CCONJ
ajlm-2846	92	17	s.r.d	s.r.d	PROPN
ajlm-2846	92	18	.	.	PROPN
ajlm-2846	92	19	have	have	AUX
ajlm-2846	92	20	read	read	VERB
ajlm-2846	92	21	and	and	CCONJ
ajlm-2846	92	22	approved	approve	VERB
ajlm-2846	92	23	the	the	DET
ajlm-2846	92	24	final	final	ADJ
ajlm-2846	92	25	version	version	NOUN
ajlm-2846	92	26	of	of	ADP
ajlm-2846	92	27	the	the	DET
ajlm-2846	92	28	article	article	NOUN
ajlm-2846	92	29	.	.	PUNCT
ajlm-2846	93	1	sources	source	NOUN
ajlm-2846	93	2	of	of	ADP
ajlm-2846	93	3	support	support	NOUN
ajlm-2846	93	4	this	this	DET
ajlm-2846	93	5	research	research	NOUN
ajlm-2846	93	6	received	receive	VERB
ajlm-2846	93	7	no	no	DET
ajlm-2846	93	8	specific	specific	ADJ
ajlm-2846	93	9	grant	grant	NOUN
ajlm-2846	93	10	from	from	ADP
ajlm-2846	93	11	any	any	DET
ajlm-2846	93	12	funding	funding	NOUN
ajlm-2846	93	13	agency	agency	NOUN
ajlm-2846	93	14	in	in	ADP
ajlm-2846	93	15	the	the	DET
ajlm-2846	93	16	public	public	ADJ
ajlm-2846	93	17	,	,	PUNCT
ajlm-2846	93	18	commercial	commercial	ADJ
ajlm-2846	93	19	,	,	PUNCT
ajlm-2846	93	20	or	or	CCONJ
ajlm-2846	93	21	not	not	PART
ajlm-2846	93	22	-	-	PUNCT
ajlm-2846	93	23	for	for	ADP
ajlm-2846	93	24	-	-	PUNCT
ajlm-2846	93	25	profit	profit	NOUN
ajlm-2846	93	26	sectors	sector	NOUN
ajlm-2846	93	27	.	.	PUNCT
ajlm-2846	94	1	data	datum	NOUN
ajlm-2846	94	2	availability	availability	NOUN
ajlm-2846	94	3	the	the	DET
ajlm-2846	94	4	data	datum	NOUN
ajlm-2846	94	5	that	that	PRON
ajlm-2846	94	6	support	support	VERB
ajlm-2846	94	7	the	the	DET
ajlm-2846	94	8	findings	finding	NOUN
ajlm-2846	94	9	of	of	ADP
ajlm-2846	94	10	this	this	DET
ajlm-2846	94	11	study	study	NOUN
ajlm-2846	94	12	are	be	AUX
ajlm-2846	94	13	not	not	PART
ajlm-2846	94	14	openly	openly	ADV
ajlm-2846	94	15	available	available	ADJ
ajlm-2846	94	16	due	due	ADP
ajlm-2846	94	17	to	to	ADP
ajlm-2846	94	18	reasons	reason	NOUN
ajlm-2846	94	19	of	of	ADP
ajlm-2846	94	20	sensitivity	sensitivity	NOUN
ajlm-2846	94	21	and	and	CCONJ
ajlm-2846	94	22	are	be	AUX
ajlm-2846	94	23	available	available	ADJ
ajlm-2846	94	24	from	from	ADP
ajlm-2846	94	25	the	the	DET
ajlm-2846	94	26	corresponding	corresponding	ADJ
ajlm-2846	94	27	author	author	NOUN
ajlm-2846	94	28	,	,	PUNCT
ajlm-2846	94	29	a.p.v.g.-k	a.p.v.g.-k	PROPN
ajlm-2846	94	30	.	.	PUNCT
ajlm-2846	94	31	,	,	PUNCT
ajlm-2846	94	32	upon	upon	SCONJ
ajlm-2846	94	33	reasonable	reasonable	ADJ
ajlm-2846	94	34	request	request	NOUN
ajlm-2846	94	35	.	.	PUNCT
ajlm-2846	95	1	disclaimer	disclaimer	VERB
ajlm-2846	95	2	the	the	DET
ajlm-2846	95	3	views	view	NOUN
ajlm-2846	95	4	and	and	CCONJ
ajlm-2846	95	5	opinions	opinion	NOUN
ajlm-2846	95	6	expressed	express	VERB
ajlm-2846	95	7	in	in	ADP
ajlm-2846	95	8	this	this	DET
ajlm-2846	95	9	article	article	NOUN
ajlm-2846	95	10	are	be	AUX
ajlm-2846	95	11	those	those	PRON
ajlm-2846	95	12	of	of	ADP
ajlm-2846	95	13	the	the	DET
ajlm-2846	95	14	authors	author	NOUN
ajlm-2846	95	15	and	and	CCONJ
ajlm-2846	95	16	are	be	AUX
ajlm-2846	95	17	the	the	DET
ajlm-2846	95	18	product	product	NOUN
ajlm-2846	95	19	of	of	ADP
ajlm-2846	95	20	professional	professional	ADJ
ajlm-2846	95	21	research	research	NOUN
ajlm-2846	95	22	.	.	PUNCT
ajlm-2846	96	1	the	the	DET
ajlm-2846	96	2	article	article	NOUN
ajlm-2846	96	3	does	do	AUX
ajlm-2846	96	4	not	not	PART
ajlm-2846	96	5	necessarily	necessarily	ADV
ajlm-2846	96	6	reflect	reflect	VERB
ajlm-2846	96	7	the	the	DET
ajlm-2846	96	8	official	official	ADJ
ajlm-2846	96	9	policy	policy	NOUN
ajlm-2846	96	10	or	or	CCONJ
ajlm-2846	96	11	position	position	NOUN
ajlm-2846	96	12	of	of	ADP
ajlm-2846	96	13	any	any	DET
ajlm-2846	96	14	affiliated	affiliated	ADJ
ajlm-2846	96	15	institution	institution	NOUN
ajlm-2846	96	16	,	,	PUNCT
ajlm-2846	96	17	funder	funder	NOUN
ajlm-2846	96	18	,	,	PUNCT
ajlm-2846	96	19	agency	agency	NOUN
ajlm-2846	96	20	,	,	PUNCT
ajlm-2846	96	21	or	or	CCONJ
ajlm-2846	96	22	that	that	PRON
ajlm-2846	96	23	of	of	ADP
ajlm-2846	96	24	the	the	DET
ajlm-2846	96	25	publisher	publisher	NOUN
ajlm-2846	96	26	.	.	PUNCT
ajlm-2846	97	1	the	the	DET
ajlm-2846	97	2	authors	author	NOUN
ajlm-2846	97	3	are	be	AUX
ajlm-2846	97	4	responsible	responsible	ADJ
ajlm-2846	97	5	for	for	ADP
ajlm-2846	97	6	the	the	DET
ajlm-2846	97	7	results	result	NOUN
ajlm-2846	97	8	,	,	PUNCT
ajlm-2846	97	9	findings	finding	NOUN
ajlm-2846	97	10	,	,	PUNCT
ajlm-2846	97	11	and	and	CCONJ
ajlm-2846	97	12	content	content	NOUN
ajlm-2846	97	13	of	of	ADP
ajlm-2846	97	14	this	this	DET
ajlm-2846	97	15	article	article	NOUN
ajlm-2846	97	16	.	.	PUNCT
ajlm-2846	98	1	references	reference	NOUN
ajlm-2846	98	2	smith	smith	PROPN
ajlm-2846	98	3	nc	nc	PROPN
ajlm-2846	98	4	,	,	PUNCT
ajlm-2846	98	5	goulart	goulart	PROPN
ajlm-2846	98	6	c	c	PROPN
ajlm-2846	98	7	,	,	PUNCT
ajlm-2846	98	8	hayward	hayward	PROPN
ajlm-2846	98	9	ja	ja	PROPN
ajlm-2846	98	10	,	,	PUNCT
ajlm-2846	98	11	kupz	kupz	PROPN
ajlm-2846	98	12	a	a	PRON
ajlm-2846	98	13	,	,	PUNCT
ajlm-2846	98	14	miller	miller	PROPN
ajlm-2846	98	15	cm	cm	PROPN
ajlm-2846	98	16	,	,	PUNCT
ajlm-2846	98	17	van	van	PROPN
ajlm-2846	98	18	dooren	dooren	PROPN
ajlm-2846	98	19	gg	gg	PROPN
ajlm-2846	98	20	.	.	PUNCT
ajlm-2846	99	1	control	control	PROPN
ajlm-2846	99	2	of	of	ADP
ajlm-2846	99	3	human	human	ADJ
ajlm-2846	99	4	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	99	5	.	.	PUNCT
ajlm-2846	100	1	int	int	PROPN
ajlm-2846	100	2	j	j	PROPN
ajlm-2846	100	3	parasitol	parasitol	NOUN
ajlm-2846	100	4	.	.	PUNCT
ajlm-2846	101	1	2021;51(2–3):95–121	2021;51(2–3):95–121	NUM
ajlm-2846	101	2	.	.	PUNCT
ajlm-2846	102	1	https://doi.org/10.1016/j.ijpara.2020.11.001	https://doi.org/10.1016/j.ijpara.2020.11.001	VERB
ajlm-2846	102	2	damar	damar	PROPN
ajlm-2846	102	3	çakırca	çakırca	PROPN
ajlm-2846	102	4	t	t	PROPN
ajlm-2846	102	5	,	,	PUNCT
ajlm-2846	102	6	can	can	AUX
ajlm-2846	102	7	i̇n	i̇n	PROPN
ajlm-2846	102	8	,	,	PUNCT
ajlm-2846	102	9	deniz	deniz	PROPN
ajlm-2846	102	10	m	m	PROPN
ajlm-2846	102	11	,	,	PUNCT
ajlm-2846	102	12	torun	torun	PROPN
ajlm-2846	102	13	a	a	PRON
ajlm-2846	102	14	,	,	PUNCT
ajlm-2846	102	15	akçabay	akçabay	ADJ
ajlm-2846	102	16	ç	ç	NOUN
ajlm-2846	102	17	,	,	PUNCT
ajlm-2846	102	18	güzelçiçek	güzelçiçek	PROPN
ajlm-2846	102	19	a.	a.	NOUN
ajlm-2846	102	20	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	102	21	:	:	PUNCT
ajlm-2846	102	22	a	a	DET
ajlm-2846	102	23	timeless	timeless	ADJ
ajlm-2846	102	24	challenge	challenge	NOUN
ajlm-2846	102	25	for	for	ADP
ajlm-2846	102	26	pregnancy	pregnancy	NOUN
ajlm-2846	102	27	.	.	PUNCT
ajlm-2846	103	1	trop	trop	X
ajlm-2846	103	2	med	me	VERB
ajlm-2846	103	3	infect	infect	PROPN
ajlm-2846	103	4	dis	dis	PROPN
ajlm-2846	103	5	.	.	PUNCT
ajlm-2846	104	1	2023;8(1):63	2023;8(1):63	X
ajlm-2846	104	2	.	.	PUNCT
ajlm-2846	105	1	https://doi.org/10.3390/tropicalmed8010063	https://doi.org/10.3390/tropicalmed8010063	PROPN
ajlm-2846	105	2	gelaw	gelaw	NOUN
ajlm-2846	105	3	ym	ym	PROPN
ajlm-2846	105	4	,	,	PUNCT
ajlm-2846	105	5	dagnew	dagnew	PROPN
ajlm-2846	105	6	gw	gw	PROPN
ajlm-2846	105	7	,	,	PUNCT
ajlm-2846	105	8	alene	alene	PROPN
ajlm-2846	105	9	gd	gd	PROPN
ajlm-2846	105	10	,	,	PUNCT
ajlm-2846	105	11	gangneux	gangneux	PROPN
ajlm-2846	105	12	jp	jp	PROPN
ajlm-2846	105	13	,	,	PUNCT
ajlm-2846	105	14	robert	robert	PROPN
ajlm-2846	105	15	-	-	PUNCT
ajlm-2846	105	16	gangneux	gangneux	PROPN
ajlm-2846	105	17	f.	f.	PROPN
ajlm-2846	105	18	toxoplasma	toxoplasma	PROPN
ajlm-2846	105	19	gondii	gondii	NOUN
ajlm-2846	105	20	seroprevalence	seroprevalence	NOUN
ajlm-2846	105	21	among	among	ADP
ajlm-2846	105	22	pregnant	pregnant	ADJ
ajlm-2846	105	23	women	woman	NOUN
ajlm-2846	105	24	in	in	ADP
ajlm-2846	105	25	africa	africa	PROPN
ajlm-2846	105	26	:	:	PUNCT
ajlm-2846	105	27	a	a	DET
ajlm-2846	105	28	systematic	systematic	ADJ
ajlm-2846	105	29	review	review	NOUN
ajlm-2846	105	30	and	and	CCONJ
ajlm-2846	105	31	meta	meta	ADJ
ajlm-2846	105	32	-	-	PUNCT
ajlm-2846	105	33	analysis	analysis	NOUN
ajlm-2846	105	34	.	.	PUNCT
ajlm-2846	106	1	plos	plos	PROPN
ajlm-2846	106	2	negl	negl	PROPN
ajlm-2846	106	3	trop	trop	X
ajlm-2846	106	4	dis	dis	PROPN
ajlm-2846	106	5	.	.	PUNCT
ajlm-2846	107	1	2024;18(5):e0012198	2024;18(5):e0012198	X
ajlm-2846	107	2	.	.	PUNCT
ajlm-2846	108	1	https://doi.org/10.1371/journal.pntd.0012198	https://doi.org/10.1371/journal.pntd.0012198	PROPN
ajlm-2846	108	2	borges	borges	PROPN
ajlm-2846	108	3	m	m	PROPN
ajlm-2846	108	4	,	,	PUNCT
ajlm-2846	108	5	magalhães	magalhães	PROPN
ajlm-2846	108	6	silva	silva	PROPN
ajlm-2846	108	7	t	t	PROPN
ajlm-2846	108	8	,	,	PUNCT
ajlm-2846	108	9	brito	brito	PROPN
ajlm-2846	108	10	c	c	PROPN
ajlm-2846	108	11	,	,	PUNCT
ajlm-2846	108	12	teixeira	teixeira	PROPN
ajlm-2846	108	13	n	n	PROPN
ajlm-2846	108	14	,	,	PUNCT
ajlm-2846	108	15	roberts	roberts	PROPN
ajlm-2846	108	16	cw	cw	PROPN
ajlm-2846	108	17	.	.	PUNCT
ajlm-2846	109	1	how	how	SCONJ
ajlm-2846	109	2	does	do	AUX
ajlm-2846	109	3	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	109	4	affect	affect	VERB
ajlm-2846	109	5	the	the	DET
ajlm-2846	109	6	maternal	maternal	ADJ
ajlm-2846	109	7	-	-	PUNCT
ajlm-2846	109	8	foetal	foetal	ADJ
ajlm-2846	109	9	immune	immune	ADJ
ajlm-2846	109	10	interface	interface	NOUN
ajlm-2846	109	11	and	and	CCONJ
ajlm-2846	109	12	pregnancy	pregnancy	NOUN
ajlm-2846	109	13	?	?	PUNCT
ajlm-2846	110	1	parasite	parasite	ADJ
ajlm-2846	110	2	immunol	immunol	NOUN
ajlm-2846	110	3	.	.	PUNCT
ajlm-2846	111	1	2019;41(3):e12606	2019;41(3):e12606	NUM
ajlm-2846	111	2	.	.	PUNCT
ajlm-2846	112	1	https://doi.org/10.1111/pim.12606	https://doi.org/10.1111/pim.12606	PROPN
ajlm-2846	112	2	bollani	bollani	PROPN
ajlm-2846	112	3	l	l	PROPN
ajlm-2846	112	4	,	,	PUNCT
ajlm-2846	112	5	auriti	auriti	ADP
ajlm-2846	112	6	c	c	NOUN
ajlm-2846	112	7	,	,	PUNCT
ajlm-2846	112	8	achille	achille	PROPN
ajlm-2846	112	9	c	c	PROPN
ajlm-2846	112	10	,	,	PUNCT
ajlm-2846	112	11	et	et	PROPN
ajlm-2846	112	12	al	al	PROPN
ajlm-2846	112	13	.	.	PROPN
ajlm-2846	112	14	congenital	congenital	ADJ
ajlm-2846	112	15	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	112	16	:	:	PUNCT
ajlm-2846	112	17	the	the	DET
ajlm-2846	112	18	state	state	NOUN
ajlm-2846	112	19	of	of	ADP
ajlm-2846	112	20	the	the	DET
ajlm-2846	112	21	art	art	NOUN
ajlm-2846	112	22	.	.	PUNCT
ajlm-2846	113	1	front	front	ADJ
ajlm-2846	113	2	pediatr	pediatr	ADJ
ajlm-2846	113	3	2022;10:894573	2022;10:894573	NUM
ajlm-2846	113	4	.	.	PUNCT
ajlm-2846	114	1	https://doi.org/10.3389/fped.2022.894573	https://doi.org/10.3389/fped.2022.894573	PROPN
ajlm-2846	114	2	gómez	gómez	NOUN
ajlm-2846	114	3	-	-	PUNCT
ajlm-2846	114	4	chávez	chávez	ADJ
ajlm-2846	114	5	f	f	PROPN
ajlm-2846	114	6	,	,	PUNCT
ajlm-2846	114	7	cañedo	cañedo	PROPN
ajlm-2846	114	8	-	-	PUNCT
ajlm-2846	114	9	solares	solare	NOUN
ajlm-2846	114	10	i	i	PROPN
ajlm-2846	114	11	,	,	PUNCT
ajlm-2846	114	12	ortiz	ortiz	PROPN
ajlm-2846	114	13	-	-	PUNCT
ajlm-2846	114	14	alegría	alegría	NOUN
ajlm-2846	114	15	lb	lb	PROPN
ajlm-2846	114	16	,	,	PUNCT
ajlm-2846	114	17	et	et	PROPN
ajlm-2846	114	18	al	al	PROPN
ajlm-2846	114	19	.	.	PROPN
ajlm-2846	114	20	maternal	maternal	ADJ
ajlm-2846	114	21	immune	immune	ADJ
ajlm-2846	114	22	response	response	NOUN
ajlm-2846	114	23	during	during	ADP
ajlm-2846	114	24	pregnancy	pregnancy	NOUN
ajlm-2846	114	25	and	and	CCONJ
ajlm-2846	114	26	vertical	vertical	ADJ
ajlm-2846	114	27	transmission	transmission	NOUN
ajlm-2846	114	28	in	in	ADP
ajlm-2846	114	29	human	human	ADJ
ajlm-2846	114	30	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	114	31	.	.	PUNCT
ajlm-2846	115	1	front	front	ADJ
ajlm-2846	115	2	immunol	immunol	NOUN
ajlm-2846	115	3	.	.	PUNCT
ajlm-2846	116	1	2019;10:285	2019;10:285	NUM
ajlm-2846	116	2	.	.	PUNCT
ajlm-2846	117	1	https://doi.org/10.3389/fimmu.2019.00285	https://doi.org/10.3389/fimmu.2019.00285	PROPN
ajlm-2846	117	2	yera	yera	PROPN
ajlm-2846	117	3	h	h	PROPN
ajlm-2846	117	4	,	,	PUNCT
ajlm-2846	117	5	paris	paris	PROPN
ajlm-2846	117	6	l	l	PROPN
ajlm-2846	117	7	,	,	PUNCT
ajlm-2846	117	8	bastien	bastien	PROPN
ajlm-2846	117	9	p	p	PROPN
ajlm-2846	117	10	,	,	PUNCT
ajlm-2846	117	11	candolfi	candolfi	PROPN
ajlm-2846	117	12	e.	e.	PROPN
ajlm-2846	117	13	diagnostic	diagnostic	PROPN
ajlm-2846	117	14	biologique	biologique	PROPN
ajlm-2846	117	15	de	de	X
ajlm-2846	117	16	la	la	PROPN
ajlm-2846	117	17	toxoplasmose	toxoplasmose	NOUN
ajlm-2846	117	18	congénitale	congénitale	NOUN
ajlm-2846	117	19	[	[	X
ajlm-2846	117	20	biological	biological	ADJ
ajlm-2846	117	21	diagnosis	diagnosis	NOUN
ajlm-2846	117	22	of	of	ADP
ajlm-2846	117	23	congenital	congenital	ADJ
ajlm-2846	117	24	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	117	25	]	]	PUNCT
ajlm-2846	117	26	.	.	PUNCT
ajlm-2846	118	1	rev	rev	PROPN
ajlm-2846	118	2	francoph	francoph	PROPN
ajlm-2846	118	3	lab	lab	PROPN
ajlm-2846	118	4	.	.	PUNCT
ajlm-2846	119	1	2015;470:65–72	2015;470:65–72	X
ajlm-2846	119	2	.	.	PUNCT
ajlm-2846	120	1	https://doi.org/10.1016/s1773-035x(15)30034-4	https://doi.org/10.1016/s1773-035x(15)30034-4	PROPN
ajlm-2846	120	2	franco	franco	PROPN
ajlm-2846	120	3	ps	ps	PROPN
ajlm-2846	120	4	,	,	PUNCT
ajlm-2846	120	5	scussel	scussel	ADJ
ajlm-2846	120	6	acmo	acmo	PROPN
ajlm-2846	120	7	,	,	PUNCT
ajlm-2846	120	8	silva	silva	PROPN
ajlm-2846	120	9	rj	rj	PROPN
ajlm-2846	120	10	,	,	PUNCT
ajlm-2846	120	11	et	et	PROPN
ajlm-2846	120	12	al	al	PROPN
ajlm-2846	120	13	.	.	PUNCT
ajlm-2846	120	14	systematic	systematic	PROPN
ajlm-2846	120	15	review	review	NOUN
ajlm-2846	120	16	and	and	CCONJ
ajlm-2846	120	17	meta	meta	NOUN
ajlm-2846	120	18	-	-	PUNCT
ajlm-2846	120	19	analysis	analysis	NOUN
ajlm-2846	120	20	of	of	ADP
ajlm-2846	120	21	congenital	congenital	ADJ
ajlm-2846	120	22	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	120	23	diagnosis	diagnosis	NOUN
ajlm-2846	120	24	:	:	PUNCT
ajlm-2846	120	25	advances	advance	NOUN
ajlm-2846	120	26	and	and	CCONJ
ajlm-2846	120	27	challenges	challenge	NOUN
ajlm-2846	120	28	.	.	PUNCT
ajlm-2846	121	1	j	j	PROPN
ajlm-2846	121	2	trop	trop	X
ajlm-2846	121	3	med	med	PROPN
ajlm-2846	121	4	.	.	PUNCT
ajlm-2846	122	1	2024;2024:1514178	2024;2024:1514178	NUM
ajlm-2846	122	2	.	.	PUNCT
ajlm-2846	123	1	https://doi.org/10.1155/2024/1514178	https://doi.org/10.1155/2024/1514178	PROPN
ajlm-2846	123	2	teimouri	teimouri	PROPN
ajlm-2846	123	3	a	a	X
ajlm-2846	123	4	,	,	PUNCT
ajlm-2846	123	5	mohtasebi	mohtasebi	X
ajlm-2846	123	6	s	s	PROPN
ajlm-2846	123	7	,	,	PUNCT
ajlm-2846	123	8	kazemirad	kazemirad	PROPN
ajlm-2846	123	9	e	e	PROPN
ajlm-2846	123	10	,	,	PUNCT
ajlm-2846	123	11	keshavarz	keshavarz	PROPN
ajlm-2846	123	12	h.	h.	PROPN
ajlm-2846	123	13	role	role	NOUN
ajlm-2846	123	14	of	of	ADP
ajlm-2846	123	15	toxoplasma	toxoplasma	NOUN
ajlm-2846	123	16	gondii	gondii	NOUN
ajlm-2846	123	17	igg	igg	PROPN
ajlm-2846	123	18	avidity	avidity	NOUN
ajlm-2846	123	19	testing	testing	NOUN
ajlm-2846	123	20	in	in	ADP
ajlm-2846	123	21	discriminating	discriminate	VERB
ajlm-2846	123	22	between	between	ADP
ajlm-2846	123	23	acute	acute	ADJ
ajlm-2846	123	24	and	and	CCONJ
ajlm-2846	123	25	chronic	chronic	ADJ
ajlm-2846	123	26	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	123	27	in	in	ADP
ajlm-2846	123	28	pregnancy	pregnancy	NOUN
ajlm-2846	123	29	.	.	PUNCT
ajlm-2846	124	1	j	j	PROPN
ajlm-2846	124	2	clin	clin	PROPN
ajlm-2846	124	3	microbiol	microbiol	PROPN
ajlm-2846	124	4	.	.	PUNCT
ajlm-2846	125	1	2020;58(9):e00505	2020;58(9):e00505	X
ajlm-2846	125	2	–	–	PUNCT
ajlm-2846	125	3	e00520	e00520	NOUN
ajlm-2846	125	4	.	.	PUNCT
ajlm-2846	126	1	https://doi.org/10.1128/jcm.00505-20	https://doi.org/10.1128/jcm.00505-20	PROPN
ajlm-2846	126	2	garnaud	garnaud	NOUN
ajlm-2846	126	3	c	c	NOUN
ajlm-2846	126	4	,	,	PUNCT
ajlm-2846	126	5	fricker	fricker	PROPN
ajlm-2846	126	6	-	-	PUNCT
ajlm-2846	126	7	hidalgo	hidalgo	PROPN
ajlm-2846	126	8	h	h	NOUN
ajlm-2846	126	9	,	,	PUNCT
ajlm-2846	126	10	evengård	evengård	PROPN
ajlm-2846	126	11	b	b	X
ajlm-2846	126	12	,	,	PUNCT
ajlm-2846	126	13	et	et	PROPN
ajlm-2846	126	14	al	al	PROPN
ajlm-2846	126	15	.	.	PUNCT
ajlm-2846	127	1	toxoplasma	toxoplasma	PROPN
ajlm-2846	127	2	gondii	gondii	NOUN
ajlm-2846	127	3	-	-	PUNCT
ajlm-2846	127	4	specific	specific	ADJ
ajlm-2846	127	5	igg	igg	NOUN
ajlm-2846	127	6	avidity	avidity	NOUN
ajlm-2846	127	7	testing	testing	NOUN
ajlm-2846	127	8	in	in	ADP
ajlm-2846	127	9	pregnant	pregnant	ADJ
ajlm-2846	127	10	women	woman	NOUN
ajlm-2846	127	11	.	.	PUNCT
ajlm-2846	128	1	clin	clin	PROPN
ajlm-2846	128	2	microbiol	microbiol	PROPN
ajlm-2846	128	3	infect	infect	PROPN
ajlm-2846	128	4	.	.	PUNCT
ajlm-2846	129	1	2020;26(9):1155–1160	2020;26(9):1155–1160	NUM
ajlm-2846	129	2	.	.	PUNCT
ajlm-2846	130	1	https://doi.org/10.1016/j.cmi.2020.04.014	https://doi.org/10.1016/j.cmi.2020.04.014	PROPN
ajlm-2846	130	2	de	de	PROPN
ajlm-2846	130	3	la	la	X
ajlm-2846	130	4	fuente	fuente	PROPN
ajlm-2846	130	5	villar	villar	PROPN
ajlm-2846	130	6	bb	bb	PROPN
ajlm-2846	130	7	,	,	PUNCT
ajlm-2846	130	8	gomes	gomes	PROPN
ajlm-2846	130	9	lhf	lhf	PROPN
ajlm-2846	130	10	,	,	PUNCT
ajlm-2846	130	11	portari	portari	PROPN
ajlm-2846	130	12	ea	ea	NUM
ajlm-2846	130	13	,	,	PUNCT
ajlm-2846	130	14	et	et	PROPN
ajlm-2846	130	15	al	al	PROPN
ajlm-2846	130	16	.	.	PUNCT
ajlm-2846	131	1	real	real	ADJ
ajlm-2846	131	2	-	-	PUNCT
ajlm-2846	131	3	time	time	NOUN
ajlm-2846	131	4	pcr	pcr	NOUN
ajlm-2846	131	5	in	in	ADP
ajlm-2846	131	6	the	the	DET
ajlm-2846	131	7	diagnosis	diagnosis	NOUN
ajlm-2846	131	8	of	of	ADP
ajlm-2846	131	9	congenital	congenital	ADJ
ajlm-2846	131	10	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	131	11	.	.	PUNCT
ajlm-2846	132	1	braz	braz	PROPN
ajlm-2846	132	2	j	j	PROPN
ajlm-2846	132	3	infect	infect	PROPN
ajlm-2846	132	4	dis	dis	PROPN
ajlm-2846	132	5	.	.	PUNCT
ajlm-2846	133	1	2023;27(5):102804	2023;27(5):102804	NOUN
ajlm-2846	133	2	.	.	PUNCT
ajlm-2846	134	1	https://doi.org/10.1016/j.bjid.2023.102804	https://doi.org/10.1016/j.bjid.2023.102804	NOUN
ajlm-2846	134	2	paquet	paquet	PROPN
ajlm-2846	134	3	c	c	PROPN
ajlm-2846	134	4	,	,	PUNCT
ajlm-2846	134	5	yudin	yudin	PROPN
ajlm-2846	134	6	mh	mh	PROPN
ajlm-2846	134	7	.	.	PUNCT
ajlm-2846	135	1	toxoplasmose	toxoplasmose	VERB
ajlm-2846	135	2	pendant	pendant	PROPN
ajlm-2846	135	3	la	la	PROPN
ajlm-2846	135	4	grossesse	grossesse	PROPN
ajlm-2846	135	5	:	:	PUNCT
ajlm-2846	135	6	prévention	prévention	NOUN
ajlm-2846	135	7	,	,	PUNCT
ajlm-2846	135	8	dépistage	dépistage	NOUN
ajlm-2846	135	9	et	et	NOUN
ajlm-2846	135	10	traitement	traitement	NOUN
ajlm-2846	135	11	[	[	X
ajlm-2846	135	12	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	135	13	during	during	ADP
ajlm-2846	135	14	pregnancy	pregnancy	NOUN
ajlm-2846	135	15	:	:	PUNCT
ajlm-2846	135	16	prevention	prevention	NOUN
ajlm-2846	135	17	,	,	PUNCT
ajlm-2846	135	18	screening	screening	NOUN
ajlm-2846	135	19	and	and	CCONJ
ajlm-2846	135	20	treatment	treatment	NOUN
ajlm-2846	135	21	]	]	PUNCT
ajlm-2846	135	22	.	.	PUNCT
ajlm-2846	136	1	j	j	PROPN
ajlm-2846	136	2	obstet	obstet	PROPN
ajlm-2846	136	3	gynaecol	gynaecol	PROPN
ajlm-2846	136	4	can	can	AUX
ajlm-2846	136	5	.	.	PUNCT
ajlm-2846	137	1	2018;40(8):e694	2018;40(8):e694	NUM
ajlm-2846	137	2	–	–	PUNCT
ajlm-2846	137	3	e702	e702	PROPN
ajlm-2846	137	4	.	.	PUNCT
ajlm-2846	137	5	https://doi.org/10.1016/j.jogc.2016.09.029	https://doi.org/10.1016/j.jogc.2016.09.029	PROPN
ajlm-2846	137	6	de	de	PROPN
ajlm-2846	137	7	tové	tové	NOUN
ajlm-2846	137	8	ys	ys	NOUN
ajlm-2846	137	9	,	,	PUNCT
ajlm-2846	137	10	hounto	hounto	NOUN
ajlm-2846	137	11	ao	ao	PROPN
ajlm-2846	137	12	,	,	PUNCT
ajlm-2846	137	13	vodouhe	vodouhe	PROPN
ajlm-2846	137	14	mv	mv	PROPN
ajlm-2846	137	15	,	,	PUNCT
ajlm-2846	137	16	et	et	PROPN
ajlm-2846	137	17	al	al	PROPN
ajlm-2846	137	18	.	.	PUNCT
ajlm-2846	138	1	séroprévalence	séroprévalence	PROPN
ajlm-2846	138	2	et	et	PROPN
ajlm-2846	138	3	facteurs	facteur	VERB
ajlm-2846	138	4	associés	associés	PROPN
ajlm-2846	138	5	à	à	X
ajlm-2846	138	6	la	la	X
ajlm-2846	138	7	toxoplasmose	toxoplasmose	ADJ
ajlm-2846	138	8	chez	chez	PROPN
ajlm-2846	138	9	la	la	X
ajlm-2846	138	10	femme	femme	X
ajlm-2846	138	11	enceinte	enceinte	X
ajlm-2846	138	12	en	en	PROPN
ajlm-2846	138	13	milieu	milieu	PROPN
ajlm-2846	138	14	rural	rural	PROPN
ajlm-2846	138	15	au	au	PROPN
ajlm-2846	138	16	bénin	bénin	PROPN
ajlm-2846	139	1	[	[	X
ajlm-2846	139	2	seroprevalence	seroprevalence	NOUN
ajlm-2846	139	3	and	and	CCONJ
ajlm-2846	139	4	factors	factor	NOUN
ajlm-2846	139	5	associated	associate	VERB
ajlm-2846	139	6	with	with	ADP
ajlm-2846	139	7	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	139	8	in	in	ADP
ajlm-2846	139	9	pregnant	pregnant	ADJ
ajlm-2846	139	10	women	woman	NOUN
ajlm-2846	139	11	living	live	VERB
ajlm-2846	139	12	in	in	ADP
ajlm-2846	139	13	rural	rural	ADJ
ajlm-2846	139	14	areas	area	NOUN
ajlm-2846	139	15	in	in	ADP
ajlm-2846	139	16	benin	benin	PROPN
ajlm-2846	139	17	]	]	PUNCT
ajlm-2846	139	18	.	.	PUNCT
ajlm-2846	140	1	pan	pan	PROPN
ajlm-2846	140	2	afr	afr	PROPN
ajlm-2846	140	3	med	med	PROPN
ajlm-2846	140	4	j.	j.	PROPN
ajlm-2846	140	5	2018;29:112	2018;29:112	PROPN
ajlm-2846	140	6	.	.	PUNCT
ajlm-2846	141	1	https://doi.org/10.11604/pamj.2018.29.112.14071	https://doi.org/10.11604/pamj.2018.29.112.14071	PROPN
ajlm-2846	141	2	amagbégnon	amagbégnon	NOUN
ajlm-2846	141	3	r	r	NOUN
ajlm-2846	141	4	,	,	PUNCT
ajlm-2846	141	5	dechavanne	dechavanne	PROPN
ajlm-2846	141	6	c	c	PROPN
ajlm-2846	141	7	,	,	PUNCT
ajlm-2846	141	8	dambrun	dambrun	PROPN
ajlm-2846	141	9	m	m	PROPN
ajlm-2846	141	10	,	,	PUNCT
ajlm-2846	141	11	et	et	PROPN
ajlm-2846	141	12	al	al	PROPN
ajlm-2846	141	13	.	.	PUNCT
ajlm-2846	141	14	seroepidemiology	seroepidemiology	PROPN
ajlm-2846	141	15	of	of	ADP
ajlm-2846	141	16	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	141	17	in	in	ADP
ajlm-2846	141	18	pregnant	pregnant	ADJ
ajlm-2846	141	19	women	woman	NOUN
ajlm-2846	141	20	and	and	CCONJ
ajlm-2846	141	21	detection	detection	NOUN
ajlm-2846	141	22	of	of	ADP
ajlm-2846	141	23	infection	infection	NOUN
ajlm-2846	141	24	acquired	acquire	VERB
ajlm-2846	141	25	during	during	ADP
ajlm-2846	141	26	pregnancy	pregnancy	NOUN
ajlm-2846	141	27	in	in	ADP
ajlm-2846	141	28	cotonou	cotonou	PROPN
ajlm-2846	141	29	,	,	PUNCT
ajlm-2846	141	30	benin	benin	PROPN
ajlm-2846	141	31	.	.	PUNCT
ajlm-2846	142	1	parasite	parasite	NOUN
ajlm-2846	142	2	.	.	PUNCT
ajlm-2846	143	1	2023;30:43	2023;30:43	NOUN
ajlm-2846	143	2	.	.	PUNCT
ajlm-2846	144	1	https://doi.org/10.1051/parasite/2023040	https://doi.org/10.1051/parasite/2023040	NUM
ajlm-2846	144	2	laboudi	laboudi	PROPN
ajlm-2846	144	3	m.	m.	NOUN
ajlm-2846	144	4	review	review	PROPN
ajlm-2846	144	5	of	of	ADP
ajlm-2846	144	6	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	144	7	in	in	ADP
ajlm-2846	144	8	morocco	morocco	PROPN
ajlm-2846	144	9	:	:	PUNCT
ajlm-2846	144	10	seroprevalence	seroprevalence	NOUN
ajlm-2846	144	11	and	and	CCONJ
ajlm-2846	144	12	risk	risk	NOUN
ajlm-2846	144	13	factors	factor	NOUN
ajlm-2846	144	14	for	for	ADP
ajlm-2846	144	15	toxoplasma	toxoplasma	ADJ
ajlm-2846	144	16	infection	infection	NOUN
ajlm-2846	144	17	among	among	ADP
ajlm-2846	144	18	pregnant	pregnant	ADJ
ajlm-2846	144	19	women	woman	NOUN
ajlm-2846	144	20	and	and	CCONJ
ajlm-2846	144	21	hivinfected	hivinfecte	VERB
ajlm-2846	144	22	patients	patient	NOUN
ajlm-2846	144	23	.	.	PUNCT
ajlm-2846	145	1	pan	pan	PROPN
ajlm-2846	145	2	afr	afr	PROPN
ajlm-2846	145	3	med	med	PROPN
ajlm-2846	145	4	j.	j.	PROPN
ajlm-2846	145	5	2017;27:269	2017;27:269	PROPN
ajlm-2846	145	6	.	.	PUNCT
ajlm-2846	146	1	https://doi.org/10.11604/pamj.2017.27.269.11822	https://doi.org/10.11604/pamj.2017.27.269.11822	PROPN
ajlm-2846	146	2	bonouman	bonouman	PROPN
ajlm-2846	146	3	-	-	PUNCT
ajlm-2846	146	4	ira	ira	PROPN
ajlm-2846	146	5	v	v	PROPN
ajlm-2846	146	6	,	,	PUNCT
ajlm-2846	146	7	bosson	bosson	PROPN
ajlm-2846	146	8	-	-	PUNCT
ajlm-2846	146	9	vanga	vanga	PROPN
ajlm-2846	146	10	ah	ah	INTJ
ajlm-2846	146	11	,	,	PUNCT
ajlm-2846	146	12	offianan	offianan	NOUN
ajlm-2846	146	13	at	at	ADP
ajlm-2846	146	14	,	,	PUNCT
ajlm-2846	146	15	angora	angora	PROPN
ajlm-2846	146	16	ke	ke	PROPN
ajlm-2846	146	17	,	,	PUNCT
ajlm-2846	146	18	djaman	djaman	NOUN
ajlm-2846	146	19	aj	aj	PROPN
ajlm-2846	146	20	.	.	PUNCT
ajlm-2846	146	21	séroprévalence	séroprévalence	PROPN
ajlm-2846	146	22	de	de	PROPN
ajlm-2846	146	23	la	la	PROPN
ajlm-2846	146	24	toxoplasmose	toxoplasmose	ADJ
ajlm-2846	146	25	chez	chez	PROPN
ajlm-2846	146	26	les	les	PROPN
ajlm-2846	146	27	femmes	femme	NOUN
ajlm-2846	146	28	enceintes	enceinte	NOUN
ajlm-2846	146	29	reçues	reçue	NOUN
ajlm-2846	146	30	au	au	ADP
ajlm-2846	146	31	laboratoire	laboratoire	PROPN
ajlm-2846	146	32	de	de	X
ajlm-2846	146	33	parasitologie	parasitologie	X
ajlm-2846	146	34	de	de	PROPN
ajlm-2846	146	35	l’institut	l’institut	PROPN
ajlm-2846	146	36	pasteur	pasteur	PROPN
ajlm-2846	146	37	de	de	PROPN
ajlm-2846	146	38	côte	côte	PROPN
ajlm-2846	146	39	d’ivoire	d’ivoire	NOUN
ajlm-2846	147	1	[	[	X
ajlm-2846	147	2	seroprevalence	seroprevalence	NOUN
ajlm-2846	147	3	of	of	ADP
ajlm-2846	147	4	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	147	5	among	among	ADP
ajlm-2846	147	6	pregnant	pregnant	ADJ
ajlm-2846	147	7	women	woman	NOUN
ajlm-2846	147	8	in	in	ADP
ajlm-2846	147	9	the	the	DET
ajlm-2846	147	10	laboratory	laboratory	NOUN
ajlm-2846	147	11	of	of	ADP
ajlm-2846	147	12	institut	institut	PROPN
ajlm-2846	147	13	pasteur	pasteur	PROPN
ajlm-2846	147	14	of	of	ADP
ajlm-2846	147	15	côte	côte	PROPN
ajlm-2846	147	16	d’ivoire	d’ivoire	PROPN
ajlm-2846	147	17	]	]	PUNCT
ajlm-2846	147	18	.	.	PUNCT
ajlm-2846	148	1	rev	rev	PROPN
ajlm-2846	148	2	int	int	PROPN
ajlm-2846	148	3	sci	sci	PROPN
ajlm-2846	148	4	méd	méd	PROPN
ajlm-2846	149	1	[	[	X
ajlm-2846	149	2	serial	serial	ADJ
ajlm-2846	149	3	online	online	NOUN
ajlm-2846	149	4	]	]	PUNCT
ajlm-2846	149	5	.	.	PUNCT
ajlm-2846	150	1	2017;19(4):267–271	2017;19(4):267–271	X
ajlm-2846	150	2	.	.	PUNCT
ajlm-2846	150	3	available	available	ADJ
ajlm-2846	150	4	from	from	ADP
ajlm-2846	150	5	:	:	PUNCT
ajlm-2846	150	6	https://www.revues-ufhb-ci.org/fichiers/fichir_article_2130.pdf	https://www.revues-ufhb-ci.org/fichiers/fichir_article_2130.pdf	PROPN
ajlm-2846	150	7	villard	villard	PROPN
ajlm-2846	150	8	o	o	PROPN
ajlm-2846	150	9	,	,	PUNCT
ajlm-2846	150	10	cimon	cimon	PROPN
ajlm-2846	150	11	b	b	PROPN
ajlm-2846	150	12	,	,	PUNCT
ajlm-2846	150	13	l’ollivier	l’ollivier	PROPN
ajlm-2846	150	14	c	c	PROPN
ajlm-2846	150	15	,	,	PUNCT
ajlm-2846	150	16	et	et	PROPN
ajlm-2846	150	17	al	al	PROPN
ajlm-2846	150	18	.	.	PROPN
ajlm-2846	150	19	serological	serological	ADJ
ajlm-2846	150	20	diagnosis	diagnosis	NOUN
ajlm-2846	150	21	of	of	ADP
ajlm-2846	150	22	toxoplasma	toxoplasma	NOUN
ajlm-2846	150	23	gondii	gondii	NOUN
ajlm-2846	150	24	infection	infection	NOUN
ajlm-2846	150	25	:	:	PUNCT
ajlm-2846	150	26	recommendations	recommendation	NOUN
ajlm-2846	150	27	from	from	ADP
ajlm-2846	150	28	the	the	DET
ajlm-2846	150	29	french	french	ADJ
ajlm-2846	150	30	national	national	ADJ
ajlm-2846	150	31	reference	reference	NOUN
ajlm-2846	150	32	center	center	NOUN
ajlm-2846	150	33	for	for	ADP
ajlm-2846	150	34	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	150	35	.	.	PUNCT
ajlm-2846	151	1	diag	diag	PROPN
ajlm-2846	151	2	microbiol	microbiol	PROPN
ajlm-2846	151	3	infect	infect	VERB
ajlm-2846	151	4	dis	dis	PROPN
ajlm-2846	151	5	.	.	PUNCT
ajlm-2846	152	1	2016;84(1):22–33	2016;84(1):22–33	NUM
ajlm-2846	152	2	.	.	PUNCT
ajlm-2846	152	3	https://doi.org/10.1016/j.diagmicrobio.2015.09.009	https://doi.org/10.1016/j.diagmicrobio.2015.09.009	PROPN
ajlm-2846	152	4	koffi	koffi	PROPN
ajlm-2846	152	5	m	m	PROPN
ajlm-2846	152	6	,	,	PUNCT
ajlm-2846	152	7	konaté	konaté	PROPN
ajlm-2846	152	8	i	i	PROPN
ajlm-2846	152	9	,	,	PUNCT
ajlm-2846	152	10	sokouri	sokouri	PROPN
ajlm-2846	152	11	dp	dp	PROPN
ajlm-2846	152	12	,	,	PUNCT
ajlm-2846	152	13	konan	konan	PROPN
ajlm-2846	152	14	t	t	PROPN
ajlm-2846	152	15	,	,	PUNCT
ajlm-2846	152	16	ahouty	ahouty	PROPN
ajlm-2846	152	17	b	b	PROPN
ajlm-2846	152	18	,	,	PUNCT
ajlm-2846	152	19	bosso	bosso	PROPN
ajlm-2846	152	20	jc	jc	PROPN
ajlm-2846	152	21	.	.	PROPN
ajlm-2846	152	22	seroepidemiology	seroepidemiology	PROPN
ajlm-2846	152	23	of	of	ADP
ajlm-2846	152	24	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	152	25	in	in	ADP
ajlm-2846	152	26	pregnant	pregnant	ADJ
ajlm-2846	152	27	women	woman	NOUN
ajlm-2846	152	28	attending	attend	VERB
ajlm-2846	152	29	antenatal	antenatal	ADJ
ajlm-2846	152	30	clinics	clinic	NOUN
ajlm-2846	152	31	at	at	ADP
ajlm-2846	152	32	the	the	DET
ajlm-2846	152	33	center	center	NOUN
ajlm-2846	152	34	for	for	ADP
ajlm-2846	152	35	maternal	maternal	ADJ
ajlm-2846	152	36	and	and	CCONJ
ajlm-2846	152	37	child	child	NOUN
ajlm-2846	152	38	health	health	NOUN
ajlm-2846	152	39	care	care	NOUN
ajlm-2846	152	40	in	in	ADP
ajlm-2846	152	41	daloa	daloa	NOUN
ajlm-2846	152	42	in	in	ADP
ajlm-2846	152	43	ivory	ivory	PROPN
ajlm-2846	152	44	coast	coast	PROPN
ajlm-2846	152	45	.	.	PUNCT
ajlm-2846	153	1	int	int	PROPN
ajlm-2846	153	2	j	j	PROPN
ajlm-2846	153	3	trop	trop	X
ajlm-2846	153	4	dis	dis	PROPN
ajlm-2846	153	5	health	health	NOUN
ajlm-2846	153	6	.	.	PUNCT
ajlm-2846	154	1	2015;6(4):125–132	2015;6(4):125–132	NUM
ajlm-2846	154	2	.	.	NOUN
ajlm-2846	154	3	https://doi.org/10.9734/ijtdh/2015/15117	https://doi.org/10.9734/ijtdh/2015/15117	PROPN
ajlm-2846	154	4	kamus	kamus	PROPN
ajlm-2846	154	5	l	l	PROPN
ajlm-2846	154	6	,	,	PUNCT
ajlm-2846	154	7	belec	belec	NOUN
ajlm-2846	154	8	s	s	PROPN
ajlm-2846	154	9	,	,	PUNCT
ajlm-2846	154	10	lambrecht	lambrecht	NOUN
ajlm-2846	154	11	l	l	NOUN
ajlm-2846	154	12	,	,	PUNCT
ajlm-2846	154	13	et	et	PROPN
ajlm-2846	154	14	al	al	PROPN
ajlm-2846	154	15	.	.	PROPN
ajlm-2846	155	1	maternal	maternal	ADJ
ajlm-2846	155	2	and	and	CCONJ
ajlm-2846	155	3	congenital	congenital	ADJ
ajlm-2846	155	4	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	155	5	in	in	ADP
ajlm-2846	155	6	mayotte	mayotte	PROPN
ajlm-2846	155	7	:	:	PUNCT
ajlm-2846	155	8	prevalence	prevalence	NOUN
ajlm-2846	155	9	,	,	PUNCT
ajlm-2846	155	10	incidence	incidence	NOUN
ajlm-2846	155	11	and	and	CCONJ
ajlm-2846	155	12	management	management	NOUN
ajlm-2846	155	13	.	.	PUNCT
ajlm-2846	156	1	plos	plos	PROPN
ajlm-2846	156	2	negl	negl	PROPN
ajlm-2846	156	3	trop	trop	X
ajlm-2846	156	4	dis	dis	PROPN
ajlm-2846	156	5	.	.	PUNCT
ajlm-2846	157	1	2023;17(3):e0011198	2023;17(3):e0011198	NUM
ajlm-2846	157	2	.	.	PUNCT
ajlm-2846	158	1	https://doi.org/10.1371/journal.pntd.0011198	https://doi.org/10.1371/journal.pntd.0011198	PROPN
ajlm-2846	158	2	ahmed	ahmed	PROPN
ajlm-2846	158	3	m	m	PROPN
ajlm-2846	158	4	,	,	PUNCT
ajlm-2846	158	5	sood	sood	PROPN
ajlm-2846	158	6	a	a	PRON
ajlm-2846	158	7	,	,	PUNCT
ajlm-2846	158	8	gupta	gupta	PROPN
ajlm-2846	158	9	j.	j.	PROPN
ajlm-2846	158	10	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	158	11	in	in	ADP
ajlm-2846	158	12	pregnancy	pregnancy	NOUN
ajlm-2846	158	13	.	.	PUNCT
ajlm-2846	159	1	eur	eur	PROPN
ajlm-2846	159	2	j	j	PROPN
ajlm-2846	159	3	obstet	obstet	PROPN
ajlm-2846	159	4	gynecol	gynecol	PROPN
ajlm-2846	159	5	reprod	reprod	PROPN
ajlm-2846	159	6	biol	biol	PROPN
ajlm-2846	159	7	.	.	PUNCT
ajlm-2846	160	1	2020;255:44–50	2020;255:44–50	NUM
ajlm-2846	160	2	.	.	PUNCT
ajlm-2846	161	1	https://doi.org/10.1016/j.ejogrb.2020.10.003	https://doi.org/10.1016/j.ejogrb.2020.10.003	NUM
ajlm-2846	161	2	tonouhewa	tonouhewa	PROPN
ajlm-2846	161	3	ab	ab	PROPN
ajlm-2846	161	4	,	,	PUNCT
ajlm-2846	161	5	amagbégnon	amagbégnon	NOUN
ajlm-2846	161	6	r	r	NOUN
ajlm-2846	161	7	,	,	PUNCT
ajlm-2846	161	8	atchadé	atchadé	VERB
ajlm-2846	161	9	sp	sp	PROPN
ajlm-2846	161	10	,	,	PUNCT
ajlm-2846	161	11	et	et	PROPN
ajlm-2846	161	12	al	al	PROPN
ajlm-2846	161	13	.	.	PUNCT
ajlm-2846	162	1	séroprévalence	séroprévalence	PROPN
ajlm-2846	162	2	de	de	PROPN
ajlm-2846	162	3	la	la	PROPN
ajlm-2846	162	4	toxoplasmose	toxoplasmose	ADJ
ajlm-2846	162	5	chez	chez	PROPN
ajlm-2846	162	6	les	les	PROPN
ajlm-2846	162	7	femmes	femme	NOUN
ajlm-2846	162	8	enceintes	enceinte	NOUN
ajlm-2846	162	9	au	au	ADV
ajlm-2846	162	10	bénin	bénin	PROPN
ajlm-2846	162	11	:	:	PUNCT
ajlm-2846	162	12	méta	méta	NOUN
ajlm-2846	162	13	-	-	PUNCT
ajlm-2846	162	14	analyse	analyse	NOUN
ajlm-2846	162	15	et	et	NOUN
ajlm-2846	162	16	métarégression	métarégression	NOUN
ajlm-2846	163	1	[	[	X
ajlm-2846	163	2	seroprevalence	seroprevalence	NOUN
ajlm-2846	163	3	of	of	ADP
ajlm-2846	163	4	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	163	5	among	among	ADP
ajlm-2846	163	6	pregnant	pregnant	ADJ
ajlm-2846	163	7	women	woman	NOUN
ajlm-2846	163	8	in	in	ADP
ajlm-2846	163	9	benin	benin	PROPN
ajlm-2846	163	10	:	:	PUNCT
ajlm-2846	163	11	meta	meta	ADJ
ajlm-2846	163	12	-	-	PUNCT
ajlm-2846	163	13	analysis	analysis	NOUN
ajlm-2846	163	14	and	and	CCONJ
ajlm-2846	163	15	meta	meta	NOUN
ajlm-2846	163	16	-	-	PUNCT
ajlm-2846	163	17	regression	regression	NOUN
ajlm-2846	163	18	]	]	PUNCT
ajlm-2846	163	19	.	.	PUNCT
ajlm-2846	164	1	bull	bull	NOUN
ajlm-2846	164	2	soc	soc	NOUN
ajlm-2846	164	3	pathol	pathol	NOUN
ajlm-2846	164	4	exot	exot	NOUN
ajlm-2846	164	5	.	.	PUNCT
ajlm-2846	165	1	2019;112(2):79–89	2019;112(2):79–89	X
ajlm-2846	165	2	.	.	PUNCT
ajlm-2846	165	3	https://doi.org/10.3166/bspe-2019-0078	https://doi.org/10.3166/bspe-2019-0078	PROPN
ajlm-2846	165	4	montoya	montoya	PROPN
ajlm-2846	165	5	jg	jg	PROPN
ajlm-2846	165	6	,	,	PUNCT
ajlm-2846	165	7	liesenfeld	liesenfeld	VERB
ajlm-2846	165	8	o.	o.	PROPN
ajlm-2846	165	9	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	165	10	.	.	PUNCT
ajlm-2846	166	1	lancet	lancet	PROPN
ajlm-2846	166	2	.	.	PUNCT
ajlm-2846	167	1	2004;363(9425):1965–1976	2004;363(9425):1965–1976	NOUN
ajlm-2846	167	2	.	.	PUNCT
ajlm-2846	168	1	https://doi.org/10.1016/s0140-6736(04)16412-x	https://doi.org/10.1016/s0140-6736(04)16412-x	PROPN
ajlm-2846	168	2	robinson	robinson	PROPN
ajlm-2846	168	3	e	e	PROPN
ajlm-2846	168	4	,	,	PUNCT
ajlm-2846	168	5	de	de	PROPN
ajlm-2846	168	6	valk	valk	PROPN
ajlm-2846	168	7	h	h	PROPN
ajlm-2846	168	8	,	,	PUNCT
ajlm-2846	168	9	villena	villena	PROPN
ajlm-2846	168	10	i	i	PROPN
ajlm-2846	168	11	,	,	PUNCT
ajlm-2846	168	12	le	le	PROPN
ajlm-2846	168	13	strat	strat	PROPN
ajlm-2846	168	14	y	y	PROPN
ajlm-2846	168	15	,	,	PUNCT
ajlm-2846	168	16	tourdjman	tourdjman	NOUN
ajlm-2846	168	17	m.	m.	PROPN
ajlm-2846	168	18	national	national	PROPN
ajlm-2846	168	19	perinatal	perinatal	ADJ
ajlm-2846	168	20	survey	survey	NOUN
ajlm-2846	168	21	demonstrates	demonstrate	VERB
ajlm-2846	168	22	a	a	DET
ajlm-2846	168	23	decreasing	decrease	VERB
ajlm-2846	168	24	seroprevalence	seroprevalence	NOUN
ajlm-2846	168	25	of	of	ADP
ajlm-2846	168	26	toxoplasma	toxoplasma	NOUN
ajlm-2846	168	27	gondii	gondii	NOUN
ajlm-2846	168	28	infection	infection	NOUN
ajlm-2846	168	29	among	among	ADP
ajlm-2846	168	30	pregnant	pregnant	ADJ
ajlm-2846	168	31	women	woman	NOUN
ajlm-2846	168	32	in	in	ADP
ajlm-2846	168	33	france	france	PROPN
ajlm-2846	168	34	,	,	PUNCT
ajlm-2846	168	35	1995	1995	NUM
ajlm-2846	168	36	to	to	ADP
ajlm-2846	168	37	2016	2016	NUM
ajlm-2846	168	38	:	:	PUNCT
ajlm-2846	168	39	impact	impact	NOUN
ajlm-2846	168	40	for	for	ADP
ajlm-2846	168	41	screening	screen	VERB
ajlm-2846	168	42	policy	policy	NOUN
ajlm-2846	168	43	.	.	PUNCT
ajlm-2846	169	1	eurosurveillance	eurosurveillance	NOUN
ajlm-2846	169	2	.	.	PUNCT
ajlm-2846	170	1	2021;26(5):1900710	2021;26(5):1900710	X
ajlm-2846	170	2	.	.	PUNCT
ajlm-2846	171	1	https://doi.org/10.2807/1560-7917.es.2021.26.5.1900710	https://doi.org/10.2807/1560-7917.es.2021.26.5.1900710	PROPN
ajlm-2846	171	2	ait	ait	VERB
ajlm-2846	171	3	hamou	hamou	NOUN
ajlm-2846	171	4	s	s	PART
ajlm-2846	171	5	,	,	PUNCT
ajlm-2846	171	6	laboudi	laboudi	ADJ
ajlm-2846	171	7	m.	m.	NOUN
ajlm-2846	171	8	an	an	DET
ajlm-2846	171	9	analytical	analytical	ADJ
ajlm-2846	171	10	study	study	NOUN
ajlm-2846	171	11	on	on	ADP
ajlm-2846	171	12	the	the	DET
ajlm-2846	171	13	awareness	awareness	NOUN
ajlm-2846	171	14	and	and	CCONJ
ajlm-2846	171	15	practice	practice	NOUN
ajlm-2846	171	16	relating	relate	VERB
ajlm-2846	171	17	toxoplasmosis	toxoplasmosis	NOUN
ajlm-2846	171	18	among	among	ADP
ajlm-2846	171	19	pregnant	pregnant	ADJ
ajlm-2846	171	20	women	woman	NOUN
ajlm-2846	171	21	in	in	ADP
ajlm-2846	171	22	casablanca	casablanca	PROPN
ajlm-2846	171	23	,	,	PUNCT
ajlm-2846	171	24	morocco	morocco	PROPN
ajlm-2846	171	25	.	.	PUNCT
ajlm-2846	172	1	bmc	bmc	PROPN
ajlm-2846	172	2	pub	pub	NOUN
ajlm-2846	172	3	.	.	PUNCT
ajlm-2846	173	1	health	health	NOUN
ajlm-2846	173	2	.	.	PUNCT
ajlm-2846	174	1	2021;21:1–9	2021;21:1–9	NUM
ajlm-2846	174	2	.	.	PUNCT
ajlm-2846	175	1	https://doi.org/10.1186/s12889-021-10474-9	https://doi.org/10.1186/s12889-021-10474-9	PROPN
ajlm-2846	175	2	vaz	vaz	PROPN
ajlm-2846	175	3	rs	rs	NOUN
ajlm-2846	175	4	,	,	PUNCT
ajlm-2846	175	5	rauli	rauli	PROPN
ajlm-2846	175	6	p	p	X
ajlm-2846	175	7	,	,	PUNCT
ajlm-2846	175	8	mello	mello	PROPN
ajlm-2846	175	9	rg	rg	PROPN
ajlm-2846	175	10	,	,	PUNCT
ajlm-2846	175	11	cardoso	cardoso	PROPN
ajlm-2846	175	12	ma	ma	PROPN
ajlm-2846	175	13	.	.	PROPN
ajlm-2846	175	14	congenital	congenital	ADJ
ajlm-2846	175	15	toxoplasmosis	toxoplasmosis	PROPN
ajlm-2846	175	16	:	:	PUNCT
ajlm-2846	175	17	a	a	DET
ajlm-2846	175	18	neglected	neglect	VERB
ajlm-2846	175	19	disease	disease	NOUN
ajlm-2846	175	20	?	?	PUNCT
ajlm-2846	176	1	current	current	ADJ
ajlm-2846	176	2	brazilian	brazilian	ADJ
ajlm-2846	176	3	public	public	ADJ
ajlm-2846	176	4	health	health	NOUN
ajlm-2846	176	5	policy	policy	NOUN
ajlm-2846	176	6	.	.	PUNCT
ajlm-2846	177	1	field	field	PROPN
ajlm-2846	177	2	act	act	PROPN
ajlm-2846	177	3	sci	sci	PROPN
ajlm-2846	177	4	rep	rep	PROPN
ajlm-2846	177	5	.	.	PROPN
ajlm-2846	177	6	2011;3:1–9	2011;3:1–9	NUM
ajlm-2846	177	7	.	.	PUNCT